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ABSTRACT OF DISSERTATION 
 
LOSS OF BLOOM SYNDROME PROTEIN CAUSES DESTABILIZATION OF 
GENOMIC ARCHITECTURE AND IS COMPLEMENTED BY ECTOPIC 
EXPRESSION OF Escherichia coli RecG IN HUMAN CELLS  
     Genomic instability driven by non-allelic homologous recombination (NAHR) 
provides a realistic mechanism that could account for the numerous chromosomal 
abnormalities that are hallmarks of cancer.  We recently demonstrated that this type of 
instability could be assayed by analyzing the copy number variation of the human 
ribosomal RNA gene clusters (rDNA).  Further, we found that gene cluster instability 
(GCI) was present in greater than 50% of the human cancer samples that were tested.  
Here, data is presented that confirms this phenomenon in the human GAGE gene cluster 
of those cancer patients.  This adds credence to the hypothesis that NAHR could be a 
driving force for carcinogenesis.  This data is followed by experimental results that 
demonstrate the same gene cluster instability in cultured cells that are deficient for the 
human BLM protein.  Bloom’s Syndrome (BS) results from a genetic mutation that 
results in the abolition of BLM protein, one of human RecQ helicase.  Studies of Bloom’s 
Syndrome have reported a 10-fold increase in sister chromatid exchanges during mitosis 
which has primarily been attributed to dysregulated homologous recombination.  BS also 
has a strong predisposition to a broad spectrum of malignancies.  Biochemical studies 
have determined that the BLM protein works in conjunction with TOPOIIIα and 
RMI1/RMI2 to function as a Holliday Junction dissolvase that suppress inadvertent 
crossover formation in mitotic cells.  Because of the similarities in their biochemical 
activities it was suggested that another DNA helicase found in E. coli, the RecG DNA 
translocase, is the functional analog of BLM.  RecG shares no sequence homology with 
BLM but it can complement both the sister chromatid exchange elevation and the gene-
cluster instability phenotype caused by BLM deficiency.  This indicates that the 
physiological function of BLM that is responsible for these phenotypes rests somewhere 
in the shared biochemical activities of these two proteins.  These data taken together give 
new insights into the physiological mechanism of BLM protein and the use of Bloom’s 
Syndrome as a model for carcinogenesis.  
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CHAPTER 1: BACKGROUND AND INTRODUCTION 
1.1  GENOMIC INSTABILITY AND CARCINOGENESIS.  
    1.1.1 CARCINOGENESIS 
 
     Cancer arises from aberrant gene expression typically thought to develop in a lengthy 
multi-step process that leads to the accumulation of gene mutations at different loci 
resulting in a gain or loss of function and leads to uncontrolled cellular growth (Sherr 
2004) (Jefford and Irminger-Finger 2006).  Although, the accumulation of single 
mutations is sufficient for carcinogenesis, the single most common trait of all cancer cells 
is an altered karyotype and gross genomic rearrangements (Murga and Fernandez-
Capetillo 2007; Calasanz and Cigudosa 2008).  Over the past few years cytogenetic 
analysis of cultured tumor cells has revealed that most solid tumors have aneuploid 
karyotypes, aberrant nuclei with altered chromosome numbers and structure (Lengauer, 
Kinzler et al. 1998; Sieber, Heinimann et al. 2003).  Although it has been debated 
whether genomic instability is a cause or consequence of tumorgenesis, recently the role 
of chromosome instability was demonstrated in tumor progression (Nowak, Komarova et 
al. 2002; Barbouti, Stankiewicz et al. 2004; Bruder, Piotrowski et al. 2008).  Furthermore, 
recent publications have suggested SOS like models in which gross genomic instability 
would play a key role in the mutator phenotype of cells in tumorgenesis (Komarova, 
Sadovsky et al. 2008).  Considering the rarity of mutations in normal cells and the large 
numbers of mutations observed in human cancers, it has been proposed that the 
spontaneous mutation rate in normal cells is not sufficient to account for the number of 
mutations found in human cancers (Loeb, Springgate et al. 1974).  It has also been 
suggested that the multiple mutations found in tumor cells would result from mutations in 
genes that guarantee the fidelity of DNA synthesis and repair (Loeb, Loeb et al. 2003).  
Mutations in genes that function in the maintenance of genomic stability would manifest 
by increases in mutation rates and could drive tumor progression.  The fact that the 
majority of chromosomal abnormalities are not tumor specific supports this underlying 
mechanism of instability in carcinogenesis (Loeb 2001).  Thus it is important to explore 
genes that provide for maintenance of genomic stability as a source of gross genomic 
changes and determine if they could be a driving force of carcinogenesis.  
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     1.1.2 SOURCES OF GENOMIC INSTABILITY 
  
     The fact that the sequence and configuration of DNA in cancer cells is typically very 
different from that of  normal cells provides some indication that carcinogenesis involves 
substantial errors in DNA replication, deficits in DNA repair, and/or alterations in 
chromosomal segregation (Loeb 2001; Komarova, Sadovsky et al. 2008).  The molecular 
components that maintain genomic stability can be broadly classified into two groups: 
pathways that maintain the fidelity of DNA replication via repair and the pathways that 
control cell division.  The DNA repair pathways are responsible for keeping genes and 
genomes intact as well as maintaining chromatin epigenetic modifications, whereas the 
pathways that control cell division help maintain mitotic stability and chromosome 
integrity via modulation of sister chromatid cohesion and chromosome migration (Jefford 
and Irminger-Finger 2006).  Genomic instability can be broadly classified into two types: 
microsatellite instability (MIN) associated with a mutator phenotype resulting in 
destabilization of DNA sequence and chromosome instability (CIN) which involves 
continuous gross alterations in chromosome number and structure. Both types of 
instability can lead to egregious consequences and there are many examples of both with 
very distinct correlations with carcinogenesis discussed below.  
 
     It is believed that changes in nucleotide sequence are in some cases sufficient for 
carcinogenesis.  It is well documented that single nucleotide mutations of genes such as 
K-Ras, p53, and BRCA1/2 directly correlate with substantial increase of cancer risk 
(Almoguera, Shibata et al. 1988; Rahman and Stratton 1998; Hainaut and Hollstein 
2000).  MIN which results in the destabilization of nucleotide sequences is the cause of 
hereditary non-polyposis colorectal cancer (HNPCC).  Although this can be caused by a 
mutation of a single gene, like hMSH2, the loss of this single gene causes the 
malfunction of the mismatch repair system responsible for repairing mistakes made by 
the polymerase during DNA synthesis (Aaltonen, Peltomaki et al. 1993; Li 2008).  The 
malfunction of the MMR system as a whole leads to genomic instability and increase 
mutation rates.   
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     Despite its direct link to cancer, MIN has not been linked to some of the most 
common traits found in tumors such as changes in chromosome number, translocations, 
amplifications, and deletions.  These characteristics fall under the realm of CIN (Jefford 
and Irminger-Finger 2006).  As discussed previously, abnormal ploidy is the most notable 
characteristic of all cancer types.  Common examples of translocations causing cancer are 
found in Burkett’s lymphoma and the Philadelphia chromosome in chronic myeloid 
leukemia (CML).  In Burkett’s lymphoma the myc oncogene is translocated to the locus 
where an immunoglobulin (Ig) enhancer resides.  This leads to a drastic increase of Myc 
expression in lymphocytes (Dean, Kent et al. 1983).  In a similar fashion the Philadelphia 
chromosome is due to the translocation of the Bcr gene to a locus where it is fused with 
the Abl kinase.  The resulting hybrid gene produces a protein that is a constitutively 
active tyrosine kinase receptor and leads to uncontrolled cell proliferation (Jeffs, Benjes 
et al. 1998). Amplifications can increase the copy number of proto-oncogenes whereas 
deletions can eliminate genetic material that activates proto-oncogenes or lead to a loss of 
tumor suppressor genes.  However, a common mechanism for how these abnormalities 
arise has not been established.  One mechanism that has been proposed is dysfunctional 
repair on DNA by Homologous Recombination (HR) (Bishop and Schiestl 2003; Reliene, 
Bishop et al. 2007).  While HR is integral to maintaining genomic stability, it can result 
in gross genomic restructuring that changes millions of base pairs at a time.  The 
mechanism that can cause this gross chromosome instability is the subject of this 
dissertation. 
 
1.2 DNA REPAIR 
     1.2.1 FAITHFUL MAINTENANCE OF THE GENOME   
 
     The maintenance of species requires that information contained in DNA be accurately 
copied and transmitted.  The fidelity with which normal human cells accurately replicate 
DNA every time they divide is exceptional, the overall mutation rate in somatic human 
cells can be measured and has been estimated to be 2.0 × 10−7 mutations/gene/cell 
division (DeMars and Held 1972). With this in mind it can be estimated that every cell 
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will accumulate at least one mutant gene during the lifespan of an individual (Loeb, 
Springgate et al. 1974).  Therefore a mechanism through which these errors might be 
corrected is critical for the propagation of all organisms.  Aside from mutations acquired 
during replication the cell can encounter a plethora of endogenous and exogenous agents 
that require repair to maintain the integrity of the genome.  Because each of these agents 
can cause very different lesions the cell has evolved a variety of mechanisms to repair 
DNA damage.  These include nucleotide excision repair (NER), base excision repair 
(BER), translesion synthesis, mismatch repair (MMR), homologous recombination (HR), 
non-homologous end joining (NHEJ) and others.  There are diseases associated with 
deficiencies in all of these pathways; however, as mentioned before the subject of this 
dissertation is homologous recombination and how the malfunction of this repair pathway 
might lead to gross alterations in genomic architecture and content.   
 
     1.2.2 DOUBLE STRAND BREAK REPAIR (DSBR) 
 
     One of the most severe lesions that can be introduced into the genome is a DNA 
double strand break (DSB).  This damage can be induced by various agents: endogenous 
factors such as free radicals formed as byproducts of metabolic functions, or stalled 
replication forks, or exogenous factors such as ionizing radiation or mutagenic chemicals.  
DSBs are often represented as clean cuts made in both strands of the DNA by restriction 
enzymes.  However, they are more likely much more complex on a molecular level.  In 
this discussion a DSB represents any gap or break found in both strands of the DNA 
leaving the chromosome discontinuous.     
 
     The importance of the DSB repair pathway for preserving genomic integrity is 
underscored by its conservation throughout evolution (Sonoda, Hochegger et al. 2006).  It 
has been shown that one unrepaired DSB can potentially be lethal to a cell (Frankenberg-
Schwager and Frankenberg 1990).  Genomic instability arising from the illegitimate 
repair of DNA DSBs is subject of intense investigation.  The human cell utilizes five 
known pathways to repair DSBs.  There is the homology independent pathway, non-
homologous end joining (NHEJ).  It is worth noting that there is some evidence that 
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microhomologies in the sequence flanking the DSB may play a role in this mechanism 
(Yu, Marshall et al. 2004).  Then there is homology-directed repair (HDR) which 
includes single strand annealing (SSA) and homologous recombination (HR).  HR can be 
further broken down into gene conversion (GC), which is HR without associated cross-
over, and non-allelic homologous recombination (NAHR), which includes associated 
crossover.  Another possible result is break-induced replication (BIR) which results in 
non-reciprocal crossover and occurs when synthesis continues on the donor strand until 
the end of the chromosome or a centromere is reached.  Although BIR has recently been 
reported to play a role in meiotic variation in humans it is not known if it plays a role in 
somatic cells (Smith, Llorente et al. 2007; Zhang, Khajavi et al. 2009; Koumbaris, 
Hatzisevastou-Loukidou et al. 2011).  Most of these pathways cooperate to ensure cell 
survival. If one pathway fails the other can be activated (Couedel, Mills et al. 2004) 
(Mills, Ferguson et al. 2004).  All of the pathways have genetic consequences.  NHEJ can 
lead to loss of the sequence surrounding the break, although this tends to localize damage 
and has far fewer consequences than an unrepaired DSB.  NHEJ is most common form of 
repair utilized in human cells (Richardson and Jasin 2000).  But GC can be the most 
faithful mechanism of repair and is often referred to as error free since it fills in the 
missing sequence by copying it from homologous sequence elsewhere in the genome.  
While this opens the door for loss of heterozygosity (LOH) it seems trivial in light of the 
consequences of NAHR.  NAHR is not thought to occur at a high frequency and 
homologous recombination in vertebrate DNA repair is typically error-free without 
crossover (Johnson and Jasin 2000; Richardson and Jasin 2000). 
 
1.2.3 REPAIR AT REPLICATION FORKS 
 
     For many years the primary role of homologous recombination had been assumed to 
be creating genetic diversity during meiosis.  In recent years there has been a shift to 
include the indispensable role that HR plays in the stabilization and recovery of collapsed 
and arrested replication forks (Bernstein, Byerly et al. 1985; Michel, Grompone et al. 
2004).  As discussed above endogenous and exogenous agents can also lead to 
dysfunction of the replication machinery.  The lesions caused by these agents can lead to 
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single strand breaks in DNA.  When the replication fork encounters these breaks it can 
lead to a DSB and a “collapsed” fork (Kuzminov 2001).  Additionally, these lesions can 
stall replication on the leading or lagging strand and lead to uncoupling of the DNA 
replication machinery eventually blocking the progress of the replication fork without 
generating a DSB.  This is typically referred to as a stalled replication fork (Cox 1999).  
The consequences of stalling are that the template strands can start to reanneal and 
migrate backward; the newly synthesized strands are displaced and also anneal creating a 
Holliday junction.  This type of junction is sometimes referred to as a “chicken foot 
structure” because of its topological appearance.  In addition to lesions causing the 
replication fork to stall and generate Holliday junctions, it has been observed that the 
superhelical tension created by normal replication can itself stall replication and cause the 
replication fork to regress to the chicken foot structure (Postow, Ullsperger et al. 2001; 
Olavarrieta, Martinez-Robles et al. 2002).  These topological structures are resolved 
through the HR repair pathway and the formation of these intermediates as well as the 
potential for generation of DSB provides an important role for recombination in the 
stabilize replication forks (Bernstein, Byerly et al. 1985; Kuzminov 1999).  It also 
provides the potential for illegitimate resolution of these intermediate substrates that can 
result in mega-base scale genomic restructuring.      
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Figure 1.1. Replication fork repair. A lesion blocks leading strand synthesis leading 
to fork collapse. Lagging strand synthesis continues for a short period. The fork 
regresses, allowing the nascent strands to anneal, creating a ‘chicken foot’ structure 
(Holliday junction). The leading strand is then extended using the longer lagging 
strand as a template. The fork is reset by branch migration of the four-way 
junction, and now the leading strand has been extended beyond the lesion.   
Adapted from  (Bachrati and Hickson 2003) used with permission.   
   
1.3 HOMOLOGY DIRECTED REPAIR (HDR) 
   1.3.1 HOMOLOGOUS RECOMBINATION 
 
     The genome is remarkably stable, however, without plasticity or a means to introduce 
variation into the genome, evolution and natural selection would not happen (Jefford and 
Irminger-Finger 2006).  The majority of this variation arises during meiosis as a product 
of recombination.  It is this mechanism that gives organisms their most efficient means 
for enriching advantageous mutations.  However it is also this mechanism that could 
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produce the genetic instability from which cancer arises, a consequence that allows for 
the selection of viable mutations that favor proliferation (Cahill, Kinzler et al. 1999).  
Homologous recombination provides a means of copying genetic sequence from a 
homologous template located elsewhere in the genome and allows a high degree of 
fidelity to be maintained in repairing DNA damage.  Unfortunately, since the template 
and the repaired locus are intertwined during HR they must be enzymatically separated.  
It is this process that is thought to distinguish GC and NAHR and determine if the repair 
is faithful or if it results in the alteration of the genomic architecture.  The abundance of 
repetitive sequence found in the genome also makes dysregulated homologous 
recombination potentially hazardous.  An inappropriate template might allow for 
homologous recombination (HR) to rearrange thousands, even millions of base pairs 
leading to deletions, amplifications, and translocations.  This can alter massive amounts 
of genetic material in a single event.  It is this illegitimate means of homologous repair 
that is believed to have the most potential for driving carcinogenesis. Although the 
majority of DSB repairs proceed through NHEJ and GC,  NAHR does rarely occur and 
several lines of evidence suggest that there is a direct link between NAHR and 
carcinogenesis (Johnson and Jasin 2000; Richardson and Jasin 2000; Bishop and Schiestl 
2003).  Yet even an isolated event could have calamitous consequences (Bishop and 
Schiestl 2003).  This possibility of genome instability caused by a single event provides a 
leadway into the hypothesis that NAHR could change a multitude of gene expression 
patterns and be one of the most efficient mechanisms through which carcinogenesis 
might proceed. 
 
   1.3.2 GENE CONVERSION (GC) vs. NON-ALLELIC HOMOLOGOUS     
   RECOMBINATION (NAHR)   
 
     During HR new DNA is synthesized at both ends of the DSB by copying both strands 
of the homologous template extending past the site of the broken DNA.  This 
intertwining of the DNA creates two separate Holliday junctions (HJ) or a double 
Holliday junction (dHJ).   The double Holliday junction presents a very interesting 
topological problem for the cell.  Distinct molecular mechanisms exist to solve this 
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problem.  The cell can “resolve” the double Holliday junction by enzymatic cleavage that 
makes two cuts in the junction and results in an exchange of genetic material between the 
two loci resulting in crossover exchange.  Alternatively, the cell can “dissolve” the 
junction such that the resulting structure does not allow for crossover (Wu and Hickson 
2003).  It is this junction that determines if the HR proceeds with GC or NAHR.  If the 
dHJ is dissolved the donor sequence is left unchanged, it is simply used as a template to 
repair the discontinuous strand.  This is termed gene conversion (GC).  In order for gene 
conversion to prevail it is necessary for the cell to resolve the topological problem in a 
fashion that distinguishes the donor strand from the recipient and prevents the illegitimate 
recombination typically attributed to a cross-over reaction.  Although, this process is not 
well characterized in mammals, the biochemistry suggests that the gene products 
involved in “dissolving” double Holliday junctions are BLM, TOPOIIIα and RMI1/RMI2 
(Wu and Hickson 2003; Ralf, Hickson et al. 2006; Mankouri and Hickson 2007).  The 
biochemistry of this reaction is discussed extensively in section 1.4. 
 
     Another potential outcome of HR is non-allelic homologous recombination (NAHR).  
NAHR is distinguished from GC because it is resolved through a cross-over reaction 
between the two homologous sequences and it changes the chromosomal context of both 
sequences, where the sequences are not alleles on homologous chromosomes or sister 
chromatids.  Here there is a physical exchange between the donor sequence and the 
repaired recipient and possibly the flanking sequence.  NAHR can lead to the deletion, 
amplification, or the translocation of millions of base pairs.  These large scale genomic 
alterations in meiosis provide many examples of genomic disorders that cause human 
disease. However, its prevalence to mitosis is unknown and its potential contribution to 
carcinogenesis is unestablished, but structural rearrangements of chromosomes due to 
repair with crossing-over have been observed (Ira, Malkova et al. 2003; Stults, Killen et 
al. 2008).  Unlike GC, the reaction resulting in NAHR does not distinguish the donor 
strand from the recipient in order to prevent illegitimate recombination.  Here the 
enzymatic resolution of the double Holliday junction is thought to proceed through GEN1 
or the Slx1-Slx4 complex (Ip, Rass et al. 2008; Svendsen, Smogorzewska et al. 2009; 
Svendsen and Harper 2010). These nucleases are thought to symmetrically cleave HJs in 
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a manner that allows for separation of the strands without additional processing, thus 
acting as a Holliday junction “resolvase”. As such, the complex cleaves the links between 
two homologous chromosomes that form during homologous recombination. This allows 
the two linked chromosomes to resolve into two unconnected double-strand DNA 
molecules (Svendsen, Smogorzewska et al. 2009; Svendsen and Harper 2010).   
 
     It is unknown how and why the cell makes the “decision” between GC and NAHR to 
pursue one repair pathway over the other.  However, the two pathways compete for the 
same repair intermediate and have their own genetic consequences (Fukushima, Takata et 
al. 2001; Pierce, Hu et al. 2001; Allen, Kurimasa et al. 2002).  Homology-dependent 
pathways can be responsible for 30-40% of all repair of DSB (Liang, Han et al. 1998; 
Takata, Sasaki et al. 1998; Johnson and Jasin 2000; Pierce, Hu et al. 2001).  The majority 
of homologous repair in mammals results in gene conversions without cross-over 
(Moynahan and Jasin 1997; Richardson, Moynahan et al. 1998).  The preference for 
homologous sequence used in homologous repair is one thousand times higher for 
sequence located on sister chromatids than the homologous chromosome and ten 
thousand times higher than a heterologous chromosome (Johnson and Jasin 2001).  One 
of the main factors in determining the involvement of HR is the temporal and spatial 
limitation placed on homologous sequences.  For instance, a sister chromatid or 
homologous chromosome is typically only available in late S phase and G2 (Takata, 
Sasaki et al. 1998; Rothkamm, Kruger et al. 2003).  When HR does occur in mitotic cells 
the majority of the time it results in gene conversion without cross-over but  occasionally 
mitotic recombination does occur with associated cross-over and recent studies in our lab 
have indicated that it is the most prevalent chromosomal alterations in adult solid tumors 
(Ira, Malkova et al. 2003; Stults, Killen et al. 2008; Stults, Killen et al. 2009).   
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Figure 1.2. Pathway of double-stranded break repair by homologous recombination.  
Recombination is initiated by nucleolytic processing of the DSB to generate 3' 
single-stranded DNA overhangs that are rapidly coated with RPA. Rad51 
recruitment displaces RPA leading to the formation of a helical nucleoprotein 
filament with which can search for homologous template and catalyze invasion of 
the ssDNA into the donor sequence to form a joint molecule.  Repair proceeds to 
form crossover and non-crossover products. Adapted from  (Aguilera and Boulton 
2007). 
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 1.4 GENE CLUSTER INSTABILITY AND CANCER 
   1.4.1 GENE CLUSTERS 
 
     A gene cluster is a set of two or more genes located in close proximity that encode for 
the same or very similar proteins.  Gene clusters are created through the process of gene 
duplication (Inoue and Lupski 2002).  The genes within the cluster then diverge or 
converge dependent on evolutionary pressure.  For our purpose gene clusters will 
represent a set of duplicated genes that convergently evolved to maintain a high degree of 
similarity from one copy to the next.  HR is thought to drive the process of gene 
duplication (Hastings, Lupski et al. 2009).  HDR can provide a mechanism for gene 
duplication and divergence through NAHR and for convergence by GC.  Human 
populations show extensive polymorphism in the numbers of copies of some genes 
(Consortium 2004; Hastings, Lupski et al. 2009).  This is known as copy number 
variation (CNV).  These repetitive sequences are estimated to account for up to 12% of 
the genome (Redon, Ishikawa et al. 2006).  With such a substantial contribution to the 
content of the genome it seems evident that HR is a driving force behind meiotic 
variation on an evolutionary timescale. Such sequences are hotspots for meiotic 
non‐allelic homologous recombination. When crossing‐over occurs between homologous 
sequence in a non‐homologous context, unequal crossing‐over occurs and can results in 
duplication, deletion, translocation, or inversion of sequence (Shaw and Lupski 2004).   
Several heritable genetic syndromes are known to arise by this mechanism, including 
Charcot‐Marie‐Tooth syndrome, Prader‐Willi syndrome and Angelman syndrome 
(Stankiewicz and Lupski 2002) (Stankiewicz and Lupski 2002).  However, CNVs have 
also been reported in somatic derived mutations in monozygotic twins indicating the 
involvement of NAHR in genomic instability in the lifespan of an individual (Bruder, 
Piotrowski et al. 2008).  It has also been shown that i(17q), a common structural 
abnormality in human neoplasias, likely arises by NAHR (Barbouti, Stankiewicz et al. 
2004).  By providing a mechanism for generating physical alterations in the genomic 
architecture, dysregulated homologous recombination between the many non-allelic 
repetitive sequences in the human genome can also have disastrous consequences for 
genomic stability (Consortium 2004; Lupski and Stankiewicz 2005).  Since NAHR is 
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thought to provide a mechanism for CNV, analysis of theses gene clusters might provide 
insight into the involvement of NAHR in carcinogenesis. 
 
     Our lab has developed an assay that evaluates gene cluster instability as a sentinel 
biomarker of dysregulated homologous recombination.  The assay involves physical 
analysis of gene clusters in which the repeated genes have very high levels of sequence 
identity and are in very high local concentration, both factors in accelerating the rate at 
which they undergo recombination-mediated structural alteration.  NAHR between 
similarly oriented repeats causes expansions and contractions of the number of repeats in 
the cluster.  These length changes can be resolved through pulsed-field gel 
electrophoresis (PFGE) and Southern hybridization (Stults, Killen et al. 2008).  Described 
in chapter 2 the Gene Cluster Instability (GCI) assay was developed for detecting 
spontaneous recombination-mediated genomic restructuring in human cells.  We have 
successfully applied this technique to show that NAHR is commonly associated with 
human adult solid tumors (Stults, Killen et al. 2009).   
 
   1.4.2 THE HUMAN RIBOSOMAL RNA GENE CLUSTER (rDNA) 
 
     Large gene clusters possess attributes conducive to recombinational alteration. The 
repeated genes that make up clusters tend to have very high levels of sequence identity, 
sufficient length to be substrates for recombination, and occur in high local concentration 
with respect to each other.  Each eukaryotic ribosome contains four RNA molecules 
which together do the catalytic work of protein synthesis.  Multiple copies of the 
ribosomal RNA (rRNA) genes are required in order to generate sufficient rRNA 
molecules to accomplish all of the ongoing protein translation in a eukaryotic cell.  They 
are transcribed by Pol I to form a single 45S transcript, which is subsequently spliced into 
the 18S, 28S, and 5.8S rRNAs (Bartova, Galiova et al. 2010).  The gene clusters 
encoding the 45S precursor transcript (collectively the ‘rDNA’) are perhaps the largest 
clustered gene arrangement in the human genome (Henderson, Warburton et al. 1972).  
There are approximately 600 copies of the 43 kb gene repeats dispersed across the 5 
human acrocentric chromosomes accounting for up to 0.5% of the genome (Gonzalez and 
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Sylvester 1995).  The short arms of the acrocentric chromosomes which contain these 
genes are localized to the nucleolar organizing region (NOR) which isolates them so they 
can be transcribed and regulated separately from the rest of the genome (Henderson, 
Warburton et al. 1972).  
 
     Previously we used the GCI assay to characterize the genomic architecture of the 
human ribosomal RNA gene clusters, evaluating their heritability and stability in normal 
healthy individuals (Stults, Killen et al. 2008).  We characterized the physical lengths of 
these rDNA gene clusters in human individuals and found essentially complete cluster 
length heterozygosity, both between clusters on different acrocentric chromosomes and 
also between clusters on individual parental homolog chromosome pairs (Stults, Killen et 
al. 2008).  This cluster length heterogeneity is driven by strong meiotic recombination at 
a rate of over 10% per cluster per meiosis. We found that meiotic rearrangements of the 
clusters occur frequently and found evidence of mitotic NAHR with associated crossover 
suggesting that the gene cluster would be suitable as sentinel biomarkers for dysregulated 
recombination (Stults, Killen et al. 2008).  We then used the human ribosomal RNA gene 
clusters to explore human genomic instability that arises from NAHR in human cancer 
samples (Stults, Killen et al. 2009).  We found that over half of the adult solid tumors had 
detectable rDNA rearrangements relative to surrounding non‐tumor tissue and normal 
peripheral blood.  This indicates that rDNA restructuring is among the most common 
chromosomal alterations in adult solid tumors (Killen, Stults et al. 2009; Stults, Killen et 
al. 2009).  This interrelatedness between this type of genomic instability and cancer is the 
basis for the work explored in the GAGE gene cluster in chapter 3. 
 
   1.4.3 THE HUMAN GAGE GENE CLUSTER  
 
     In chapter 3 I investigate genomic instability in the GAGE gene cluster in human 
cancer. GAGE is a member of the CT family of genes, defined as having expression only 
in cancer and in testis (Scanlan, Simpson et al. 2004).  Like many of the protein products 
of the CT genes, GAGE is potentially immunoreactive.  Since testis is an 
immunoprivileged site, this provides a potential protein based immunotherapeutic 
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strategies for cancer treatment (Machiels, van Baren et al. 2002).  However, here the 
GAGE gene cluster simply serves as a substrate for GCI analysis.  We used the GCI 
assay with blood samples from human families and clinical specimens from human 
cancers to determine the range of human variation of the GAGE cluster, and the stability 
of the cluster under normal human meiosis and in the genomic pathology of human 
cancers. 
 
      This series of experiments were performed to complement previous work that 
demonstrated mitotic instability in the rDNA gene clusters in human cancer (Stults, 
Killen et al. 2008; Stults, Killen et al. 2009).  The rDNA clusters have high local 
concentration, high sequence similarity and multiple copies which make the rDNA 
clusters ideal substrates for HR. (Stults, Killen et al. 2008)  However, as mentioned, the 
rDNA has some other characteristics that might contribute to its behavior that are not 
common to most genes.  The rDNA is largely nucleolar and is transcribed by Pol I unlike 
the majority of genes (Russell and Zomerdijk 2006).  The genomic structure of the 
GAGE gene cluster is similar in nature to the clustered rDNA.  It has a high local 
concentration, high sequence similarity and multiple copies.  However, the unit repeat of 
the gene that produces the GAGE transcript is only 9.6 kb and the tandemly repeated 
cluster is estimated to only have 15 gene copies on the X chromosome (Hofmann, 
Caballero et al. 2008).  The unit repeats are oriented in a head-to-tail manner without any 
intervening sequences making them very similar to the rDNA genomic structure.  
However the GAGE gene cluster has significantly fewer unit repeats and is transcribed 
by Pol II which makes this locus more similar to gene clusters elsewhere in the genome 
(Warburton, Hasson et al. 2008).  Thus the GAGE gene cluster is employed in this 
dissertation to model homologous sequence that more typical of the human genome. 
 
1.5 BLOOM SYNDROME 
     1.5.1 BLOOM SYNDROME PATIENTS AND CANCER 
 
     Diseases that lead to genomic instability are typically marked by progeria and/or a 
high disposition to cancer.  Several of these diseases result from mutations in genes that 
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encode DNA helicases in the RecQ family and include Werner’s (WS), Bloom’s (BS), 
and Rothmund-Thomson (RTS) syndromes.  Bloom’s syndrome is a rare autosomal 
recessive disorder that displays a broad spectrum of cancer tissue types, representing a 
model of generalized cancer.  However, the cancers tend to occur earlier in life and tend 
to be more aggressive (German and Passarge 1989; German 1997).  Bloom syndrome 
displays the strongest known correlations between chromosomal instability and an 
increased risk of malignancy at an early age. Speculation that BLM-deficient cells escape 
apoptotic death by constitutively inducing a SOS-like response dependent on 
recombination has recently been raised (Amor-Gueret 2006). This hypothesis is 
consistent with the hyper-recombinatory phenotypes characteristic of BS cells and further 
illustrates the plausibility of a role for HR as a mechanism in carcinogenesis in the 
general population (Amor-Gueret 2006). 
 
    1.5.2 CLINICAL MANIFESTATION 
 
     Bloom’s syndrome (BS) was first described by dermatologist Dr. David Bloom in 
1954 (Bloom 1954).  Bloom syndrome is an autosomal recessive disorder characterized 
by growth deficiency; sun-sensitivity; telangiectasia; hypo- and hyper-pigmented skin; 
immunodeficiency associated with otitis media and pneumonia; predisposition to 
malignancy; and most importantly chromosomal instability (German, Bloom et al. 1984).  
BS comes from a genetic mutation that results in the total loss in production of the 
Bloom’s Syndrome Helicase (BLM) (Ellis and German 1996). BLM is a member of the 
RecQ family of helicases and is a 1417 amino acid protein that is produced from the 
BLM gene found on chromosome 15 (Ellis, Groden et al. 1995). BS cells display an 
increased frequency of crossing over between homologous chromosomes, chromosome 
breaks, quadraradial formation and high spontaneous mutation rates (Vijayalaxmi, Evans 
et al. 1983; Kyoizumi, Nakamura et al. 1989; Langlois, Bigbee et al. 1989). 
Consequently, BS cells have been classified as hyper-recombinatory and manifest with a 
10-fold elevated frequency of sister chromatid exchange (SCE) (Vijayalaxmi, Evans et al. 
1983).  This can be seen in Figure 1.3 below.  Clinical diagnosis of BS is now assayed by 
the molecular sequence of the BLM gene.  However, until recent years this diagnosis was 
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derived through cytogenetic analysis of sister-chromatid exchanges (SCEs).  This 
analysis was typically preformed on blood lymphocytes in short-term culture.  Because of 
the 10-fold increase in SCEs, BLM cells are typically associated with increased 
homologous recombination.  However, this exchange of genetic material between sister 
chromatids is generally regarded as genetically silent since the sister chromatids are 
genetically identical.  SCE analysis is used as a companion assay with GCI in chapters 4 
and 5.   
 
 
 
Figure 1.3.  Left: Sister chromatid analysis of wild-type cell line GM00637.  Right: 
Sister chromatid analysis of cell line deficient for BLM protein GM08505.  Notice 
the harlequin pattern distinguishing the high number of exchanges between sister 
chromatids in BLM cells.   
  
     The BS registry currently has 265 registered patients of which 150 which are still 
living.  Of the 103 patients who are deceased the mean age of death is 26 years.  The 
mean age of those living is 30 years (range from 1-53 years of age).  The 265 persons 
with BS are from 222 families (siblingships). 167 (75.2%) of the affected families 
are/were non-Jewish. The remaining 55 (24.8%) are Jewish, which argues against the use 
of the term “Jewish genetic disease” which is typically used to describe BS.  Of the 265 
patients, 122 (46%) individuals have been affected by cancer.  The average age of onset 
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for all cancers was 26 years (range from 1-49 years of age) (data adapted from BLM 
registry web site, http://www.med.cornell.edu/bsr/data_from_registry ).  Based on data 
from the US National Cancer Institute's Surveillance Epidemiology and End Results 
(SEER) Database this is a 100-fold increase in cancer risk for Bloom’s Syndrome patient 
compared to normal individuals.  The likelihood of being diagnosed with any type of 
cancer for both sexes and all races between the age of 20 and 30 is 0.45% compared to 
46% at 26 years with BS as mentioned above (data adapted from 
http://seer.cancer.gov/csr/1975_2007/results_merged/topic_lifetime_risk.pdf , and is 
based on incidence and mortality data for the United States from 2005 through 2007).  In 
figure 1.4 below affected individuals are depicted.  The plate on the left shows an 
individual with a sun-sensitive response.   The second plate on the right depicts an 
affected individual and their sibling demonstrating the aforementioned growth deficiency.  
 
 
                                  
 
Figure 1.4.  Left: Individual with butterfly rash resulting from sun-sensitive 
response.  Right: Affected individual and sibling demonstrating proportional 
growth deficiency (images from http://weill.cornell.edu/bsr/).    
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1.6 BLOOM SYNDROME PROTEIN (BLM) 
     1.6.1 BIOCHEMISTRY OF RECQ HELICASES 
 
     The RecQ helicase was first identified in E. coli as a component of the RecF 
recombinational repair pathway.  A null mutation at this locus confers a significant 
reduction in recombination frequency (∼100-fold) and increases UV sensitivity (∼20-
fold) in a recBC/sbcBC background (Nakayama, Nakayama et al. 1984).  The primary 
function of E. coli RecQ is to process linear double-strand DNA (dsDNA) substrates and 
provide a single-strand DNA (ssDNA) substrate for RecA protein.  Thus, RecQ helicase 
can act as an initiator during the early steps of homologous recombination.  E. coli RecQ 
can also disrupt nascent joint molecules in vitro (Harmon and Kowalczykowski 1998).  
RecQ helicase action, however, is not solely confined to an initiation role and displays a 
late role with its propensity to unwind the D-loops formed by the RecA protein.  Because 
the RecQ helicase can also disrupt the homologous pairing products formed in these 
reactions it may have additional roles in DNA metabolism. However the RecQ protein is 
not a branch migration-specific helicase because, in contrast to the RuvAB and RecG 
helicases, it displays no greater helicase activity on a four-way junction DNA substrate 
than it does on other DNA substrates. In addition the RecQ helicase displays a broad 
DNA binding specificity at internal regions of duplex DNA, such as at ssDNA gaps 
which are believed to be mediated by RecF pathway proteins (Lloyd and Buckman 1985; 
Lanzov, Stepanova et al. 1991). 
 
     Five human homologs of RecQ have been identified: RECQL, BLM, WRN, RECQL4 
and RECQL5.    Of these five homologs, defects in BLM causes Bloom’s syndrome (BS), 
mutations in WRN leads to Werner syndrome (WS), and defects in RECQL4 cause one 
form of Rothmund-Thomson syndrome (RTS).  No human diseases have been identified 
with defects in RECQL or RECQL5.  All three human syndromes have an elevated 
cancer risk, with the risk associated with BS being the most pronounced.  Alignment of 
the amino acid sequence of these proteins shows definite homology with bacterial RecQ. 
However, some of the human RecQs have specific and unique protein domains.  For 
instance, the WRN protein contains an exonuclease domain.  The biochemistry also 
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points to each member of the family having a unique function in maintaining the human 
genome, although some functions may overlap or substitute for some vital functions 
when another member is defective.   
 
 
Figure 1.5. The RecQ family of DNA helicases. Selected members from various 
species are shown aligned by the conserved central helicase domain. Six regions of 
homology are defined. The central helicase domain contains seven helicase motifs is 
depicted in green and present in all cases.  Also included are the RecQ C-terminal 
domain (red), the helicase and RNase D C-terminal (blue), conserved stretches of 
acidic amino acids (purple), and the nuclear and localization signals (black).  The 
exonuclease (exo) domain of WRN is shown in yellow. Adapted from  (Ouyang, Woo 
et al. 2008) 
  
1.6.2 BIOCHEMISTRY OF BLM 
 
     It has been proposed that BLM helicase resolves aberrant paired structures at stalled 
replication forks and DSB, reducing the availability of substrate for HR (Cheok, Wu et al. 
2005; Friedburg 2006).  In the early stages of HR, BLM can promote resection of DNA 
ends to create the 3' single–stranded DNA tails required for RAD51 to facilitate DNA 
strand invasion. However, the resulting D-loop can also be disrupted by BLM. In the 
latter stages of HR, the BLM complex or GEN1/Slx1-Slx4 complex complete the HR 
reaction by catalyzing Holliday junction dissolution or resolution, respectively (Wu and 
Hickson 2003; Ip, Rass et al. 2008; Svendsen, Smogorzewska et al. 2009; Svendsen and 
Harper 2010). The outcome of different HR pathways in terms of crossover or non-
crossover recombinant products is dependent on the enzymatic processing.  BLM has 
been shown to stimulate 5’-3’ end resection activity of EXO1 creating a 3’ hydroxyl 
21 
 
overhand necessary for Rad51 loading and single strand annealing activity (Gravel, 
Chapman et al. 2008; Mimitou and Symington 2008).  Another enzymatic activity of 
BLM is its ability to displace D-loop structures or prevent their formation by removing 
Rad51 from the 3’ single stranded DNA tail (Bachrati, Borts et al. 2006; Bugreev, Yu et 
al. 2007).  Displacement of the D-loop can both promote and inhibit recombination.  
Displacement of the strand before replication will prevent recombinational repair from 
proceeding.  Displacement of the D-loop after sufficient synthesis will drive HR and lead 
to GC.  Preventing D-loop formation in the first place would inhibit recombinational 
repair suggesting a possible role for BLM in the “decision” to pursue HR or NHEJ.  
Displacement of the D-loop after sufficient synthesis driving HR toward gene conversion 
might serve as an alternative role for BLM in  preventing NAHR (van Brabant, Ye et al. 
2000; Bachrati, Borts et al. 2006).    
 
     The BLM protein, thought to decreases illegitimate recombination, has been 
implicated in resolution of Holiday junctions in DSB repair in a process called 
dissolution (Wu and Hickson 2003).  BLM protein in conjunction with topoisomerase 
IIIα and RMI1/RMI2 can dismantle double holiday junctions without cleavage or 
ligation.  This process has been named “dissolution” (Wu and Hickson 2003; Raynard, 
Bussen et al. 2006). BLM binds and migrates double Holliday junctions to promote 
convergent branch migration, creating a hemicatenane structure that is “dissolved” to 
allow the two linked chromosomes to resolve into two unconnected double-strand DNA 
molecules. TOPOIIIα is required during this step to relieve the superhelical tension 
created by the convergence of the two branches. The hemicatenane is then decatenated by 
the single-stranded DNA passing activity of TOPOIIIα, in a reaction strongly stimulated 
by the RMI1–RMI2 complex. The outcome of the dissolution process is the exclusive 
formation of non-crossover recombinant products. This is believed to be the mechanism 
by which BLM suppresses NAHR. 
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Figure 1. 6.  Graphic depiction of BLM binding double Holliday junctions to 
promote convergent branch migration, creating a hemicatenane. In concert with 
TOPOIIIα and RMI1–RMI2, BLM the Hemicatenane structure is decatenated to 
form only non-crossover products.  Adapted from  (Chu and Hickson 2009). 
 
1.7 RECG HELICASE PROTEIN  
        1.7.1 BIOCHEMISTRY OF RECG HELICASE 
 
     The Escherichia coli RecG protein is a 76-kDa DNA-dependent ATPase that binds 
specifically to model Holliday intermediates and drives branch migration of those 
Holliday intermediates in genetic recombination and DNA repair (Sharples and Lloyd 
1991; Lloyd and Sharples 1993; Whitby, Ryder et al. 1993).  RecG can catalyze the 
formation of Holliday junctions at stalled replication forks by promoting fork regression 
(McGlynn and Lloyd 2002).  RecG unwinds both the nascent leading and lagging strands 
which anneal to each other and allow the parental strands to also reanneal generating a 
four-stranded Holliday junction.  This process is depicted below in figure 1.7.  
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Figure 1.7 Processing of damaged replication forks by RecG.  Model of RecG action 
at stalled replication forks.  The leading and lagging strand templates are shown in 
blue and green, respectively, whereas the leading strand is depicted in black and the 
lagging strand in pink. Half arrows represent 3′ ends of the nascent strands.   
(McGlynn and Lloyd 2002) with permission. 
 
     Aside from its ability to bind and migrate Holliday structures and regress multi-
stranded DNA structures as mentioned above RecG has also been shown to dismantle D-
loops where a 3'-OH single stranded nucleofilament has invaded a homologous DNA 
duplex (Whitby, Vincent et al. 1994; Vincent, Mahdi et al. 1996; Fukuoh, Iwasaki et al. 
1997; McGlynn, Al-Deib et al. 1997).  The crystal structure of RecG has provided great 
insight into how the enzyme accomplishes these tasks.  The crystal structure in a complex 
with a partial DNA replication is depicted below in figure 1.8.  RecG has conserved 
helicase domains linked to a novel N-terminal 'wedge' domain.  This domain provides the 
specificity for binding three-way branched DNA structures. It has been proposed that the 
helicase motor acts as a double-stranded DNA translocase, differing from other helicases 
analyzed in that they typically mediate strand separation via translocation on single-
stranded DNA (Mahdi, Briggs et al. 2003).  This allows RecG to pull the two parental 
strands of a replication fork structure through two separate channels flanking the wedge 
domain, neither wide enough to accommodate dsDNA (Singleton, Scaife et al. 2001). 
This has the effect of “stripping off” the nascent strands, allowing the parental strands to 
re-anneal, as suggested by earlier biochemical studies (McGlynn, Lloyd et al. 2001; 
McGlynn and Lloyd 2002).  Thus RecG protein also differs from many helicases in that it 
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functions primarily as a monomer (McGlynn, Lloyd et al. 2001; McGlynn and Lloyd 
2002).   
  
 
 
Figure 1.8.  Domain structure of RecG from Thermatoga maritima in a complex with 
a partial replication fork structure lacking a leading strand (72).   The N-terminal 
section of RecG shows the wedge domain responsible for specific DNA binding and 
unwinding  (Mahdi, Briggs et al. 2003) with permission. 
 
     Similar to BLM, RecG has several roles in controlling recombination.  Recently an 
alternative function to RecG in DNA synthesis was uncovered.  Replication in E. coli 
generates 3' flaps as the two replication forks collide and which displaces the nascent 
leading strands and provides potential targets for PriA to restart new replication forks.  
Here, RecG is thought to prevent replication fork restart by disassembling the D-loop 
after strand invasion.  Essentially RecG and ssDNA exonucleases act to limit PriA-
mediated re-replication of the chromosome and the consequent generation of linear DNA 
branches that provoke recombination.  Like BLM, RecG seems to act to both promote 
and prevent recombination dependent upon the scenario (Rudolph, Upton et al. 2009; 
Rudolph, Mahdi et al. 2010).  
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1.7.2 BIOCHEMICAL SIMILARITY OF RECG AND BLM  
 
    BLM is a human homolog of bacterial RecQ, this homology is apparent in figure 1.5.  
However, unlike BLM, bacterial RecQ protein is not a branch migration-specific helicase 
as it does not display greater helicase activity on a four-way junction DNA substrates 
than it does on other DNA substrates (Harmon and Kowalczykowski 1998; Sun, Karow 
et al. 1998; Wu and Maizels 2001).  This activity is thought to be the most prevalent 
biochemical activities of BLM.  According to overlapping biochemistry, BLM seems to 
be more functionally similar to RecG with which it shares no homology.  Both BLM and 
RecG  can bind to and regress multi-stranded DNA structures that model stalled 
replication forks (McGlynn, Lloyd et al. 2001; Robu, Inman et al. 2004; Machwe, Xiao et 
al. 2006; Ralf, Hickson et al. 2006).  Both proteins also have the capacity to bind and 
branch migrate Holliday junctions (Karow, Constantinou et al. 2000; Plank, Wu et al. 
2006) (Whitby, Vincent et al. 1994) (Grove, Harris et al. 2008).  BLM and RecG have 
also been shown to dismantle D-loops where a 3' single strand DNA has invaded a 
homologous DNA duplex (Whitby, Vincent et al. 1994; McGlynn, Al-Deib et al. 1997; 
van Brabant, Ye et al. 2000; Briggs, Mahdi et al. 2004; Bachrati, Borts et al. 2006; 
Grove, Harris et al. 2008).  Chapter 5 explores this relationship in order to assess the 
importance of these overlapping biochemical activities to determine if they are in fact 
responsible for the genomic instability phenotypes observed in BLM deficient cells 
(Killen, Stults et al. 2009).  If RecG and BLM are functional analogs this likeness can be 
exploited to explore the mechanism by which BLM suppresses genomic instability.   
 
 
 
 
 
 
26 
 
1.8: REFERENCES 
 
Aaltonen, L. A., P. Peltomaki, et al. (1993). "Clues to the pathogenesis of familial 
colorectal cancer." Science 260(5109): 812-816. 
Aguilera, A. and S. J. Boulton (2007). "How to exchange your partner. Workshop on 
recombination mechanisms and the maintenance of genomic stability." EMBO 
Rep 8(1): 28-33. 
Allen, C., A. Kurimasa, et al. (2002). "DNA-dependent protein kinase suppresses double-
strand break-induced and spontaneous homologous recombination." Proc Natl 
Acad Sci U S A 99(6): 3758-3763. 
Almoguera, C., D. Shibata, et al. (1988). "Most human carcinomas of the exocrine 
pancreas contain mutant c-K-ras genes." Cell 53(4): 549-554. 
Amor-Gueret, M. (2006). "Bloom syndrome, genomic instability and cancer: the SOS-
like hypothesis." Cancer Lett 236(1): 1-12. 
Bachrati, C. Z., R. H. Borts, et al. (2006). "Mobile D-loops are a preferred substrate for 
the Bloom's syndrome helicase." Nucleic Acids Res 34(8): 2269-2279. 
Bachrati, C. Z. and I. D. Hickson (2003). "RecQ helicases: suppressors of tumorigenesis 
and premature aging." Biochem J 374(Pt 3): 577-606. 
Barbouti, A., P. Stankiewicz, et al. (2004). "The breakpoint region of the most common 
isochromosome, i(17q), in human neoplasia is characterized by a complex 
genomic architecture with large, palindromic, low-copy repeats." Am J Hum 
Genet 74(1): 1-10. 
Bartova, E., G. Galiova, et al. (2010). "Genome instability in the context of chromatin 
structure and fragile sites." Crit Rev Eukaryot Gene Expr 20(3): 181-194. 
Bernstein, K. A., S. Gangloff, et al. (2010). "The RecQ DNA helicases in DNA repair." 
Annu Rev Genet 44: 393-417. 
Bernstein, H., H. C. Byerly, et al. (1985). "Genetic damage, mutation, and the evolution 
of sex." Science 229(4719): 1277-1281. 
Bishop, A. J. and R. H. Schiestl (2003). "Role of homologous recombination in 
carcinogenesis." Exp Mol Pathol 74(2): 94-105. 
Bloom, D. (1954). "Congenital telangiectatic erythema resembling lupus erythematosus 
in dwarfs; probably a syndrome entity." AMA Am J Dis Child 88(6): 754-758. 
27 
 
Briggs, G. S., A. A. Mahdi, et al. (2004). "Interplay between DNA replication, 
recombination and repair based on the structure of RecG helicase." Philos Trans R 
Soc Lond B Biol Sci 359(1441): 49-59. 
Bruder, C. E., A. Piotrowski, et al. (2008). "Phenotypically concordant and discordant 
monozygotic twins display different DNA copy-number-variation profiles." Am J 
Hum Genet 82(3): 763-771. 
Bugreev, D. V., X. Yu, et al. (2007). "Novel pro- and anti-recombination activities of the 
Bloom's syndrome helicase." Genes Dev 21(23): 3085-3094. 
Cahill, D. P., K. W. Kinzler, et al. (1999). "Genetic instability and darwinian selection in 
tumours." Trends Cell Biol 9(12): M57-60. 
Calasanz, M. J. and J. C. Cigudosa (2008). "Molecular cytogenetics in translational 
oncology: when chromosomes meet genomics." Clin Transl Oncol 10(1): 20-29. 
Cheok, C. F., L. Wu, et al. (2005). "The Bloom's syndrome helicase promotes the 
annealing of complementary single-stranded DNA." Nucleic Acids Res 33(12): 
3932-3941. 
Chu, W. K. and I. D. Hickson (2009). "RecQ helicases: multifunctional genome 
caretakers." Nat Rev Cancer 9(9): 644-654. 
Consortium, I. (2004). "Finishing the euchromatic sequence of the human genome." 
Nature 431(7011): 931-945. 
Couedel, C., K. D. Mills, et al. (2004). "Collaboration of homologous recombination and 
nonhomologous end-joining factors for the survival and integrity of mice and 
cells." Genes Dev 18(11): 1293-1304. 
Cox, M. M. (1999). "Recombinational DNA repair in bacteria and the RecA protein." 
Prog Nucleic Acid Res Mol Biol 63: 311-366. 
Dean, M., R. B. Kent, et al. (1983). "Transcriptional activation of immunoglobulin alpha 
heavy-chain genes by translocation of the c-myc oncogene." Nature 305(5933): 
443-446. 
DeMars, R. and K. R. Held (1972). "The spontaneous azaguanine-resistant mutants of 
diploid human fibroblasts." Humangenetik 16(1): 87-110. 
Ellis, N. A. and J. German (1996). "Molecular genetics of Bloom's syndrome." Hum Mol 
Genet 5 Spec No: 1457-1463. 
Ellis, N. A., J. Groden, et al. (1995). "The Bloom's syndrome gene product is 
homologous to RecQ helicases." Cell 83(4): 655-666. 
28 
 
Frankenberg-Schwager, M. and D. Frankenberg (1990). "DNA double-strand breaks: 
their repair and relationship to cell killing in yeast." Int J Radiat Biol 58(4): 569-
575. 
Friedburg, E., Walker, GC, Siede, W, Schultz, RA (2006). DNA repair and mutagenesis. 
Washington, D.C., ASM Press. 
Fukuoh, A., H. Iwasaki, et al. (1997). "ATP-dependent resolution of R-loops at the ColE1 
replication origin by Escherichia coli RecG protein, a Holliday junction-specific 
helicase." EMBO J 16(1): 203-209. 
Fukushima, T., M. Takata, et al. (2001). "Genetic analysis of the DNA-dependent protein 
kinase reveals an inhibitory role of Ku in late S-G2 phase DNA double-strand 
break repair." J Biol Chem 276(48): 44413-44418. 
German, J. (1997). "Bloom's syndrome. XX. The first 100 cancers." Cancer Genet 
Cytogenet 93(1): 100-106. 
German, J., D. Bloom, et al. (1984). "Bloom's syndrome XI. Progress report for 1983." 
Clin Genet 25(2): 166-174. 
German, J. and E. Passarge (1989). "Bloom's syndrome. XII. Report from the Registry 
for 1987." Clin Genet 35(1): 57-69. 
Gonzalez, I. L. and J. E. Sylvester (1995). "Complete sequence of the 43-kb human 
ribosomal DNA repeat: analysis of the intergenic spacer." Genomics 27(2): 320-
328. 
Gravel, S., J. R. Chapman, et al. (2008). "DNA helicases Sgs1 and BLM promote DNA 
double-strand break resection." Genes Dev 22(20): 2767-2772. 
Grove, J. I., L. Harris, et al. (2008). "DNA double strand break repair and crossing over 
mediated by RuvABC resolvase and RecG translocase." DNA Repair (Amst) 
7(9): 1517-1530. 
Hainaut, P. and M. Hollstein (2000). "p53 and human cancer: the first ten thousand 
mutations." Adv Cancer Res 77: 81-137. 
Harmon, F. G. and S. C. Kowalczykowski (1998). "RecQ helicase, in concert with RecA 
and SSB proteins, initiates and disrupts DNA recombination." Genes Dev 12(8): 
1134-1144. 
Hastings, P. J., J. R. Lupski, et al. (2009). "Mechanisms of change in gene copy number." 
Nat Rev Genet 10(8): 551-564. 
Henderson, A. S., D. Warburton, et al. (1972). "Location of ribosomal DNA in the human 
chromosome complement." Proc Natl Acad Sci U S A 69(11): 3394-3398. 
29 
 
Hofmann, O., O. L. Caballero, et al. (2008). "Genome-wide analysis of cancer/testis gene 
expression." Proc Natl Acad Sci U S A 105(51): 20422-20427. 
Inoue, K. and J. R. Lupski (2002). "Molecular mechanisms for genomic disorders." Annu 
Rev Genomics Hum Genet 3: 199-242. 
Ip, S. C., U. Rass, et al. (2008). "Identification of Holliday junction resolvases from 
humans and yeast." Nature 456(7220): 357-361. 
Ira, G., A. Malkova, et al. (2003). "Srs2 and Sgs1-Top3 suppress crossovers during 
double-strand break repair in yeast." Cell 115(4): 401-411. 
Jefford, C. E. and I. Irminger-Finger (2006). "Mechanisms of chromosome instability in 
cancers." Crit Rev Oncol Hematol 59(1): 1-14. 
Jeffs, A. R., S. M. Benjes, et al. (1998). "The BCR gene recombines preferentially with 
Alu elements in complex BCR-ABL translocations of chronic myeloid 
leukaemia." Hum Mol Genet 7(5): 767-776. 
Johnson, R. D. and M. Jasin (2000). "Sister chromatid gene conversion is a prominent 
double-strand break repair pathway in mammalian cells." EMBO J 19(13): 3398-
3407. 
Johnson, R. D. and M. Jasin (2001). "Double-strand-break-induced homologous 
recombination in mammalian cells." Biochem Soc Trans 29(Pt 2): 196-201. 
Karow, J. K., A. Constantinou, et al. (2000). "The Bloom's syndrome gene product 
promotes branch migration of holliday junctions." Proc Natl Acad Sci U S A 
97(12): 6504-6508. 
Killen, M. W., D. M. Stults, et al. (2009). "Loss of Bloom syndrome protein destabilizes 
human gene cluster architecture." Hum Mol Genet 18(18): 3417-3428. 
Kolodner, R., R. A. Fishel, et al. (1985). "Genetic recombination of bacterial plasmid 
DNA: effect of RecF pathway mutations on plasmid recombination in Escherichia 
coli." J Bacteriol 163(3): 1060-1066. 
Komarova, N. L., A. V. Sadovsky, et al. (2008). "Selective pressures for and against 
genetic instability in cancer: a time-dependent problem." J R Soc Interface 5(18): 
105-121. 
Koumbaris, G., H. Hatzisevastou-Loukidou, et al. (2011). "FoSTeS, MMBIR and NAHR 
at the human proximal Xp region and the mechanisms of human Xq 
isochromosome formation." Hum Mol Genet 20(10): 1925-1936. 
Kuzminov, A. (1999). "Recombinational repair of DNA damage in Escherichia coli and 
bacteriophage lambda." Microbiol Mol Biol Rev 63(4): 751-813, table of 
contents. 
30 
 
Kuzminov, A. (2001). "Single-strand interruptions in replicating chromosomes cause 
double-strand breaks." Proc Natl Acad Sci U S A 98(15): 8241-8246. 
Kyoizumi, S., N. Nakamura, et al. (1989). "Frequency of variant erythrocytes at the 
glycophorin-A locus in two Bloom's syndrome patients." Mutat Res 214(2): 215-
222. 
Langlois, R. G., W. L. Bigbee, et al. (1989). "Evidence for increased in vivo mutation 
and somatic recombination in Bloom's syndrome." Proc Natl Acad Sci U S A 
86(2): 670-674. 
Lanzov, V., I. Stepanova, et al. (1991). "Genetic control of recombination exchange 
frequency in Escherichia coli K-12." Biochimie 73(2-3): 305-312. 
Lengauer, C., K. W. Kinzler, et al. (1998). "Genetic instabilities in human cancers." 
Nature 396(6712): 643-649. 
Li, G. M. (2008). "Mechanisms and functions of DNA mismatch repair." Cell Res 18(1): 
85-98. 
Liang, F., M. Han, et al. (1998). "Homology-directed repair is a major double-strand 
break repair pathway in mammalian cells." Proc Natl Acad Sci U S A 95(9): 
5172-5177. 
Lloyd, R. G. and C. Buckman (1985). "Identification and genetic analysis of sbcC 
mutations in commonly used recBC sbcB strains of Escherichia coli K-12." J 
Bacteriol 164(2): 836-844. 
Lloyd, R. G. and G. J. Sharples (1993). "Dissociation of synthetic Holliday junctions by 
E. coli RecG protein." EMBO J 12(1): 17-22. 
Loeb, L. A. (2001). "A mutator phenotype in cancer." Cancer Res 61(8): 3230-3239. 
Loeb, L. A., K. R. Loeb, et al. (2003). "Multiple mutations and cancer." Proc Natl Acad 
Sci U S A 100(3): 776-781. 
Loeb, L. A., C. F. Springgate, et al. (1974). "Errors in DNA replication as a basis of 
malignant changes." Cancer Res 34(9): 2311-2321. 
Lupski, J. R. and P. Stankiewicz (2005). "Genomic disorders: molecular mechanisms for 
rearrangements and conveyed phenotypes." PLoS Genet 1(6): e49. 
Machiels, J. P., N. van Baren, et al. (2002). "Peptide-based cancer vaccines." Semin 
Oncol 29(5): 494-502. 
Machwe, A., L. Xiao, et al. (2006). "The Werner and Bloom syndrome proteins catalyze 
regression of a model replication fork." Biochemistry 45(47): 13939-13946. 
31 
 
Mahdi, A. A., G. S. Briggs, et al. (2003). "A model for dsDNA translocation revealed by 
a structural motif common to RecG and Mfd proteins." EMBO J 22(3): 724-734. 
Mankouri, H. W. and I. D. Hickson (2007). "The RecQ helicase-topoisomerase III-Rmi1 
complex: a DNA structure-specific 'dissolvasome'?" Trends Biochem Sci 32(12): 
538-546. 
McGlynn, P., A. A. Al-Deib, et al. (1997). "The DNA replication protein PriA and the 
recombination protein RecG bind D-loops." J Mol Biol 270(2): 212-221. 
McGlynn, P. and R. G. Lloyd (2002). "Genome stability and the processing of damaged 
replication forks by RecG." Trends Genet 18(8): 413-419. 
McGlynn, P., R. G. Lloyd, et al. (2001). "Formation of Holliday junctions by regression 
of nascent DNA in intermediates containing stalled replication forks: RecG 
stimulates regression even when the DNA is negatively supercoiled." Proc Natl 
Acad Sci U S A 98(15): 8235-8240. 
Michel, B., G. Grompone, et al. (2004). "Multiple pathways process stalled replication 
forks." Proc Natl Acad Sci U S A 101(35): 12783-12788. 
Mills, K. D., D. O. Ferguson, et al. (2004). "Rad54 and DNA Ligase IV cooperate to 
maintain mammalian chromatid stability." Genes Dev 18(11): 1283-1292. 
Mimitou, E. P. and L. S. Symington (2008). "Sae2, Exo1 and Sgs1 collaborate in DNA 
double-strand break processing." Nature 455(7214): 770-774. 
Monnat, R. J., Jr. (2010). "Human RECQ helicases: roles in DNA metabolism, 
mutagenesis and cancer biology." Semin Cancer Biol 20(5): 329-339. 
Moynahan, M. E. and M. Jasin (1997). "Loss of heterozygosity induced by a 
chromosomal double-strand break." Proc Natl Acad Sci U S A 94(17): 8988-
8993. 
Murga, M. and O. Fernandez-Capetillo (2007). "Genomic instability: on the birth and 
death of cancer." Clin Transl Oncol 9(4): 216-220. 
Nakayama, H., K. Nakayama, et al. (1984). "Isolation and genetic characterization of a 
thymineless death-resistant mutant of Escherichia coli K12: identification of a 
new mutation (recQ1) that blocks the RecF recombination pathway." Mol Gen 
Genet 195(3): 474-480. 
Nowak, M. A., N. L. Komarova, et al. (2002). "The role of chromosomal instability in 
tumor initiation." Proc Natl Acad Sci U S A 99(25): 16226-16231. 
Olavarrieta, L., M. L. Martinez-Robles, et al. (2002). "Supercoiling, knotting and 
replication fork reversal in partially replicated plasmids." Nucleic Acids Res 
30(3): 656-666. 
32 
 
Ouyang, K. J., L. L. Woo, et al. (2008). "Homologous recombination and maintenance of 
genome integrity: cancer and aging through the prism of human RecQ helicases." 
Mech Ageing Dev 129(7-8): 425-440. 
Pierce, A. J., P. Hu, et al. (2001). "Ku DNA end-binding protein modulates homologous 
repair of double-strand breaks in mammalian cells." Genes Dev 15(24): 3237-
3242. 
Pierce, A. J., J. M. Stark, et al. (2001). "Double-strand breaks and tumorigenesis." Trends 
Cell Biol 11(11): S52-59. 
Plank, J. L., J. Wu, et al. (2006). "Topoisomerase IIIalpha and Bloom's helicase can 
resolve a mobile double Holliday junction substrate through convergent branch 
migration." Proc Natl Acad Sci U S A 103(30): 11118-11123. 
Postow, L., C. Ullsperger, et al. (2001). "Positive torsional strain causes the formation of 
a four-way junction at replication forks." J Biol Chem 276(4): 2790-2796. 
Rahman, N. and M. R. Stratton (1998). "The genetics of breast cancer susceptibility." 
Annu Rev Genet 32: 95-121. 
Ralf, C., I. D. Hickson, et al. (2006). "The Bloom's syndrome helicase can promote the 
regression of a model replication fork." J Biol Chem 281(32): 22839-22846. 
Raynard, S., W. Bussen, et al. (2006). "A double Holliday junction dissolvasome 
comprising BLM, topoisomerase IIIalpha, and BLAP75." J Biol Chem 281(20): 
13861-13864. 
Redon, R., S. Ishikawa, et al. (2006). "Global variation in copy number in the human 
genome." Nature 444(7118): 444-454. 
Reliene, R., A. J. Bishop, et al. (2007). "Involvement of homologous recombination in 
carcinogenesis." Adv Genet 58: 67-87. 
Richardson, C. and M. Jasin (2000). "Coupled homologous and nonhomologous repair of 
a double-strand break preserves genomic integrity in mammalian cells." Mol Cell 
Biol 20(23): 9068-9075. 
Richardson, C., M. E. Moynahan, et al. (1998). "Double-strand break repair by 
interchromosomal recombination: suppression of chromosomal translocations." 
Genes Dev 12(24): 3831-3842. 
Robu, M. E., R. B. Inman, et al. (2004). "Situational repair of replication forks: roles of 
RecG and RecA proteins." J Biol Chem 279(12): 10973-10981. 
Rothkamm, K., I. Kruger, et al. (2003). "Pathways of DNA double-strand break repair 
during the mammalian cell cycle." Mol Cell Biol 23(16): 5706-5715. 
33 
 
Rudolph, C. J., A. A. Mahdi, et al. (2010). "RecG protein and single-strand DNA 
exonucleases avoid cell lethality associated with PriA helicase activity in 
Escherichia coli." Genetics 186(2): 473-492. 
Rudolph, C. J., A. L. Upton, et al. (2009). "Replication fork collisions cause pathological 
chromosomal amplification in cells lacking RecG DNA translocase." Mol 
Microbiol 74(4): 940-955. 
Russell, J. and J. C. Zomerdijk (2006). "The RNA polymerase I transcription machinery." 
Biochem Soc Symp(73): 203-216. 
Scanlan, M. J., A. J. Simpson, et al. (2004). "The cancer/testis genes: review, 
standardization, and commentary." Cancer Immun 4: 1. 
Sharples, G. J. and R. G. Lloyd (1991). "Resolution of Holliday junctions in Escherichia 
coli: identification of the ruvC gene product as a 19-kilodalton protein." J 
Bacteriol 173(23): 7711-7715. 
Shaw, C. J. and J. R. Lupski (2004). "Implications of human genome architecture for 
rearrangement-based disorders: the genomic basis of disease." Hum Mol Genet 13 
Spec No 1: R57-64. 
Sherr, C. J. (2004). "Principles of tumor suppression." Cell 116(2): 235-246. 
Sieber, O. M., K. Heinimann, et al. (2003). "Genomic instability--the engine of 
tumorigenesis?" Nat Rev Cancer 3(9): 701-708. 
Singleton, M. R., S. Scaife, et al. (2001). "Structural analysis of DNA replication fork 
reversal by RecG." Cell 107(1): 79-89. 
Smith, C. E., B. Llorente, et al. (2007). "Template switching during break-induced 
replication." Nature 447(7140): 102-105. 
Sonoda, E., H. Hochegger, et al. (2006). "Differential usage of non-homologous end-
joining and homologous recombination in double strand break repair." DNA 
Repair (Amst) 5(9-10): 1021-1029. 
Stankiewicz, P. and J. R. Lupski (2002). "Genome architecture, rearrangements and 
genomic disorders." Trends Genet 18(2): 74-82. 
Stankiewicz, P. and J. R. Lupski (2002). "Molecular-evolutionary mechanisms for 
genomic disorders." Curr Opin Genet Dev 12(3): 312-319. 
Stults, D. M., M. W. Killen, et al. (2008). "Genomic architecture and inheritance of 
human ribosomal RNA gene clusters." Genome Res 18(1): 13-18. 
Stults, D. M., M. W. Killen, et al. (2009). "Human rRNA gene clusters are 
recombinational hotspots in cancer." Cancer Res 69(23): 9096-9104. 
34 
 
Sun, H., J. K. Karow, et al. (1998). "The Bloom's syndrome helicase unwinds G4 DNA." 
J Biol Chem 273(42): 27587-27592. 
Svendsen, J. M. and J. W. Harper (2010). "GEN1/Yen1 and the SLX4 complex: 
Solutions to the problem of Holliday junction resolution." Genes Dev 24(6): 521-
536. 
Svendsen, J. M., A. Smogorzewska, et al. (2009). "Mammalian BTBD12/SLX4 
assembles a Holliday junction resolvase and is required for DNA repair." Cell 
138(1): 63-77. 
Takata, M., M. S. Sasaki, et al. (1998). "Homologous recombination and non-
homologous end-joining pathways of DNA double-strand break repair have 
overlapping roles in the maintenance of chromosomal integrity in vertebrate 
cells." EMBO J 17(18): 5497-5508. 
van Brabant, A. J., T. Ye, et al. (2000). "Binding and melting of D-loops by the Bloom 
syndrome helicase." Biochemistry 39(47): 14617-14625. 
Vijayalaxmi, H. J. Evans, et al. (1983). "Bloom's syndrome: evidence for an increased 
mutation frequency in vivo." Science 221(4613): 851-853. 
Vincent, S. D., A. A. Mahdi, et al. (1996). "The RecG branch migration protein of 
Escherichia coli dissociates R-loops." J Mol Biol 264(4): 713-721. 
Warburton, P. E., D. Hasson, et al. (2008). "Analysis of the largest tandemly repeated 
DNA families in the human genome." BMC Genomics 9: 533. 
Whitby, M. C., L. Ryder, et al. (1993). "Reverse branch migration of Holliday junctions 
by RecG protein: a new mechanism for resolution of intermediates in 
recombination and DNA repair." Cell 75(2): 341-350. 
Whitby, M. C., S. D. Vincent, et al. (1994). "Branch migration of Holliday junctions: 
identification of RecG protein as a junction specific DNA helicase." EMBO J 
13(21): 5220-5228. 
Wu, L. and I. D. Hickson (2003). "The Bloom's syndrome helicase suppresses crossing 
over during homologous recombination." Nature 426(6968): 870-874. 
Wu, X. and N. Maizels (2001). "Substrate-specific inhibition of RecQ helicase." Nucleic 
Acids Res 29(8): 1765-1771. 
Yu, J., K. Marshall, et al. (2004). "Microhomology-dependent end joining and repair of 
transposon-induced DNA hairpins by host factors in Saccharomyces cerevisiae." 
Mol Cell Biol 24(3): 1351-1364. 
35 
 
Zhang, F., M. Khajavi, et al. (2009). "The DNA replication FoSTeS/MMBIR mechanism 
can generate genomic, genic and exonic complex rearrangements in humans." Nat 
Genet 41(7): 849-853. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright© Michael Wayne Killen 2011 
36 
 
CHAPTER 2: GENE CLUSTER INSTABILITY ASSAY 
2.1: SYNOPSIS 
 
     A newly developed method for quantitatively detecting genomic restructuring in 
cultured human cell lines as the result of recombination is presented:  the “gene cluster 
instability” (GCI) assay.  The assay is physiological in that it detects spontaneous 
restructuring without the need for exogenous recombination-initiating treatments such as 
DNA damage.  As an assay for genotoxicity, the GCI assay is complementary to well-
established sister chromatid exchange (SCE) methods.  Analysis of the U-2 OS 
osteosarcoma cell line is presented as an illustration of the method. 
 
 2.2 INTRODUCTION 
 
     Homologous recombination (HR) is essential in the maintenance of the integrity of the 
human genome and is the only mechanism for error-free DNA repair of double strand 
breaks.  This form of repair utilizes non-broken homologous sequence located elsewhere 
in the genome, such as on a sister chromatid, to effectively replace damaged sequence 
through the process of gene conversion.  However, dysregulated homologous 
recombination between the many non-allelic repetitive sequences in the human genome 
(Consortium 2004)can also have disastrous consequences for genomic stability (Lupski 
and Stankiewicz 2005) by providing a mechanism for generating physical alterations in 
the genomic architecture, including chromosomal translocations, inversions and 
deletions.  Depending on the relative orientiations of the recombining sequences, the 
formation of dicentric and acentric chromosomes is also possible (Acilan, Potter et al. 
2007) (McClintock 1939).  These structural anomalies may contribute to cellular cancer 
phenotypes (Tonon, Wong et al. 2005).  This type of dysregulated homologous 
recombination is referred to as non-allelic homologous recombination (NAHR) and 
involves the physical exchange of genetic material through crossover between two 
different chromosomal loci with a high degree of sequence identity.  Like error-free HR, 
NAHR is sequence similarity dependent and becomes more efficient when sequence 
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similarity between the recombining sequences is greater than 98% (Elliott, Richardson et 
al. 1998). 
     We describe here the Gene Cluster Instabilty (GCI) assay we developed for detecting 
spontaneous recombination-mediated genomic restructuring in human cells.  We have 
successfully applied this technique to elucidate the genetics that regulates the NAHR 
reaction (Killen, Stults et al. 2009) and to show that NAHR is commonly associated with 
human adult solid tumors (Stults, Killen et al. 2009).  In principle the assay is also 
suitable for evaluating the genomic toxicity of drugs.  The assay involves physical 
analysis of gene clusters, genomic loci in which the repeated genes have very high levels 
of sequence identity and are in very high local concentration, both factors in accelerating 
the rate at which they undergo recombination-mediated structural alteration.  NAHR 
between similarly oriented repeats causes expansions and contractions of the number of 
repeats in the cluster.  These length changes can be monitored by excising the gene 
clusters of interest from the genome enzymatically, resolving cluster lengths through 
pulsed-field electrophoresis and detecting the clusters by Southern hybridization (Stults, 
Killen et al. 2008). 
The gene clusters we usually employ (and describe here) to monitor recombination are 
the clusters expressing the precursor transcript to the three largest of the four ribosomal 
RNA molecules.  There are ten such gene clusters in the human genome found at both 
paternal and maternal 13p12, 14p12, 15p12, 21p12, and 22p12 chromosomal loci 
(Henderson, Warburton et al. 1972) each consisting of a tandemly repeated 43 kb genes 
(the “rDNA”) with a variety of relative orientations (Caburet, Conti et al. 2005) but 
commonly oriented such that transcription proceeds towards the centromere (Worton, 
Sutherland et al. 1988).  The individual rDNA clusters range from 1 to over 140 repeat 
copies representing overall lengths ranging from 43 kb to over 6 Mb with very strong 
variability demonstrated between individual humans (Stults, Killen et al. 2008).  We have 
found that assaying cluster length changes in the size range from 50 kb to 1 Mb combines 
good sensitivity for detecting recombination-mediated genomic structural alterations with 
relative technical ease. 
     A schematic of the procedure is shown in Figure 2.1.  High molecular weight genomic 
DNA from cells of interest is isolated in solid phase agarose to prevent mechanical 
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shearing and subjected to restriction digestion, also in the solid phase.  Restriction 
enzymes are selected that do not have a recognition site in the gene cluster unit repeat.  
Since the gene repeats are nearly identical to each other, such an enzyme will likely not 
cut anywhere within the entire cluster, whereas non-repetitive flanking genomic DNA of 
essentially random sequence will be subject to digestion.  So long as the cluster length is 
large relative to the cutting frequency of the enzyme in random sequence DNA, the 
cluster will be liberated with a relatively negligible length tail of non-cluster DNA on 
each end.  For the rDNA, we find EcoRV to be an excellent enzyme:  no recognition site 
in the rDNA clusters, frequent cutting in random sequence DNA, digests DNA in solid-
phase agarose efficiently, and is affordable.  (see Note 1). 
     Separation of the clusters using pulsed-field electrophoresis and detection though 
Southern hybridization generates a characteristic electrophoretic karyotype of the gene 
clusters.  For a clonal cell line with no recombinational instability, this pattern will be 
well-defined with one band for each cluster, each band with a radioactive hybridization 
signal in proportion to the number of repeats in the cluster (Figure 2.2:  ‘Initial Pattern’).  
If there is no recombination-mediated gene cluster restructuring, this pattern will be 
faithfully transmitted to all daughter cells.  Recombination can, however, change the 
lengths of these clusters as cells are cultured.  Thus, recombinational instability is 
manifested as subpopulations of cells in a culture with a different electrophoretic 
karyotype.  Experimentally, these sub-populations can be detected by reduced-intensity 
bands that differ in length from the initial pattern superimposed upon the initial pattern 
(Figure 2.2:  ‘Low GCI’).  In the case of extreme instability, such as when the Bloom 
syndrome protein is lost or inactivated, active restructuring generates a ladder-like pattern 
that essentially completely obscures the initial pattern (Figure 2.2:  ‘High GCI’) (Killen, 
Stults et al. 2009).  The ladder-like banding is diagnostic for recombination-mediated 
changes, since recombination requires alignment of the repeated sequences and can 
thereby only change cluster lengths by integer multiples of the unit repeat length. 
 
    GCI analysis results for the human osteosarcoma line U-2 OS are illustrative.  Figure 
2.3A shows the electrophoretic karyotype for a stock culture of U-2 OS cells along with 
the SV40-transformed wild-type fibroblast line GM00637 (Coriell) and the HeLa S3 
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cervical carcinoma line (ATCC).  Since these three lines are derived from three different 
individuals, the initial pattern of bands is expected to be different between the three lines, 
as indeed it is; this attribute of the rDNA clusters is useful to ensure that cell lines do not 
become confused with each other.  The U-2 OS culture shows a profusion of minor-
intensity bands with no well-defined pattern, indicative of recombinational instability.  In 
a non-clonal culture such as that shown for the U-2 OS cells in Figure 2.3A, however, the 
total accumulated instability is a factor of three independent parameters:  i) the 
spontaneous per-cell-division recombination rate, ii) the number of cell divisions elapsed 
since clonality, and iii) the degree to which the culture has been subject to periodic 
genetic population bottlenecks due to repeated splitting of the culture.  Usually it is the 
spontaneous recombination rate that is of interest.  This can be determined directly by re-
initiating a culture from single-cell derived subclones to clear out all sub-populations, 
followed by free expansion without limit until genomic DNA is prepared.  DNA isolated 
from such single-cell-derived subclones of the U-2 OS parental population yields the data 
shown in Figure 2.3B.  Unlike the mixed parental population, now the subclones reveal 
relatively recombination-stable initial patterns with few minor-intensity bands.  The 
process can be reiterated by generating sub-subclonal lines from individual cells of the 
now well-defined subclonal populations.  Figure 2.4 shows such analysis from sub-
subclonal populations generated from the U-2 OS parental subclones A and B 
respectively.  Recombinational instability is still present, as indicated by missing initial 
pattern bands and new minor-intensity bands, but of a similar rate to that seen with other 
wild-type immortalized cell lines (Killen, Stults et al. 2009).  Clearly the majority of the 
instability seen in the non-clonal parental U-2 OS culture (Figure 2.3A) was due to 
extended time in culture and/or repeated high-dilution passaging. 
 
2.3.  Materials 
2.3.1  Thawing cryopreserved cells 
1. Latex or nitrile gloves. 
2. 10-cm tissue culture plates (or tissue culture flasks for non-adherent cells). 
3. Adherent or non-adherent human cells. 
4. Humidified, CO2 supplemented tissue culture incubator. 
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5. Laminar flow tissue culture biosafety hood with standard tissue culture setup, 
including serological pipettes, micropipettes, and vacuum aspiration apparatus.  
6. Tissue culture medium appropriate for each cell type such as minimal essential 
medium (MEM) or RPMI 1640 
7. 95% reagent grade ethanol. 
8. Fetal bovine serum. 
9. L-glutamine/Penicillin/Streptomycin 100x solution (10,000 U/mL penicillin; 10,000 
μg/mL streptomycin; 200 mM L-gln). 
10. Plasmocin 25 mg/mL (for mycoplasma prophylaxis). 
11. Clinical centrifuge (e.g., Marathon model 3200, Fisher, Pittsburg, PA). 
12. 15 mL conical centrifugation tubes. 
13. Complete culture medium appropriate for tissue culture growth of cells:  MEM or 
RPMI supplemented with 5% to 10% fetal bovine serum, a 1:100 dilution of the stock 
Pen/Strep/L-gln solution, and a 1:10,000 dilution of the stock Plasmocin 25 mg/mL 
solution. 
14. 70% ethanol:  95% ethanol diluted to 70% with sterile distilled water.  
 
2.3.2  Subculturing cells for GCI analysis 
1. Laminar flow hood with standard tissue culture setup, including serological pipettes, 
micropipettes, and vacuum aspiration apparatus.  
2. Trypsin/EDTA solution (0.05% Trypsin, 0.53 mM EDTA). 
3. Tissue culture medium such as MEM or RPMI 1640, suitably supplemented with fetal 
bovine serum and antibiotics. 
4. 10-cm tissue culture plates (or tissue culture flasks for non-adherent cells). 
 
2.3.3  Deriving and expanding clonal lines 
1. 20 µL Pipetman (Gilson or equivalent) and sterile pipette tips. 
2. 96-well flat bottom shaped well plates for adherent cells or V-bottom shaped well 
plates for non-adherent cells. 
3. 24-well tissue culture plates. 
4. 6-well tissue culture plates. 
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5. 10 cm tissue culture plates. 
6. Hemocytometer or flow cytometer (e.g., Partec Analysis System PAS, Partec, Münster, 
Germany) for cell counting. 
 
2.3.4  Preparing subcultured cells for DNA extraction 
1. Trypsin/EDTA solution (0.05% Trypsin, 0.53 mM EDTA). 
2. Tissue culture medium such as MEM or RPMI 1640, suitably supplemented with fetal 
bovine serum and antibiotics. 
3. Clinical centrifuge. 
4. 15 mL conical centrifugation tubes. 
5. Sterile phosphate-buffered saline (also known as PBS or DPBS). 
6. Hemocytometer or flow cytometer for cell counting. 
 
2.3.5  Isolation of solid-phase high molecular weight genomic DNA from human cells 
1. Low-melting-point (LMP) agarose, analytical grade (cat. #V2111, Promega, Madison, 
WI). 
2. DPBS (cat. #21-031-CV, Mediatech, Manassas, VA). 
3. 1 mL syringes (cat. #309602, Becton, Dickinson, San Jose, CA). 
4. Single-edged safety razor blades. 
5. 8 mL flat bottom tubes. 
6. Cell digestion buffer with proteinase K 
7. Environmental incubator shaker capable of maintaining 50°C (e.g., G24 environmental 
incubator shaker, New Brunswick Scientific, Edison, NJ). 
8. 50 mL conical tubes. 
9. TE solution. 
10. TE/glycerol solution. 
11. Saturated phenylmethanesulfonylfluoride (PMSF) in isopropanol.  CAUTION:  very 
toxic! 
12. Room temperature shaker 
13. Proteinase K powder.  Store at -20°C. 
14. Proteinase K solution:  Dissolve in water to 15 mg/ml.  Store in 160 µl aliquots at   
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-20°C.  CAUTION:  proteinase K fines are intensely irritating.  Wear suitable respiratory 
protection when using powered proteinase K. 
15. Cell digestion buffer with proteinase K:  500 mM EDTA pH 8.0, 1% sarcosyl.  Store 
at room temperature.  Add 160 ml proteinase K per 5 ml digestion buffer for a final 
proteinase K concentration of approximately 0.5 mg / ml immediately before use. 
16. TE:  10 mM Tris pH 8.0, 1mM EDTA pH 8.0 
17. TE/glycerol solution. (10 mM Tris, 1 mM EDTA, 50% glycerol(w/v),  pH 8.0) 
18. Saturated PMSF in isopropanol:  Add isopropanol to PMSF crystals to make a 
saturated solution. Some PMSF crystals should remain undissolved in the bottom of the 
container.  Store at room temperature. 
 
2.3.6 Enzymatic digestion of high molecular weight DNA for PFGE 
1. Standard single edge safety razor blades. 
2. 1.5 mL eppendorf tubes. 
3. NEB buffer 3 (cat. #B7003S, New England Biolabs, Beverly, MA) or other suitable 
buffer for the restriction enzyme of choice. 
4. EcoRV restriction enzyme (ca.# R0195L, New England Biolabs, Beverly, MA) 
5. Warm room capable of maintaining 37°C or environmental incubator shaker capable of 
maintaining 37°C. 
6. Mini-Labroller with 1.5 ml eppendorf tube holder attachment or equivalent (Labnet 
International). 
 
2.3.7 Preparation of agarose gel for PFGE 
1. Pulsed field certified (PFC) grade agarose (cat. #162-0137, Bio-Rad Laboratories, 
Hercules, CA). 
2. 125 mL clean glass bottle with screw-cap lid. 
3. 500 mL pyrex beaker. 
4. Hot plate. 
5. Nanopure H2O. 
6. Bio-Rad agarose gel casting system (cat. #107-3689, Bio-Rad Laboratories, Hercules, 
CA). 
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7. Bio-Rad universal comb holder and 15 or 20 well comb (cat. #170-3699; 170-3627; 
170-4322, Bio-Rad Laboratories, Hercules, CA). 
8. Bio-Rad leveling table (cat. #170-4046, Bio-Rad Laboratories, Hercules, CA). 
9. Parafilm M sealing film (cat. #PM-996, SPI supplies). 
10. 0.5x TBE (45.5 mM Tris / 45.5 mM Borate/ 2.0 mM EDTA):  To 1000 mL nanopure 
H2O add 6.6 g Boric acid, 12.94 g TRIS base, and 4.8 mL of a 500mM EDTA  pH 8.0 
solution.  Bring volume up to 2400 mL with water.  Make fresh before each use. 
 
2.3.8  Loading digested DNA samples into the agarose gel for PFGE 
1. 0.5x TBE. 
2. 200 µL Pipetman (Gilson or similar) and tips. 
3. Low-melting-point (LMP) agarose, analytical grade (cat. #V2111, Promega, Madison, 
WI). 
4. DPBS (cat. #21-031-CV, Mediatech, Manassas, VA). 
5. Standard single edge razor blade. 
6. Environmental incubator shaker capable of maintaining 50°C. 
7. S. cerevisiae chromosome molecular weight markers (New England Biolabs:  cat. 
#N0345S).  Store at -20°C. 
 
2.3.9  Loading and running pulsed field electrophoresis gels 
1. Bio-Rad CHEF MAPPER XA with cooling module system (Bio-Rad Laboratories). 
 
2.3.10  Ethidium staining and preparing the gel for in-gel hybridization of a 
radiolabeled probe 
1. Gel imaging documentation system 
2. Flat stainless steel pan 
3. Hybridization oven. (TECHNE) 
4. Kimwipes (Kimberly-Clark). 
5. Ethidium bromide:  1% solution in water stored at 4°C.  CAUTION:  Ethidium 
bromide is a known carcinogen.  Wear suitable respiratory protection when manipulating 
ethidium bromide powder. 
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6. Ethidium bromide/glycerol solution.  To 197 mL nanopure H2O add 3 mL 50% 
glycerol solution (w/v) and 15 µL of the 1% stock solution of ethidium bromide. 
 
2.3.11  PCR reaction:  non-radiolabeled Southern blot probe template preparation 
and radiolabeled 45S rDNA Southern blot probe generation 
1. Oligonucleotides:  rDNA11-T:  GGGCTCGAGATTTGGGACGTCAGCTTCTG and                
                                  rDNA11-B:  GGGTCTAGAGTGCTCCC TTCCTCTGTGAG 
2. Thermocycler (e.g., Mastercycler gradient, Eppendorf Scientific) 
3. dGATC-TP nucleotide mix, combined and diluted to a final concentration of 10 mM 
each nucleotide (cat. #10297-018, invitrogen, Carlsbad, CA). 
4. dGCT-TP nucleotide mix, combined and diluted to a final concentration of 40 µM 
each nucleotide (see Note 2). 
5. dATP diluted to a final concentration of 20 µM. 
6. α-32P-dATP (50 uCi at 3000 Ci/mmol) (Perkin Elmer) 
7. TAQ polymerase (New England Biolabs) 
8. 10x TAQ buffer (New England Biolabs) 
9. spin-50 mini-column (USA Scientific) 
10. FlexiGene DNA Kit (Qiagen). 
11. Illustra GFX PCR DNA and Gel Band Purification Kit (GE Biosciences). 
 
2.3.12  Southern blot analysis using in-gel hybridization of the radiolabeled rDNA 
probe 
1.  Hybridization tube (TECHNE) 
2.  Nylon mesh (PGC Scientifics) 
3.  Hybridization oven (TECHNE) 
4.  Polyvinyl-chloride plastic wrap 
5.  Molecular Probes Phosphor Screen (GE Lifesciences) 
6.  PhosphorImager  (e.g., Storm 860, Molecular Dynamics) 
7.  SYBR®safe stain (Invitrogen) 
8.  Denaturation solution (0.4N NaOH, 0.8M NaCl):  1.6 g of NaOH pellets and 4.67 g 
NaCl dissolved in water to 100 mL.  Make fresh before use. 
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9.  Neutralization solution (0.5M Tris pH 8.0, 0.8M NaCl):  Add 4.67 g NaCl to 50 ml of 
1M Tris pH 8.0 solution and add water to 100 mL final volume.  Make fresh before use. 
10.  20x SSC (3M NaCl and 300mM sodium citrate):  Dissolve 175.4 g of NaCl and 88.2 
g of sodium citrate dihydrate in 800 ml nanopure H2O.  Adjust volume to 1 liter. 
11.  Hybridization solution (2x SSC, 7% SDS, 0.5% Hammersten casein):  Add 100 mL 
20x SSC to 700 mL nanopure H2O.  Warm to 65°C.  Dissolve 70 g SDS and 5 g 
Hammersten casein (USB corp. cat. #12840).  Adjust volume to 1 liter.  Store at room 
temperature.  CAUTION:  SDS power fines are very irritating.  Wear suitable respiratory 
protection. 
12.  Wash solution 1 (2x SSC and 0.1% SDS):  Add 10 mL of 20x SSC to 89 ml 
nanopure H2O.  Lastly add 1 mL of a 10% SDS solution and mix well.  Make fresh 
before each use. 
13.  Wash solution 2 (0.5x SSC and 0.1 % SDS) Add 2.5 mL of 20x SSC to 96.5 ml 
nanopure H2O.  Lastly add 1 mL of a 10% SDS solution and mix well.  Make fresh 
before each use. 
 
2.4 Methods. 
2.4.1 Thawing cryopreserved cells 
1.  Prepare a tissue culture plate with pre-warmed culture medium at least an hour before 
thawing cells allowing for ample time for it to equilibrate to the correct pH and 
temperature in the tissue culture incubator at 37°C and with 5% CO2.   
2.  Remove a vial of frozen cells from liquid nitrogen storage and wipe it down with 70% 
EtOH in a laminar flow tissue culture hood. 
3.  Open the vial slightly to allow the gas pressure inside the cryovial to equalize with the 
ambient atmosphere.  Close the vial of cells and continue thawing in your gloved hand 
until there is a still-frozen pellet in thawed liquid that is mobile when the tube is shaken. 
4.  Shake the vial vigorously, then remove the lid from the vial and pour the liquid and 
semi-frozen pellet of cells into the medium of the prepared tissue culture dish.  Swirl the 
cells to thaw the residual frozen pellet and to get an even distribution of cells across the 
plate.  Place the plate containing the cells immediately back in the tissue culture 
incubator overnight. 
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5. The next day the medium should be replaced to get remove any residual 
cryopreservative from the freezing media.  For adherent cells the medium should be 
aspirated off and replaced with fresh pre-warmed medium.  For non-adherent cells the 
cell suspension should be removed to a 15 mL conical tube and centrifuged at 200 g for 5 
minutes.  The media can then be aspirated off and the resulting cell pellet be resuspended 
in pre-warmed culture medium and placed in a new tissue culture plate. 
 
2.4.2  Subculturing cells 
1.  Once the cells are growing and semi-confluent in their tissue culture dish, remove the 
cells from the incubator and place them in a laminar flow tissue culture hood.  For non-
adherent cell lines, skip to step 6. 
2.  Aspirate the medium completely from the plate. 
3.  Add an appropriate amount of trypsin/EDTA solution to the plate making sure that the 
entire bottom surface of the plate is evenly covered.  For a 10-cm dish 2 mL is typically 
sufficient. 
4.  Allow cells to sit for several minutes while gently rocking the plate to maintain an 
even distribution of the solution and monitor the cells as they start to detach from the 
plate.  The amount of time it takes for the cells to detach will vary widely depending on 
the cell type, however, this is easily determined by careful observation. 
5.  Once most of the cells have detached add 2x the volume of culture medium containing 
at least 5% FBS.  The FBS in the culture medium inactivates the trypsin and prevents it 
from damaging the cells through prolonged exposure.  If the trypsin is not inactivated, 
prolonged expose can cause the cells to lyse. 
6.  Pipette the cells up and down vigorously in order to break up any clumps and to 
ensure all cells have detached from the plate and are homogenously suspended. 
7.  Once you have a single cell suspension distribute the suspension among new culture 
dishes with pre-warmed medium in a ratio that is ideal for the cell line of interest.  This 
can typically range from a 1:3 dilution for slower growing cells to a 1:10 dilution for 
faster growing cells such as HeLa. 
 
2.4.3  Deriving and expanding clonal lines 
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When the GCI assay is used to determine ongoing genomic instability in cultured cell 
lines it requires the development of clonal lines derived from a given cell line. 
1.  Start by preparing a single cell suspension in the same fashion as you would above as 
if subculturing the cells.  The single cell suspension is then used to prepare a limiting 
dilution series and derive colonies grown from a single cell. 
2a.  For adherent cells set up a dilution series and plate the cells in 10-cm plates at 1:10; 
1:50; 1:250; 1:500; 1:1000; 1:2000; and 1:4000 dilutions. 
or 
2b.  For non-adherent cells determine the cell density with a hemocytometer or flow 
cytometer, then dilute cells suitably with medium and aliquot cells into separate 96-well 
V-bottom plates at dilutions of 100 cells/well; 10 cells/well; 5 cells/well; 1 cell/well; and 
1 cell/5 wells.  Place cells into all 96 wells for each of the plates used (see Note 3). 
Over the next 8 to 14 days colonies from begin to form either on plates for adherent cells 
or in wells for non-adherent cells. 
3.  For adherent cells only:  once colonies are sufficiently 2-3mm in diameter they can be 
picked from the plate with a 20 µL pipette and moved to a single well in a 96-well tissue 
culture plate.  For fragile cells, partial trypsinization by treatment with trypsin/EDTA 
solution diluted 10:1 with DPBS will help ensure cell integrity in the colony transfer 
process.  Henceforth, treat adherent and non-adherent cultures similarly. 
4. For all cells:  clones should be expanded from 96-well plates to 24-well plates, 6-well 
plates and finally 10 cm dishes successively.  Cells should be allowed to grow to 
confluency before each expansion step.  Once confluent they are subcultured as described 
above using smaller volumes of trypsin/EDTA solution for adherent cells:  50 µl per each 
well of a 96-well plate, 200 µl per well for 24-well plates, 500 µl per well for 6 well 
plates.  Each step represents approximately a 1:4 expansion of the cells, which in our 
hands works well for almost any line chosen. 
 
2.4.4  Preparing cultured cells for high-molecular weight solid-phase DNA isolation 
1.  Melt certified nuclease-free low-melting-point (LMP) agarose at 1.2% weight/volume 
in DPBS (phosphate-buffered saline without Ca+2 or Mg+2, tissue culture grade) at 
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70°C, place the melted gel solution in a waterbath or oven at 42°C and allow the 
temperature to equilibrate. 
2.  With adherent cells, treat with trypsin/EDTA to detach cells followed by addition of a 
2x volume of culture medium and pipeting up and down in a serological pipette to 
achieve a single cell suspension.  Likewise non-adherent cells can simply be pipetted up 
and down to break up clumps and create a single cell suspension.   From this point cells 
are stored on ice at all times except during centrifugation which can be performed at 
room temperature. 
3.  Remove the suspension to a 15-mL conical vial and centrifuge at 200 g for 5 minutes. 
4.  Resuspend the cells in 10 mL DPBS to rinse. 
5.  Determine the concentration of cells with either a hemocytometer or flow cytometer. 
6.  Centrifuge cells at 200 g for 5 minutes and aspirate the DPBS rinse solution. 
7.  Resuspend cells in DPBS to a final concentration of 3x107 cells / ml, taking into 
account the non-zero volume of the pelleted cells themselves.  Store cells on ice 
temporarily if necessary. 
8.  Add two volumes of melted 1.2% LMP agarose solution to the 3x107 cells / ml cell 
suspension for a final concentration of 1x107 cell/ml in 0.8% LMP agarose and mix 
thoroughly by vortexing. 
9.  Draw the cell/gel suspension into a 1 ml syringe and immediately place the syringe on 
ice and cover with ice to solidify the agarose before the cells have a chance to settle. 
10.  After the agarose solution has solidified cut the end off the syringe with a single 
edged razor blade and extrude the DNA/agarose “worm” carefully into an 8 ml flat-
bottomed tube. 
11.  Add 5 ml of digestion buffer with proteinase K, invert gently several times to mix 
and incubate overnight at 50°C with gentle agitation (see Note 4). 
12.  After suitable digestion has cleared the appearance of the DNA/agaorse, remove the 
DNA/agarose “worm” to a fresh 50 ml tube, add 40 ml TE and agitate gently at room 
temperature for 30 minutes.  Do this step twice. 
13. Decant the TE and transfer the “worm” to a new 8 ml flat-bottomed tube. 
14.  Add 6 ml TE and 6 µl saturated PMSF in isopropanol.  Mix well and gently agitate at 
room temperature for 60 minutes. 
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15.  Remove the TE/PMSF solution and add 6 mL of fresh TE without PMSF to rinse 
with gentle agitation at room temperature for 30 minutes.  Do this step twice. 
16.  Pour off the TE and add back chilled TE-glycerol and gently agitate at 4°C for 30 
minutes. 
17.  Remove the TE/glycerol and add back 6 ml fresh TE/glycerol.  Gently agitate 
overnight at room temperature. 
18.  Cut off the tip of a fresh 1 mL syringe with a clean razor blade and transfer the 
TE/glycerol equilibrated agarose “worm” into this syringe.  Seal the syringe with 
Parafilm and store indefinitely at -20°C. 
 
2.4.5  Enzymatic Digestion of high molecular weight DNA for PFGE 
1.  Agarose/DNA slices of ∼15 μL volume are cut from the high molecular weight 
DNA/agarose “worms” prepared and stored in 1 ml syringes with a standard single edge 
razor blade.  Each slice should be approximately 0.8 to 0.9 mm thick.  It is helpful to 
practice your slicing technique with an agarose “worm” that does not contain DNA, 
measuring slice volumes on an analytical balance until uniform thickness slices can be 
consistently achieved.  Aim for a consistent slice weight of approximately 15 mg. 
2.  Place the DNA-containing agarose slice inside the lid of an inverted 1.5 mL eppendorf 
tube.  The lid of an inverted 1.5 mL eppendorf tube provides a perfect sized container for 
the slice with a flat bottom and walls that also holds 200 µL of buffer. 
3.  Remove the glycerol/TE from the slice by washing the slice in the lid of the 1.5 ml 
eppendorf tube 3 times with 200 µL of 1x NEB buffer 3 by pipetting gently up and down 
so the slice is agitated in the buffer solution and then pipetting off the wash solution.  
Take care not to damage the slice with the pipette tip during the washes. 
4.  Remove the last wash and replace with 200 µL of NEB buffer 3 containing 20 units of 
EcoRV restriction enzyme. 
5.  While keeping the eppendorf tube inverted, gently but firmly close the eppendorf tube 
lid.   Mount the inverted eppendorf tube in the Mini-Labroller at 30° off vertical so that 
when the Labroller is turned on the tubes will be gently agitated while maintaining their 
inverted orientation.  Place the Labroller with the inverted eppendorf tubes in a 
warmroom at 37C overnight, and turn on the Labroller. 
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6.  The next day, remove the Labroller apparatus with eppendorf tubes from the warm 
room.  Remove the inverted eppendorf tubes from the Labroller, while maintaining their 
inverted orientation. 
7.  Rinse the agarose slices containing the now digested genomic DNA with 0.5x TBE by 
pipetting gently up and down and then pipetting off the rinse, taking care not to disrupt 
the delicate agarose slices with the pipette.  Do this rinse twice.  Additionally, slice off 
and likewise rinse a thin sample of S. cerevisiae chromosome molecular weight markers. 
8.  The slices are now ready to load into the pulsed-field gel.  Leave the slices in the final 
rinse solution in sealed inverted eppendorf tubes until ready to load the samples. 
 
2.4.6  Preparation of an agarose gel for PFGE 
1.  Make 2.4 L of 0.5x TBE. 
2.  Place 1 gram of PFC grade agarose into a 125 ml glass bottle (eg. Kimax) along with 
100 ml of 0.5x TBE.  Gently swirl to ensure the agarose is hydrated and non-clumpy.  
Try not to let agarose clumps adhere to the walls of the bottle above the liquid.  Cap the 
bottle tightly. 
3.  Place 250 ml water in a 500 ml glass beaker and bring to a gentle boil on a hot plate.  
Melt the agarose in 0.5x TBE by placing the sealed bottle containing the agarose/0.5x 
TBE mixture into the boiling water bath.  Heat with periodic gentle swirling until all the 
agarose has been completely homogenously melted.  The melted agarose solution should 
be clear, colorless and featureless when swirled. 
4.  Allow the melted agarose to cool only slightly (less than 5 minutes) on the benchtop 
prior to pouring into the gel casting set up.  This should be ample time to set up the 
casting apparatus.  We have found the pouring the gel while it is hot produces optimal 
resolution of the gene cluster bands.  The gel casting system should be set up with the 
universal comb holder and 15 or 20 well comb and placed flat on a Bio-Rad (or similar) 
leveling table. 
5.  Once the casting apparatus is prepared pour the melted agarose solution slowly into 
the casting tray trying to avoid forming any bubbles.  Eliminate any bubbles that may 
arise while the agarose solidifies.  Pay special attention to any bubbles that might form 
along the wells of the comb and the edges of the casting tray.  Allow the gel to solidify at 
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room temperature on the benchtop for one hour.  Then, place the solidified gel, still in the 
casting tray, in a refrigerator at 4°C for an additional hour.  The gel will then be ready for 
loading the prepared DNA samples (see Note 5). 
 
2.4.7  Loading digested DNA samples into the agarose gel for PFGE 
1.  Place a mixture of 0.8% LMP agarose suspended in 0.5x TBE into a tightly capped 50 
ml plastic conical tube and heat in a boiling water bath until the agarose mixture is 
uniformly melted.  Remove from the bath and place at room temperature (see Note 6). 
2.  Remove the solidified pulsed-field gel from the refrigerator and carefully remove the 
comb from the wells. 
3.  Remove the 0.5x TBE final buffer rinse from the first agarose slice in the lid of an 
inverted 1.5 ml eppendorf tube.  Gently flick the lid of the eppendorf tube onto a clean 
razor blade so the gel slice lands flat on the razor blade.  Remove excess liquid from the 
gel slice with a pipette tip or the corner of a Kimwipe (see Note 7). 
4.  Push the slice from the razor blade into the well of the gel with a clean pipette tip.  
Make sure that the agarose slice flatly contacts the front of the well facing the direction in 
which the gel will be run.  Allowing the slice to stick to the back of the well instead will 
compromise the resolution and final location of resulting bands. 
5.  Gently push the slice down into the well until the bottom of the slice rests on the 
bottom of the well, then fill the remaining space in the well carefully with melted 0.8% 
LMP agarose. 
6.  Repeat this step for each sample to be loaded, including the S. cerevisiae chromosome 
molecular weight markers. 
7.  Once the samples are all loaded the gel should be allowed to sit at room temperature 
for 10 minutes to allow the sealing agarose to begin to set (see Note 8). 
8.  Next the casting stand should be removed taking care not to dislodge the gel from the 
black running platform. 
9.  Wipe away any accumulated gel waste on the bottom of the running platform.   
10.  The gel and platform should then be placed at 4°C for 30 minutes.  Again this step is 
essential for optimal resolution. 
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2.4.8  Loading and running the Bio-Rad CHEF MAPPER apparatus for PFGE 
We have found that the optimal range for GCI analysis of the human rDNA gene clusters 
is from 50 kb up to 1 Mb.  The instructions and the algorithm provided here are 
optimized for this size range.  If this methodology is used to look at gene clusters other 
than the rDNA or in of size ranges of the rDNA clusters the conditions will require 
optimization for the desired size range.  Consult Birren and Lai (Birren 1993) for more 
details. 
1.  Once the gel is loaded and has been chilled at 4°C, place the remaining 0.5x TBE 
buffer into the electrophoresis cell of the Bio-Rad CHEF MAPPER XA system. 
2.  The buffer pump should be turned on to circulate buffer and eliminate air bubbles 
from the system before the gel is place into the cell. 
3.  Once this is done turn the pump off and place the gel into the cell making sure the 
retention bracket is in place to prevent the gel from moving and that the wells are 
oriented at the top of the gel relative to the direction the DNA is going to travel. 
4.  Close the lid and make sure the safety interlock is engaged and turn the buffer pump 
back on. 
5.  Engage the cooling module of the Bio-Rad CHEF MAPPER XA system and allow it 
to cool the buffer and the gel to 14°C. 
6. Enter a two state program such that the electrical field vector included angle is 120° 
and the electrical field strength for each vector is 6V/cm.  Set the run time for 24 hours 
and the switch time from 3 seconds to 90 seconds with a ramp factor of 0.357.  Once you 
are sure the algorithm is entered correctly and the chiller has cooled the buffer and gel to 
14°C press “START” on the MAPPER.  Look for bubbles from the electrodes to be sure 
the gel is running correctly. 
 
2.4.9  Ethidium staining and drying the gel in preparation for in-gel hybridization 
with a radio-labeled probe 
The next day, after the PFGE program has completed running, the gel can be stained with 
ethidium bromide and visualized to determine the outcome.  The gel also needs to be 
prepared for in-gel hybridization of the radiolabeled probe.  The in-gel hybridization 
involves drying the gel so that it is thin enough to permit the probe to easily diffuse into 
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and out of the gel yet not so thin as to shatter.  This is accomplished by equilibrating the 
gel to a final concentration of 0.5% glycerol and then drying the gel at 65°C (see Note 9). 
1.  After the PFGE program has finished its run carefully remove the gel and place it in 
200 ml of ethidium bromide/glycerol solution.  Including the 100 ml volume of the gel, 
the final concentration of glycerol will be 0.5%.  Incubate at room temperature for 30 
minutes with gentle agitation. 
2.  After incubation the gel can be placed on the imaging system so that the ethidium 
stained gel can be documented.  Here it is important to minimize the amount of UV 
exposure as it can degrade the DNA especially in the presence of EtBr.   
3.  After the ethidium stained gel has been documented the surfaces of the gel are dried 
with a Kimwipe.  Place the gel upside-down on a flat surface such that the flat side of the 
gel is on top.  Fold up two Kimwipes together, then partially wet one edge of the folded 
Kimwipes with 0.5% glycerol solution and use this pre-wet edge of the Kimwipe 
“sandwich” to wick liquid from the top surface of the gel.  Using the partially wet edge of 
the Kimwipes will prevent the Kimwipes from adhering to the gel surface.  Similarly 
wick liquid away from all sides of the gel.  Now invert the gel so the flat wiped-dry face 
points down and place the gel in a metal pan.  Wick any remaining liquid from the top 
surface of the gel using Kimwipes (see Note 10). 
4.  Place the gel and pan in the hybridization over at 65°C until the gel appears 
homogenously dry and flat.  The gel will dry to a thickness similar to a sheet of paper.  
The gel can be left overnight to dry but we have found that removal of the gel 
immediately after it finishing drying results in better hybridization of the radiolabeled 
probe and thereby better results. 
5.  Once the gel is dry it can be processed immediately or stored covered with PVC wrap 
(eg. Saran Wrap) for up to 2 weeks in a dark dry area. 
 
2.4.10  Preparing the template DNA for PCR radiolabeling 
Template DNA is prepared by PCR-amplifying a region of the rDNA gene from human 
genomic DNA using primers 5′-GGGCTCGAGATTTGGGACGTCAGCTTCTG and   
5′-GGGTCTAGAGTGCTCCC TTCCTCTGTGAG, to yield a 532-bp fragment.  The 
PCR product can be subsequently digested with XhoI and XbaI and subcloned into 
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pBluescript II SK− or other suitable cloning vector for long term propagation.  It is also 
possible to simply use the PCR product as a template in the subsequent radiolabeling 
PCR reaction directly without subcloning, although this is not recommended. 
1. Isolate human genomic DNA from any human cell line using a Qiagen FlexiGene 
DNA kit.  Dissolve the DNA to a final concentration of 1 ml/ml in water. 
2. Set up the following PCR reaction: 
2.0 µl 10x TAQ buffer with MgCl2 
1.0 µl genomic DNA at 1 µg/µl 
0.4 µl dGATC-TP nucleotide mix at 10 mM each nucleotide 
2.0 µl rDNA11-T primer at 1 µM concentration 
2.0 µl rDNA11-B primer at 1 µM concentration 
0.4 µl TAQ DNA polymerase (2U total) 
12.2 µl water 
20 µl FINAL VOLUME 
 
3. Run the following PCR program with lid temperature set to 105C: 
#    Instructions Comment 
1. 94°C for 3 minutes initial denaturation 
2. 94°C for 30 seconds denature 
3. 45°C for 30 seconds anneal 
4. 72°C for 1 minute, plus 2 seconds per cycle extend 
5. goto step 2, repeat 29 times 30 cycles total 
6. 72°C for 7 minutes polish 
7. hold at 4°C store indefinitely 
 
4.  Run the complete PCR reaction on a 1% agarose gel with suitable size makers. 
5.  Stain with ethidium bromide, visualize with UV light and excise the 523bp band with 
a clean razor blade. 
6.  Purify the template DNA from the gel slice using the GFX Kit. 
7.  Quantify the recovered DNA using Hoechst 33258 fluorimetry or similar 
methodology.  Store at -20°C. 
8.  Optional, but recommended:  Subclone the PCR product into a convenient cloning 
vector and have sequenced to ensure the rDNA probe is correct. 
 
2.4.11  Preparing the radiolabeled 45S rDNA probe 
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The radio labeled probe is prepared by PCR using a32P radiolabeled dATP.  This method 
yields a probe that has very high specific activity (see Note 11). 
1. If using plasmid as a template, dilute an aliquot of concentrated plasmid stock 
solution to 50 pg/ml.  If using isolated PCR product as a template, dilute an 
aliquot of the PCR product to 10 pg/ml (see Note 12). 
2. Set up the following PCR reaction: 
2.0 µl 10x TAQ buffer with MgCl2 
2.0 µl rDNA containing plasmid at 50 pg/µl or PCR product at 10 pg/µl 
2.0 µl rDNA11-T primer at 1 µM concentration 
2.0 µl rDNA11-B primer at 1 µM concentration 
5.0 µl α32P dATP (50 µCi @ 3000 Ci/mmol) 
2.0 µl dGTC-TP at 40 µM concentration each 
1.0 µl dATP at 20 µM concentration – not radioactive 
0.4 µl TAQ DNA polymerase (2U total)  
3.6 µl water 
20 µl FINAL VOLUME OF THE REACTION 
 
3. Run the following PCR program with lid temperture set to 105C: 
#    Instructions Comment 
1. 94°C for 3 minutes initial denaturation 
2. 94°C for 30 seconds denature 
3. 45°C for 30 seconds anneal 
4. 72°C for 1 minute, plus 2 seconds per cycle extend 
5. goto step 2, repeat 39 times 40 cycles total 
6. 72°C for 7 minutes polish 
7. hold at 4°C store indefinitely 
 
4. After the PCR reaction the probe is separated from the unincorporated nucleotides 
and primers with a USA scientific spin-50 mini-column.  The radiolabeled probe 
is in the flow-through non-bound liquid phase (see Note 13). 
5. Boil the probe for 2 minutes in a boiling water bath and then snap cool on water-
saturated ice with periodic agitation for 2 minutes. 
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6. The probe should be kept on ice until it is used for hybridization.  The probe 
should be used immediately rather than stored long-term to avoid radiolytic 
degradation. 
 
2.4.12  In-gel hybridization of the radiolabeled rDNA probe and Southern analysis 
While the radiolabeled probe is being prepared the dried gel can be processed to 
prepare it for hybridization. 
1.  Place the dried gel into H2O for 10 minutes with gentle agitation and allow it to 
rehydrate. 
2.  After that the gel should be easily removable from the surface of the pan and can be 
placed in a deeper stainless steel pan or glass dish for the subsequent washes. 
3.  Wash the gel with 100ml of H2O for 5 minutes.  Do this step twice. 
4.  Remove the water and replace it with 100ml of denaturation solution, incubate for 30 
minutes with gentle agitation. 
5.  Remove the denaturation solution and replace it with 100 ml of neutralization 
solution, incubate for 30 minutes with gentle agitation. 
6.  Remove the gel from the neutralization solution and transfer it to a hybridization roller 
tube placing nylon mesh between the gel and the glass surface.  The mesh allows the gel 
to get an even exposure to hybridization solution on both sides. 
7.  Pre-hybridize the gel for 3 hours in 35 ml of hybridization solution at 65°C in the 
hybridization oven. 
8.  After 3 hours replace the hybridization solution with 25 ml of fresh pre-heated 
hybridization (65°C) solution. 
9.  Add the radiolabeled probe directly into the hybridization solution and close the end 
caps on the bottle.  Place the hybridization tube back in the hybridization oven at 65°C 
and allow the gel to hybridize for at least 12 hours (see Note 14). 
10.  Following hybridization, remove the cap from the hybridization tube and discard the 
radioactive solution appropriately.  Add 50 ml of wash solution 1.  Place the tube back in 
the hybridization oven and incubate for 30 minutes at 65°C. 
11.  Discard the wash solution 1 from the hybridization tube and add 50 ml of fresh wash 
solution 1 for and additional 60 minutes at 65°C. 
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12.  Discard the wash solution 1 and rinse the gel twice with wash solution 2.  Each wash 
uses 50 ml solution 2 and a two hour incubation at 65°C. 
13.  Remove the gel from the hybridization tube and rinse briefly in 2x SSC. 
14.  Place the washed gel in all-purpose polyvinyl-chloride plastic wrap (Saran Wrap or 
equivalent) so that it does not dry out, being careful to blot up excess liquid with a paper 
towel or Kimwipe. 
15.  Expose the gel on a PhosphorImager screen overnight and detect the following day 
on a Molecular Dynamics Storm PhosphorImager or similar (see Note 15). 
16.  After data is acquired the gel can be stained in a 1:10,000 dilution of SYBR®safe 
dye.  This fluorescently stained gel can be scanned on the Molecular Probes Storm 
PhosphorImager in fluorescent mode to give an accurate representation of the location of 
the size markers on the dehydrated gel. 
17.  Process the gel image using suitable image processing software.   
 
Table 2.1. Adobe Photoshop and the following algorithm: 
1. Convert the image to 8-bit grayscale and save in TIFF format. 
2. Crop the image suitably. 
3. Adjust the levels of the grayscale to maximize the difference between the 
white background and the darkest band present. 
4. Blur using the following horizontal band-enhancing 
custom filter with a scale factor of 105 and zero offset to 
leave overall intensities unchanged: 
 
 
1 1 1 1 1 
5 5 5 5 5 
9 9 9 9 9 
5 5 5 5 5 
1 1 1 1 1 
5. Unsharp mask:  200% with 5.0 pixel radius and zero threshold. 
6. Unsharp mask again:  50% with 3.0 pixel radius and zero threshold. 
 
  
2.5  Notes 
1.  The radiolabeled probe sequence and restriction enzymes described herein are specific 
for the human rDNA sequence.  Gene cluster analysis in other other species and/or with 
non-rDNA clusters will require a different suitable choice of Southern hybridization 
probe and restriction enzymes. 
2.  There is no dATP in this solution.  Low concentration dATP will be added separately. 
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3.  The V-bottoms on the 96-well plates tend to concentrate the diluted cells and 
drastically improve non-adherent cell plating efficiencies at these low dilutions.  In most 
cases use of these V-bottom plates is indispensable.  Single plates are usually sufficient 
for the higher dilutions but it is usually necessary to prepare up to 10 plates at the two 
lowest dilutions. This way of deriving single cell colonies relies on a probability 
distribution and on the plating efficiency of the cell line.  To be reasonably confident that 
all the clones at a given dilution level arose from a single cell, that dilution needs to 
produce no more than 10 wells showing growth per 96-well plate.  Colonies are only 
expanded from this lowest dilution plate. 
4. Incubation in digestion buffer should be allowed to proceed until the initial cloudy 
appearance of the agarose “worm” has cleared.  For some cell types, this may take two 
days rather than overnight.  It is permissible to incubate the DNA/agarose at 50°C in 
digestion buffer for longer periods of time if convenient. 
5. Placing the gel on the benchtop for an hour and then leaving it at 4°C for an hour may 
seem trivial, however, in our hands this procedure gives reproducibly sharp bands when 
the gel is run. 
6. The 0.8% LMP agarose will be used to seal the digested agarose slices into the wells of 
the pulsed-field gel.  The 0.8% LMP agarose usually takes at least 30 minutes to solidify 
at room temperature in the 50 ml plastic tube after removal from the boiling water bath, 
which is easily sufficient time for loading the pulsed-field gel. 
7.  Sometimes, particularly with extra thin agarose slices, the slice may flick out of the 
eppendorf tube and land on the razor blade folded in half.  If this should happen, the slice 
can be gently unfolded by pipetting 100 µl 0.5x TBE buffer onto the folded slice in a 
manner that swirls the liquid.  After the slice has unfolded, wick away the excess liquid 
with a Kimwipe. 
8.  Since the gel was at 4°C prior to loading, the 0.8% agarose will solidify rapidly after 
addition to the wells. 
9.  Never run PFGE with gels that have ethidium bromide already in them – the ethidium 
bromide intercalates the DNA and will drastically effect run time and results. 
10.  Be sure that there is no liquid trapped under the gel between the gel and the pan.  
Gels will shatter upon drying if there is residual trapped liquid. 
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11.  To avoid chain termination by misincorporation of unlabeled dNTPs, it is necessary 
to decrease the concentration of the unlabeled dNTPs to be similar to that of the limiting 
radiolabeled dATP (Mertz and Rashtchian 1994). 
12. We have found it helpful to store the template in concentrated form and to dilute 
aliquots suitably for each labeling reaction.  Storing very dilute solutions of DNA long-
term is not recommended as adherence to the container of the DNA solution can 
dramatically reduce the DNA concentration and the final yield of radiolabeled product. 
13. The degree of radiolabeling can be roughly measured by using a Geiger counter to 
observe the amount of radioactivity in the liquid flow-through vs that trapped in the spin-
column.  For a successful radiolabeling reaction, the liquid should have at least twice as 
much radioactivity as the column. 
14. Longer hybridization times make no difference. 
15. We often re-expose the gel on the screen for an additional three-day exposure to give 
a good reduction in background noise and sharper bands. 
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2.6: FIGURES 
 
 
Figure 2.1:  Schematic of the restriction digestion procedure for liberating intact 
gene clusters from bulk genomic DNA.  Vertical arrows:  hypothetical restriction 
enzyme recognition sites; Open Rectangles:  individual repeated genes in a gene 
cluster.  Reproduced from  (Stults, Killen et al. 2008). 
 
 
 
 
Figure 2.2:  Schematic of expected results.  Solid horizontal lines:  gene cluster 
bands detected by Southern hybridization following size separation by pulsed-field 
electrophoresis; Dotted horizontal lines:  potentially allowable cluster lengths 
contrained by the requirement that recombination change cluster lengths by integer 
multiples of the unit repeat length; Small horizontal arrows:  minor-intensity gene 
cluster bands indicative of sub-populations within the culture possessing cluster 
lengths that have been altered by non-allelic homologous recombination (NAHR).  
Adapted from  (Killen, Stults et al. 2009). 
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Figure 2.3:  GCI analysis.  Panel A:  non-clonal cell lines.  Panel B:  clonal isolates of 
the U-2 OS population from A).  Brackets:  multiple bands of uneven intensity from 
mixed sub-populations in the U-2 OS parental population.  Star:  resolution limit of 
the pulsed field gel. 
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Figure 2.4:  GCI analysis of clonal cell lines:  Panel A:  subclonal isolates from the 
clonal U-2 OS-A line shown in Figure 3B.  Panel B:  subclonal isolates from the 
clonal U-2 OS-B line shown in Figure 3B.  Arrows:  minor intensity bands indicative 
of genomic restructuring during the expansion of the indicated subclonal lines.  
Open triangles:  gene clusters found in the subclonal lines but not found in the 
parental lines.  Open brackets:  gene clusters not found in the subclonal lines but 
present in the parental clonal lines.  Star:  resolution limit of the pulsed field gel. 
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CHAPTER 3: Configuration and rearrangement of the human GAGE gene clusters. 
 
*This chapter has been published:   Killen MW, Taylor TL, Stults DM, Jin W, Wang, 
LL, Moscow JA, Pierce AJ.  Am J Transl Res. 2011 May 15;3(3):234-42.  
 
 3.1: SYNOPSIS 
 
     The GAGE protein is detected only in cancer and in testis and is expressed from a 
cluster of nearly identical gene copies on the X-chromosome.  We determined the lengths 
of these GAGE gene clusters from human families, identical twins, and in clinical 
samples from cancer patients.  The GAGE cluster lengths proved to be highly 
heterogeneous, ranging from 13 to 39 gene copies, with an average content of 20 GAGE 
genes per cluster.  Low levels of meiotic rearrangement in families and mitotic 
rearrangement in adult solid tumors are detectable.  Analysis of Rothmund-Thomson 
syndrome (RTS) kindreds and probands showed GAGE cluster inheritance and stability 
indistinguishable from that found in non-RTS individuals.  These observations support 
the concept of evolutionarily rapid rearrangement of clustered repetitive sequences in the 
human genome. 
 
3.2: INTRODUCTION 
 
     GAGE is a member of the CT family of genes, defined as having expression only in 
cancer and in testis (reviewed in (Scanlan, Simpson et al. 2004)).  The founding member 
of the class, MAGE, was identified in melanoma cells using a T cell epitope cloning 
technique (van der Bruggen, Traversari et al. 1991).  Since that time the list of CT genes 
has expanded to include over 100 members (Almeida, Sakabe et al. 2009).  Importantly, 
many of the protein products of the CT genes have proven to be immunoreactive.  Since 
testis is an immunoprivileged site, this has opened the door to potential CT protein based 
immunotherapeutic strategies for cancer treatment.  Indeed, several early phase clinical 
trials have already been conducted with promising results (Marchand, van Baren et al. 
1999; Davis, Chen et al. 2004; Jager, Karbach et al. 2006; Odunsi, Qian et al. 2007; 
Uenaka, Wada et al. 2007). 
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     GAGE is a small, acid protein 117 amino acids (12.9 kDa) and has been found in 24% 
of melanoma samples, 25% of sarcoma, 19% of non-small cell lung cancers, 19% of 
head/neck tumors and 12% of bladder cancers (reviewed in (Gjerstorff and Ditzel 2008)).  
GAGE transcripts are seen in melanoma (De Backer, Arden et al. 1999; Eichmuller, 
Usener et al. 2002), lung cancer (De Backer, Arden et al. 1999), thyroid carcinoma 
(Ruschenburg, Kubitz et al. 1999; Maio, Coral et al. 2003), breast cancer (Mischo, 
Kubuschok et al. 2006), hepatocellular carcinomas (Kobayashi, Higashi et al. 2000) and 
ovarian cancer (30%) (Russo, Dalerba et al. 1996; Gillespie, Rodgers et al. 1998).  
Clinically, GAGE expression has been demonstrated to correlate with poor prognosis in 
stomach cancer (Kong, Koo et al. 2004), esophageal cancer (Zambon, Mandruzzato et al. 
2001) and neuroblastoma (Cheung, Chi et al. 2000).  The GAGE protein has been 
characterized as having anti-apoptotic activity, conferring resistance to Fas-ligand, taxol 
and gamma irradiation (Cilensek, Yehiely et al. 2002).  GAGE expression also confers 
cellular resistance to killing by interferon gamma (IFN-γ) through post-translational 
downregulation of interferon regulatory factor 1 (IRF1) with subsequent downregulation 
of caspases 1 and 7, and through stabilization of nucleophsomin (Kular, Yehiely et al. 
2009). 
 
     The GAGE transcript has five spliced exons, the first of which is untranslated.  The 
gene producing the GAGE transcript is multicopy, with a unit gene repeat of 9556 bp.  
Over one third of all CT genes have multiple gene copies in the genome, with 12 of the 
individual CT proteins expressed from at least six gene copies each (Hofmann, Caballero 
et al. 2008).  The multiple copies of the GAGE gene are structured as a tandemly 
repeated cluster of at least 15 gene copies at Xp11.23.  The repeated genes in the GAGE 
cluster are oriented in a head-to-tail manner, without any intervening sequences.  The 
intimately clustered genomic structure is similar in nature to the clustered ribosomal 
RNA genes (rDNA) we have already characterized (Stults, Killen et al. 2008; Killen, 
Stults et al. 2009; Stults, Killen et al. 2009), as well as to other gene clusters elsewhere in 
the genome (Warburton, Hasson et al. 2008). 
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     The GAGE cluster is “young,” being found only in human, chimpanzee and macaque, 
is under apparent positive selection for protein function and has undergone steady copy 
number expansion of the last 4 million years (Liu, Zhu et al. 2008).  Other CT-genes on 
the X chromosome are similar:  recent evolutionary additions diverging faster and under 
stronger selection than either CT-genes found on autosomes, or non-CT genes on the X 
chromosome (Stevenson, Iseli et al. 2007).  In this work, we describe a physical assay we 
developed to measure the number of gene copies in each GAGE cluster.  We used this 
assay with blood samples from human families, human cancer susceptibility (Rothmund-
Thomson syndrome) kindreds and probands, and clinical specimens from human cancers 
to determine the range of human variation of the GAGE cluster, and the stability of the 
cluster under normal human meiosis and in the genomic pathology of human cancers. 
 
3.3: MATERIALS AND METHODS 
 
     High molecular weight genomic DNA was prepared in the solid phase from cells, 
blood and tissues embedded in agarose as described previously (Killen, Stults et al. 2009; 
Stults, Killen et al. 2009).  All human studies adhere to University of Kentucky protocols 
set forth in IRB #06-0576-F2L, “Correlation of Human Phenotypic Variation with 
Polymorphic rDNA Genomic Structure” filed by Dr. Andrew Pierce.  Genomic DNA was 
subjected to restriction digestion with StuI (New England Biolabs) unless otherwise 
noted, and loaded onto 1% PFC agarose (Bio-Rad) pulsed field gels.  Gels were run in 
0.5 x TBE (44.5 mM Tris base, 44.5 mM boric acid, 1 mM EDTA pH 8.0) for 20 hours 
with 6 V/cm electrical field vectors at 120º separation, with a switching frequency that 
varied linearly from 10" to 40", at 14°C.  Following electrophoresis, gels were 
equilibrated to 0.5% final concentration glycerol, dried, rehydrated and Southern blotted 
as described previously (Stults, Killen et al. 2008). 
 
     Southern probe templates specific to the GAGE cluster were isolated by PCR from 
human genomic DNA either with the primer set 1: GAGE-1F: 
GTCCTCCTTCCCTTCACAGG and GAGE-1R: TTCTCGTGATTGCTGCTTTG or 
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with primer set 2: GAGE-2F: AGACCCAGTTCAGAGGAGCA and GAGE-2R: 
CGTGAAGAACAAAGCACCAA. 
 
Radiolabeled Southern probes were generated by PCR amplification of the template 
products derived from human genomic DNA described above using the appropriate 
primer sets.  PCR conditions were: 
                          Reaction component                                                   PCR program 
2.0 TP @ 40 µM each 
1.0 µl dATP @ 20 µM (not radioactive) 
0.4 µl TAQ (2U) 
3.6 µl H2O µl TAQ buffer (10x) 
2.0 µl PCR product @ 10 pg/µl 
2.0 µl forward primer @ 1 µM 
2.0 µl reverse primer @ 1 µM 
5.0 µl α32P-dATP (50 µCi @ 3000 Ci/mmol) 
2.0 µl d(GTC) 
 
94°C 30 sec 
65°C 30 sec 
72°C 1 min + 2 sec/cycle 
• 40 cycles total 
72°C 7' 
hold at 4°C 
 
 
3.4: RESULTS  
 
     Our experimental strategy is shown in Fig. 3.1A.  For tandemly repeated genes with 
very high sequence identity, the gene cluster can be liberated from bulk genomic DNA by 
digestion with a restriction enzyme that lacks a recognition site in the unit gene repeat.  
The liberated cluster can be size-resolved by pulsed field gel electrophoresis, detected 
though Southern hybridization, and the number of gene copies inferred from the length of 
the cluster with a small correction for flanking non-cluster DNA.  Each repeat of the 
GAGE gene is 9556 bp.  We initially selected two different Southern probes with 
predicted minimal cross-reactivity to the reference human genome, and three different 
restriction enzymes, AvrII, StuI and SwaI to liberate the GAGE cluster from bulk 
genomic DNA (Fig. 3.1B).  Anticipating that evolutionarily rapid GAGE cluster 
restructuring due to homologous recombination would cause a diversity of cluster lengths 
in the human population, we assayed genomic DNA from two human females, with the 
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prediction that each X-chromosome would have a different sized GAGE cluster and 
thereby show two different length clusters, in a manner similar to the 5S rDNA gene 
cluster at 1q42 (Stults, Killen et al. 2008).  We were able to resolve these two predicted 
GAGE clusters (Fig. 3.1C) using either AvrII or StuI (SwaI failed to efficiently digest the 
agarose-embedded genomic DNA), and with either Southern probe.  The three bands seen 
with AvrII digestion in the FASHY individual suggests that the GAGE repeats do not 
share perfect sequence identity with each other, such that a cryptic AvrII site can exist 
within the cluster, a phenomenon we also observed in analysis of the 5S rDNA clusters.  
The non-GAGE flanking sequence according to the Human Genome Project is 3859 bp 
when the clusters are liberated by AvrII digestion (2828 bp telomeric and 1031 bp 
centromeric with respect to the GAGE cluster) and 9781 bp when liberated by StuI 
digestions (537 bp telomeric and 9244 bp centromeric with respect to the GAGE cluster).  
Consistent with the predicted smaller amount of flanking sequence after cluster liberation 
by AvrII relative to StuI, we observed that the GAGE clusters identified by Southern 
blotting are slightly shorter when liberated by AvrII than by StuI (Fig. 3.1C).  After 
verifying the DNA sequence of probe 2, we selected StuI and probe 2 as an optimal 
combination for further experiments. 
 
     To establish the range of normal human variation in GAGE cluster lengths and to 
determine the degree of meiotic cluster rearrangement, we analyzed the GAGE cluster 
lengths in human families (Fig. 3.2A).  We found strong heterogeneity in the lengths of 
the GAGE cluster ranging from 135 kb up to 380 kb, corresponding to from 13 to 39 
gene copies, after subtracting the predicted 9.7 kb of non-GAGE flanking DNA, with an 
average cluster length of approximately 20 GAGE repeats.  Females generally show two 
distinct GAGE clusters and males only one, consistent with the X-linkage of the cluster.  
We observed primarily predicted patterns of Mendelian inheritance without 
rearrangement, with the exception of one potential meiotic recombination event in the 
female germline of the PYFI family (Fig. 3.2A, blue dotted circle).  To further establish 
the reproducibility of the assay, we determined GAGE cluster lengths in 10 sets of female 
identical twins.  In all cases, the twins shared the identical GAGE cluster configuration 
(Fig. 3.2B). 
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     Next we sought to determine whether the GAGE cluster was stable under potentially 
elevated recombination rates in human cancer.  We compared the GAGE cluster 
configuration in individual human lung and colorectal tumors to matched control DNA 
from the same individuals isolated from either peripheral blood or surgically excised 
pathologically confirmed non-tumor tissue.  In one male lung cancer (Fig. 3.3A, 
‘XEPRY’) we observe evidence of mitotic rearrangement generating a new GAGE 
cluster length in the tumor not seen in the surrounding non-tumor tissue.  We observed 
the same mitotic rearrangement phenomenon in one of the colon cancers (Fig. 3.3C, 
‘DAPEB’).  Otherwise the GAGE cluster configuration in tumors was comparable to that 
in normal tissues, with the exception of loss of one GAGE cluster in a female lung cancer 
(Fig. 3.3B, ‘TIPOR’), likely due to X-chromosome aneuploidy.  The two confirmed 
mitotic events in these 36 solid tumor sets would indicate a detectable rearrangement 
frequency of around 5%. 
   
     In order to assess potential GAGE restructuring in pediatric leukemia, in addition to 
the adult solid tumors described above, we compared the GAGE cluster genomic 
architecture between peripheral blood containing blasts and peripheral blood from the 
same patients after their disease was in remission.  We detected no differences in the 
GAGE cluster configurations between disease-containing and disease-free blood sample 
from eight different pediatric patients (Fig. 3.4). 
 
     Finally we sought to extend our analysis of GAGE architecture to families with 
hereditary cancer syndromes.  We assayed GAGE architecture in EBV-immortalized 
lymphocytes from eight kindreds containing Rothmund-Thomson syndrome Type 2 
probands, and from four Rothmund-Thomson syndrome Type 1 probands (Fig. 3.5).  We 
found that GAGE cluster lengths segregated with in the normal Mendelian manner in the 
kindreds, and that the immortalized cells from Rothmund-Thomson probands displayed 
well-defined stable banding patterns. 
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3.5: CONCLUSION 
     We found that the normal human variation in GAGE gene copy number is from 13 to 
39 GAGE gene repeats on each X chromosome.  This is considerably less variation that 
we had earlier found in the ribosomal RNA genes that varied from 1 to over 140 copies 
per cluster (Stults, Killen et al. 2008).  The GAGE clusters also recombine with reduced 
frequency relative to the rDNA clusters.  There are several plausible factors that may 
account for this reduced frequency of rearrangement:  the GAGE unit repeat at 9.6 kb is 
shorter than the 43 kb rDNA repeat and there are only one or two GAGE clusters per 
genome (in males and females respectively) compared to the ten rDNA clusters.  
Nevertheless, the high degree of inter-person GAGE cluster heterogeneity indicates that 
the GAGE clusters are restructuring rapidly in evolutionary time, even if less rapidly than 
the rDNA.  In a similar manner, although we can detect GAGE cluster alterations in adult 
solid tumors at a frequency of around 5%, this is considerably less than the greater than 
50% frequency of rDNA restructuring we observed in human adult solid tumors.  
Interestingly, both of the cancer patients in which we detected GAGE cluster 
restructuring also exhibited rDNA cluster restructuring in their disease, suggesting a 
potential mechanistic link between the two processes (Stults, Killen et al. 2009). 
 
     Rothmund-Thomson syndrome arising as a result of mutations in RECQL4 (RTS type 
2) confers an increased cancer risk, particularly of osteosarcoma (Siitonen, Sotkasiira et 
al. 2009).  As RECQL4 is a member of the RecQ family of proteins associated with 
altered replication and recombination phenotypes (Bohr 2008), we hypothesized that a 
potentially recombination-prone genomic locus like GAGE might display accelerated 
instability in lines defective for RECQL4.  Counter to this hypothesis, we found that cells 
from Rothmund-Thomson probands either with RECQL4 defects (RTS type 2) or without 
RECQL4 defects (RTS type 1) display well-defined discrete banding patterns with no 
overt evidence of instability.  GAGE clusters inherited from parents heterozygous for 
RECQL4 mutation segregated in the normal Mendelian manner.  The average human 
GAGE gene cluster length exhibits strong heterogeneity, varying from 13 to 39 gene 
copies, with an average of approximate 20 copies per X-chromosome.  Both meiotic and 
mitotic alterations to GAGE cluster length occur at detectable frequencies. 
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3.6: FIGURES 
 
 
Figure 3.1:  Human GAGE gene clusters 
A)  Experimental schematic showing a model GAGE cluster containing six gene 
copies.  Restriction digestion with enzymes that do not have a recognition site in the 
unit gene repeat will liberate entire gene clusters (straight blue lines), with a small 
amount of additional flanking-sequence DNA (wavy blue lines).  Open rectangles: 
unit GAGE clusters; double black lines: non-GAGE genomic DNA. B)  GAGE unit 
gene repeat.  Transcription proceeds clockwise from the indicated transcription 
start site.  Exons: thick green bars; introns: thin green bars; high copy genomic 
repeats: pink regions and thin arrows; unique genomic sequences: black bars.  The 
positions of Southern blot probe 1 and probe 2 are indicated by red arrows.  C)  
Southern blot of GAGE clusters liberated from genomic DNA by the indicated 
restriction enzymes and detected with the indicated Southern probe.  Digests were 
overnight:  AvrII: 12 units at 37C, StuI: 20 units at 37C, SwaI: 20 units at room 
temperature.  Genomic DNA isolated from the peripheral blood from two different 
unrelated female donors (FASHY, XAVIL).  Open star: unresolved DNA due to 
inefficient digestion with the SwaI enzyme. 
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Figure 3. 2:  GAGE clusters in families and identical twins. 
A)  Families (all names are coded).  Circles: females, squares: males.  A potential 
meiotic recombination event (dotted blue oval) is shown in the first PYFI son (blue 
square). 
B)  10 sets of female identical twins. 
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Figure 3.3:  GAGE clusters in adult solid tumors. 
A) Lung cancer in males.  B: blood, T: tumor, N: non-tumor surrounding tissue.  A 
mitotic recombination event is shown in the XEPRY tumor sample (red arrow). 
B) Lung cancer in females:  B: blood, T: tumor, N: non-tumor surrounding tissue.  
Loss of one allele see in the peripheral blood of TIPOR is indicated (red pushpin). 
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C) Colorectal cancer.  B: blood; T: tumor; N: non-tumor surrounding tissue.  A 
mitotic recombination even that altered GAGE cluster length is seen in the DAPEB 
tumor samples (red arrow). 
 
 
 
Fi gure 3.4:  GAGE clusters in pediatric leukemia. 
Peripheral blood either with or without blasts is analyzed for GAGE clusters by 
Southern blotting.  No alterations between the blasts and the normal cells was 
detected. 
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Figure 3.5:  GAGE clusters in Rothmund-Thomson kindred and probands. 
Circles: females, squares: males.  R-T probands indicated in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
3.7 REFERENCES 
 
Almeida, L. G., N. J. Sakabe, et al. (2009). "CTdatabase: a knowledge-base of high-
throughput and curated data on cancer-testis antigens." Nucleic Acids Res 
37(Database issue): D816-819. 
Bohr, V. A. (2008). "Rising from the RecQ-age: the role of human RecQ helicases in 
genome maintenance." Trends Biochem Sci 33(12): 609-620. 
Cheung, I. Y., S. N. Chi, et al. (2000). "Prognostic significance of GAGE detection in 
bone marrows on survival of patients with metastatic neuroblastoma." Med 
Pediatr Oncol 35(6): 632-634. 
Cilensek, Z. M., F. Yehiely, et al. (2002). "A member of the GAGE family of tumor 
antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, 
Interferon-gamma, taxol and gamma-irradiation." Cancer Biol Ther 1(4): 380-
387. 
Davis, I. D., W. Chen, et al. (2004). "Recombinant NY-ESO-1 protein with 
ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and 
CD8(+) T cell responses in humans." Proc Natl Acad Sci U S A 101(29): 10697-
10702. 
De Backer, O., K. C. Arden, et al. (1999). "Characterization of the GAGE genes that are 
expressed in various human cancers and in normal testis." Cancer Res 59(13): 
3157-3165. 
Eichmuller, S., D. Usener, et al. (2002). "mRNA expression of tumor-associated antigens 
in melanoma tissues and cell lines." Exp Dermatol 11(4): 292-301. 
Gillespie, A. M., S. Rodgers, et al. (1998). "MAGE, BAGE and GAGE: tumour antigen 
expression in benign and malignant ovarian tissue." Br J Cancer 78(6): 816-821. 
Gjerstorff, M. F. and H. J. Ditzel (2008). "An overview of the GAGE cancer/testis 
antigen family with the inclusion of newly identified members." Tissue Antigens 
71(3): 187-192. 
Hofmann, O., O. L. Caballero, et al. (2008). "Genome-wide analysis of cancer/testis gene 
expression." Proc Natl Acad Sci U S A 105(51): 20422-20427. 
Jager, E., J. Karbach, et al. (2006). "Recombinant vaccinia/fowlpox NY-ESO-1 vaccines 
induce both humoral and cellular NY-ESO-1-specific immune responses in 
cancer patients." Proc Natl Acad Sci U S A 103(39): 14453-14458. 
Killen, M. W., D. M. Stults, et al. (2009). "Loss of Bloom syndrome protein destabilizes 
human gene cluster architecture." Hum Mol Genet 18(18): 3417-3428. 
77 
 
Kobayashi, Y., T. Higashi, et al. (2000). "Expression of MAGE, GAGE and BAGE genes 
in human liver diseases: utility as molecular markers for hepatocellular 
carcinoma." J Hepatol 32(4): 612-617. 
Kong, U., J. Koo, et al. (2004). "The expression of GAGE gene can predict aggressive 
biologic behavior of intestinal type of stomach cancer." Hepatogastroenterology 
51(59): 1519-1523. 
Kular, R. K., F. Yehiely, et al. (2009). "GAGE, an antiapoptotic protein binds and 
modulates the expression of nucleophosmin/B23 and interferon regulatory factor 
1." J Interferon Cytokine Res 29(10): 645-655. 
Liu, Y., Q. Zhu, et al. (2008). "Recent duplication and positive selection of the GAGE 
gene family." Genetica 133(1): 31-35. 
Maio, M., S. Coral, et al. (2003). "Analysis of cancer/testis antigens in sporadic 
medullary thyroid carcinoma: expression and humoral response to NY-ESO-1." J 
Clin Endocrinol Metab 88(2): 748-754. 
Marchand, M., N. van Baren, et al. (1999). "Tumor regressions observed in patients with 
metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-
3 and presented by HLA-A1." Int J Cancer 80(2): 219-230. 
Mischo, A., B. Kubuschok, et al. (2006). "Prospective study on the expression of cancer 
testis genes and antibody responses in 100 consecutive patients with primary 
breast cancer." Int J Cancer 118(3): 696-703. 
Odunsi, K., F. Qian, et al. (2007). "Vaccination with an NY-ESO-1 peptide of HLA class 
I/II specificities induces integrated humoral and T cell responses in ovarian 
cancer." Proc Natl Acad Sci U S A 104(31): 12837-12842. 
Ruschenburg, I., A. Kubitz, et al. (1999). "MAGE-1, GAGE-1/-2 gene expression in 
FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia 
in nodular goiter." Int J Mol Med 4(4): 445-448. 
Russo, V., P. Dalerba, et al. (1996). "MAGE BAGE and GAGE genes expression in fresh 
epithelial ovarian carcinomas." Int J Cancer 67(3): 457-460. 
Scanlan, M. J., A. J. Simpson, et al. (2004). "The cancer/testis genes: review, 
standardization, and commentary." Cancer Immun 4: 1. 
Siitonen, H. A., J. Sotkasiira, et al. (2009). "The mutation spectrum in RECQL4 
diseases." Eur J Hum Genet 17(2): 151-158. 
Stevenson, B. J., C. Iseli, et al. (2007). "Rapid evolution of cancer/testis genes on the X 
chromosome." BMC Genomics 8: 129. 
78 
 
Stults, D. M., M. W. Killen, et al. (2008). "Genomic architecture and inheritance of 
human ribosomal RNA gene clusters." Genome Res 18(1): 13-18. 
Stults, D. M., M. W. Killen, et al. (2009). "Human rRNA gene clusters are 
recombinational hotspots in cancer." Cancer Res 69(23): 9096-9104. 
Uenaka, A., H. Wada, et al. (2007). "T cell immunomonitoring and tumor responses in 
patients immunized with a complex of cholesterol-bearing hydrophobized 
pullulan (CHP) and NY-ESO-1 protein." Cancer Immun 7: 9. 
van der Bruggen, P., C. Traversari, et al. (1991). "A gene encoding an antigen recognized 
by cytolytic T lymphocytes on a human melanoma." Science 254(5038): 1643-
1647. 
Warburton, P. E., D. Hasson, et al. (2008). "Analysis of the largest tandemly repeated 
DNA families in the human genome." BMC Genomics 9: 533. 
Zambon, A., S. Mandruzzato, et al. (2001). "MAGE, BAGE, and GAGE gene expression 
in patients with esophageal squamous cell carcinoma and adenocarcinoma of the 
gastric cardia." Cancer 91(10): 1882-1888. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright© Michael Wayne Killen 2011 
79 
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 4.1: SYNOPSIS 
     Bloom syndrome confers strong predisposition to malignancy in multiple tissue types. 
The Bloom syndrome patient protein (BLM) defective in the disease biochemically 
functions as a Holliday junction dissolvase and human cells lacking functional BLM 
show 10-fold elevated rates of sister chromatid exchange. Collectively, these phenomena 
suggest that dysregulated mitotic recombination drives the genomic instability 
underpinning the development of cancer in these individuals. Here we use physical 
analysis of the highly repeated, highly self-similar human ribosomal RNA gene clusters 
as a sentinel biomarker for dysregulated homologous recombination to demonstrate that 
loss of BLM protein function causes a striking increase in spontaneous molecular level 
genomic restructuring. Analysis of single-cell derived sub-clonal populations from wild-
type human cell lines shows that gene cluster architecture is ordinarily very faithfully 
preserved under mitosis, but is so unstable in cell lines derived from BLMs as to make 
gene cluster architecture in different sub-clonal populations essentially unrecognizable 
one from another. Human cells defective in a different RecQ helicase, the WRN protein 
involved in the premature aging Werner syndrome, do not exhibit the gene cluster 
instability (GCI) phenotype, indicating that the BLM protein specifically, rather than 
RecQ helicases generally, holds back this recombination-mediated genomic instability. 
An ataxia-telangiectasia defective cell line also shows elevated rDNA GCI, although not 
to the extent of BLM defective cells. Genomic restructuring mediated by dysregulated 
recombination between the abundant low-copy repeats in the human genome may prove 
to be an important additional mechanism of genomic instability driving the initiation and 
progression of human cancer. 
 
 
80 
 
 
4.2: INTRODUCTION    
 
     Early onset of multiple malignancies is a clinical hallmark of Bloom syndrome, with 
mean age of death in Bloom syndrome patients (BS) younger than 24 years (German 
1997) suggesting a critical loss of genomic stability. Cytologically, cells from BLMs 
show a 10-fold elevation in rates of sister chromatid exchange (SCE) when differentially 
stained following incorporation of various thymidine analogs, as well as a spontaneous 
increase in chromosomal abnormalities such as quadraradial structures (German, 
Archibald et al. 1965; Chaganti, Schonberg et al. 1974). Although dramatic in appearance 
when visualized in the standard assay for SCE (Perry and Wolff 1974), exchanges 
between sister chromatids are genetically silent, and therefore not directly contributory to 
genomic instability per se. Nevertheless, the class of genomic alteration represented by 
SCE, the physical relocation of genetic material, without associated change in either the 
amount or sequence of this material, is an important but poorly examined mechanism of 
chromosomal alteration, particularly when these alterations are in the sub-microscopic 
size range. In this report, we present a sensitive assay of ribosomal gene cluster instability 
(GCI) that demonstrates exactly this kind of non-silent molecular level alterations to 
chromosomal architecture resulting from the absence of the Bloom syndrome protein. We 
also use this assay to show that unlike loss of the Bloom syndrome protein, neither loss of 
the BLM-related Werner protein nor inactivation of either transcription-coupled 
nucleotide excision repair or non-homologous end-joining (NHEJ) appreciably increase 
this GCI. 
     The BLM protein inactivated in BS is a member of the RecQ helicase family of 
helicases (Ellis, Groden et al. 1995). In humans, there are five known RecQ homologs 
implicated in the maintenance of genomic stability (reviewed in (Bohr 2008)). 
Mechanistically, the BLM protein, in conjunction with binding partners RMI1, RMI2 and 
TOPOIIIα (Raynard, Zhao et al. 2008; Xu, Guo et al. 2008), can function as a Holliday 
junction dissolvasome (Raynard, Bussen et al. 2006; Wu, Bachrati et al. 2006) that 
reverses the strand exchanges in a double Holliday junction structure to prevent potential 
junction resolution involving crossover products. In the absence of sufficient BLM-
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complex activity, such recombination intermediates may be subject instead to resolution 
by the human Holliday junction resolvase GEN1 (Ip, Rass et al. 2008), with the risk of 
production of both crossover and non-crossover products. 
     Although crossover recombination between precisely aligned sister chromatids is not 
inherently destabilizing, the human genome contains abundant low-copy repeats (LCRs) 
with sufficiently high levels of sequence similarity as to be susceptible to non-allelic 
homologous recombination (NAHR) (Consortium 2004). Structural alterations to 
genomic architecture caused by NAHR between LCRs include deletions, inversions and 
translocations with the possible generation of both acentric and dicentric chromosomes 
(reviewed in (Gu, Zhang et al. 2008)). Although the consequences of recombination-
mediated genomic restructuring can be dire, spontaneous occurrences of NAHR are rare, 
hindering the identification of genetic components important for suppressing this class of 
genomic instability. Early work with BLM defective cells gave phenotypic evidence that 
the BLM protein could suppress NAHR in repetitive genomic loci (Kyoizumi, Nakamura 
et al. 1989; Langlois, Bigbee et al. 1989), later supported by molecular evidence of loss 
of heterozygosity between parentally homologous chromosomes (Groden, Nakamura et 
al. 1990; Ellis, Lennon et al. 1995), and in instability of a 40 bp repetitive mini-satellite 
sequence (Groden and German 1992). We now extend this work to much larger gene 
clusters distributed on multiple chromosomes. 
     Large gene clusters possess attributes predicted to be conducive to recombinational 
alteration. The repeated genes that make up clusters tend to have very high levels of 
sequence identity, sufficient length to be substrates for recombination, and occur in high 
local concentration with respect to each other. The gene clusters encoding the 45S 
precursor transcript to the 18S, 5.8S and 28S ribosomal RNA molecules (collectively the 
‘rDNA’) are perhaps the largest clustered gene arrangement in the human genome, with 
approximately 600 repeats of the unit 43 kb gene (Gonzalez and Sylvester 1995) divided 
among the five pairs of acrocentric chromosomes (Henderson, Warburton et al. 1972). 
We recently characterized the physical lengths of these rDNA gene clusters in human 
individuals and found essentially complete cluster length heterozygosity, both between 
clusters on different acrocentric chromosomes and also between clusters on individual 
parental homolog chromosome pairs (Stults, Killen et al. 2008). This cluster length 
82 
 
heterogeneity is driven by strong meiotic recombination at a rate of over 10% per cluster 
per meiosis. We were also able to detect spontaneous mitotic rearrangement in these 
clusters, suggesting that they would be suitable as sentinel biomarkers for dysregulated 
recombination. Accordingly, we screened a panel of cell lines representing diverse 
human chromosomal instability syndromes for hyper-recombination in the rDNA gene 
clusters and used both shRNA knockdowns and complemented mutant cell lines to 
establish that the BLM protein is a crucial suppressor of GCI.  
      
 4.3: RESULTS 
     We assay dysregulated recombination by ascertaining the stability of the length of 
gene clusters. The lengths are determined by restriction digestion of high molecular 
weight genomic DNA with enzymes that do not have a recognition site in the repeated 
gene unit. Since the repeated genes in clusters are generally highly conserved, an enzyme 
that does not cut in one repeat tends not to cut in any and can thereby liberate intact gene 
clusters from bulk genomic DNA, with the addition of a small amount of randomly sized 
flanking DNA (Fig. 4.1A). Liberated gene clusters can then be separated by size using 
pulsed-field gel electrophoresis and identified by Southern blotting. The goal is to utilize 
this pulsed-field based assay to quantify the GCI in human cells. In any cell population 
derived from a single cell, including human individuals, genomic gene clusters will have 
a well-defined initial length. We call the size-resolved pattern of these initial cluster 
lengths the ‘major banding pattern’ (Fig. 4.1B, ‘Initial Pattern’). As the cell population 
expands, if the gene clusters are completely stable, the initial cluster lengths found in the 
progenitor cell will be faithfully transmitted to all subsequent daughter cells (Fig. 4.1B, 
‘No GCI’). Alternatively, recombination in the expanding population can generate sub-
populations with altered gene cluster lengths. Since these sub-populations only represent 
a fraction of the total population, bands detected by Southern blotting will be reduced in 
intensity accordingly. We call these reduced-intensity bands the ‘minor banding 
population’ (Fig. 4.1B, ‘Low GCI’). The amount of this minor-intensity banding found in 
any cell population is indicative of the degree of GCI in that population. Since 
recombination requires precise alignment of homologous sequences, cluster lengths can 
only change by integer multiples of the unit repeat length. This constraint upon allowable 
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gene cluster lengths (Fig. 4.1B, dotted lines) means that very high levels of instability 
will generate a ladder-like pattern of bands in a Southern blot (Fig. 4.1B, ‘High GCI’), 
consistent with a recombination-based mechanism. If cluster length alterations were due 
to random breakage and rejoining, a smear would be observed, rather than a ladder. 
We screened a panel of cell lines including various known human chromosomal 
instability syndromes (Fig. 4.1C). Stable gene clusters result in a well-defined pattern of 
major bands, with largely empty intervening space and few minor bands. As expected, 
since every individual human has a unique pattern of major bands (21), the human cell 
lines also possess unique patterns of major bands. Instability will be indicated by the 
presence of minor-intensity bands. Four lines wild-type for major DNA repair pathways, 
BJ-5ta, CGM1, GM06990 and HeLa S3 (left side of the panel), largely exhibit such gene 
cluster stability, with only a few minor-intensity bands observed. BJ-5ta is immortalized 
by the expression of telomerase, CGM1 and GM06990 by EBV and HeLa S3 is a 
cultured cancer line, collectively indicating that cellular transformation and 
immortalization per se is generally not destabilizing to the faithful transmission of gene 
cluster lengths. Of the SV40-transformed lines from a panel of patients exhibiting defects 
in a variety of DNA repair pathways (right side of the panel), only that derived from a 
BLM is strongly destabilized (rounded box), with a clear ladder-pattern consistent with 
integer multiple differences of 43 kb: the size of the repeated rRNA genes. In contrast, 
the wild-type, DNA ligase 1-defective, DNA ligase IV-defective and Nijmegen breakage 
syndrome lines appear to be gene cluster stable. The ATM cells show minor banding 
consistent with a GCI-low phenotype; the HeLa and ATM cells are explored in more 
detail in Figure 4.7.  
     The basic GCI screen (Fig. 4.1) measures the amount of GCI that has occurred in the 
history of a given cell population rather than the rate at which GCI occurs. In this context, 
we can understand the presence of minor bands in the GCI profile of a cell population as 
being the result of a gradual cumulative stochastic process of recombination-mediated 
alterations from the initial major banding pattern subjected to genetic drift. The fraction 
of cells in a cultured population that has gene cluster lengths not represented in the major 
banding pattern is a function of the inherent GCI rate of the cells in question, the total 
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number of cell divisions undergone by the culture, and the degree to which the culture 
has been subjected to population bottlenecks.  
     We can uncover the GCI rate by unrestricted expansion of single-cell derived sub-
clones. This procedure, in essence Luria–Delbruck fluctuation analysis (Luria and 
Delbruck 1943), is sensitive only to the GCI rate since freely expanded sub-clonal 
populations experience the same number of cell divisions and no population bottlenecks. 
Sub-cloning cell populations from single cells can be applied iteratively: minor bands in 
any parental population will produce new major bands in derivative sub-clonal 
populations with a frequency of occurrence determined by the fractional intensity of the 
minor bands in the parental population. New spontaneous GCI in any sub-clonal 
population will appear as de novo minor bands. This clonal GCI analysis of the wild-type 
GM00637 cell line (Fig. 4.2A) shows relatively stable gene cluster lengths. The lane ‘WT 
clonal’ is derived from a single cell. Single-cell derived sub-clones from this clonal 
population are shown in the right of the panel. Changes to the major banding pattern in 
the sub-clones are seen in sub-clones ‘C’ and ‘H’ (triangle and brackets indicating new 
major band and missing major bands, respectively). These represent mitotic gene cluster 
alterations occurring in the expansion of the ‘WT clonal’ cells that occurred too late in 
the expansion to yield visible minor bands in the ‘WT clonal’ lane. A minor band (arrow) 
is seen in sub-clone ‘E’, from a spontaneous gene cluster length alteration in the 
expansion of this individual sub-clone. We can reliably detect minor bands with an 
intensity of <10% of the major bands. For 10% of the population to show an altered 
gene cluster length, the alteration had to occur sometime in the initial three or four 
rounds of cell division, i.e. before the population derived from a single cell had 
expanded to a total of 10 cells. In contrast to the rare minor banding of the wild-type 
population, the Bloom syndrome line GM08505 (Fig. 4.2B) shows such extensive minor 
banding that for practical purposes no major banding pattern of rDNA gene clusters can 
be defined. Gene cluster lengths in the BLM cells are changing on the order of every 
mitotic division.  
     To establish that the genetic defect causing the GCI-high phenotype in the BLM-
syndrome GM08505 cells is lack of BLM, we surveyed BLM lines derived from three 
other individual BLMs (Fig. 4.3A and 4.3B). The bulk wild-type cell populations appear 
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stable with well-defined major bands and little or no minor banding evident. In contrast, 
each of the three BLM-patient derived lines, BLM Ash.1, BLM Ash.2 and BLM F.C., 
shows the ladder-pattern indicative of the GCI-high phenotype. BLM Ash.1 and BLM 
Ash.2 are from patients of Ashkenazi Jewish descent, each homozygous for the 6 bp 
deletion/7 bp insertion frameshifting Ashkenazi founder mutation. BLM F.C. is from a 
French-Canadian Bloom patient and is homozygous for a S595X translation terminating 
mutation. All three lines show a distinct ladder-pattern of minor bands (rounded boxes). 
In order to determine whether the gene cluster destabilization preceded either 
transformation or tumorigenesis, we analyzed cells from primary fibroblast explants (Fig. 
4.3B). Primary cells from an apparently healthy 11-year-old girl (GM10652) show well-
defined major bands, and no minor banding, whereas primary cells from a 28-year-old 
male BLM (GM02932) show minor band laddering, indicating that GCI is inherent to 
Bloom syndrome cells generally and therefore is a potential contributor to the genomic 
instability that initiates tumor development in these patients. The contrast-enhanced right-
hand panel allows direct comparison of the spacing of the BLM gene cluster laddering 
with the well-defined length lambda phage concatemers. The BLM ladder (arrows) shows 
slightly closer spacing than the lambda ladder, consistent with the 43.0 kb rDNA unit 
gene repeat versus the 48.5 kb lambda genome size.  
     Complementation of the BLM defect restores rDNA gene cluster stability. Minor band 
laddering is seen in the bulk populations of two BLM derived lines: BLM-comp and 
BLM-vec (Fig. 4.3A). These non-clonal lines are the product of transfection and stable 
selection of BLM-defective BLM Ash.1 cells with either the pcDNA3 vector expressing 
full-length wild-type BLM or the pcDNA3 vector alone, respectively (Gaymes, North et 
al. 2002). Since these are non-clonal lines, the BLM-comp population shows the minor 
banding pattern of instability that was generated during the BLM-null history of this line. 
The current stability of the BLM-comp line is revealed by clonal analysis (Fig. 4.4A). As 
expected, the minor band laddering in the BLM-comp bulk population resolves as 
variability in the pattern of major bands in the BLM-comp clonal isolates. The clonal 
isolates themselves, however, contain a greatly reduced amount of de novo minor 
banding relative to the BLM-vec non-complemented isogenic line (Fig. 4.4B), indicating 
that restoration of the BLM protein has stabilized the rDNA gene clusters.  
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Since the BLM-comp cells are not completely complemented for the elevated SCE 
phenotype of Bloom syndrome cells (Gaymes, North et al. 2002) (Figure 4.9) and still 
show some minor banding indicative of ongoing GCI in the clonal sub-lines (Fig. 4.4A), 
we wanted to verify the importance of the BLM protein in promoting gene cluster 
stability by assaying loss of stability in an otherwise stable line upon loss of the BLM 
protein. Accordingly, we used shRNA (Stegmeier, Hu et al. 2005) to knockdown 
expression of BLM in a clonal wild-type GM00637 cell population. We used a ‘semi-
stable’ knockdown technique where the selectable shRNA expression plasmid was 
transfected and selected for 7 days to kill untransfected cells, followed by dilution plating 
to single cells and unselected sub-clonal expansion. We used this semi-stable technique 
to prevent eventual overgrowth by cells losing shRNA expression. After 7 days of 
selection, BLM levels measured by western blotting were decreased by 70% (Fig. 4.5C), 
at which time sub-clonal lines were rederived from single cells. Sub-clonal lines from the 
clonal cell population transfected with the negative-control shRNA construct pCPM-neg 
show only limited gene cluster length alterations (Fig. 4.5A: arrows, brackets and 
triangles), whereas sub-clonal lines from the same clonal cell population transfected 
instead with the BLM knockdown shRNA construct pCPM-234 show an approximately 
3-fold greater number of gene cluster length alterations (Fig. 4.5B), again implicating the 
expression of BLM as a critical stabilizer of these rDNA gene clusters. 
     Having established a role for BLM in the maintenance of gene cluster genomic 
integrity, we wanted to determine whether RecQ helicases other than BLM were also 
involved. We performed clonal GCI analysis on SV40-immortalized fibroblasts from a 
Werner syndrome patient (Fig. 4.6) homozygous for a truncating R368X mutation in the 
WRN gene, a RecQ helicase defective in a strong progeroid syndrome (Yu, Oshima et al. 
1996). We see no minor bands in a clonal derivative of these WRN-deficient AG11395 
cells, and neither changes to the major banding pattern nor new minor bands in single-
cell derived sub-clonal populations derived from the clonal cells. We conclude that the 
suppression of rDNA GCI is not a property of the RecQ helicase family generally, 
although we have not yet assayed cells deficient in the remaining RecQ helicases: 
RECQL, RECQL4 and RECQL5. 
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     An ataxia-telangiectasia mutated cell line has more GCI than HeLa cells. The minor 
banding we observed in a bulk population of ATM-deficient cells (Fig. 4.1C) motivated 
us to use clonal analysis to determine whether there was ongoing GCI in this line. 
Starting with a clonal isolate each of the apparently gene cluster stable HeLa cells and the 
apparently gene cluster unstable ATM cells, we generated sub-clonal lines for analysis. In 
ten sub-clonal HeLa lines (Fig. 4.7A), we observed one altered major band (triangle) and 
two new minor bands (arrows) showing the general stability of the HeLa rDNA gene 
cluster architecture. In contrast, in eight ATM-deficient sub-clones (Fig. 4.7B), we found 
one new major band (triangle) and seven newly generated minor bands (arrows), 
suggesting an elevated rate of GCI in the ATM-deficient line. 
     We also found that defects in transcription-coupled nucleotide excision repair do not 
greatly enhance GCI. The Cockayne's syndrome B (CSB) protein ERCC6 required for 
transcription-coupled nucleotide excision repair (Hanawalt and Spivak 2008) has been 
implicated in the stability of gene clusters with the observation that defects in CSB cause 
aberrant metaphase figures at gene clusters (Yu, Fan et al. 2000). Therefore to ascertain 
whether a CSB defect obviously compromised stability of the rDNA gene clusters, we 
generated a clonal population of CSB defective (GM00739) cells. This clonal population 
‘CSB clonal’ exhibited one visible minor band (Fig. 4.8A, arrow) that is reflected as a 
major banding pattern gain of this cluster length in four of twelve sub-clones, ‘D’, ‘F’, 
‘H’ and ‘L’ (triangles). Since these four sub-clones also all lose the same major band 
(bracket), a reasonable interpretation is that around the third mitosis in the expanding 
‘CSB clonal’ population, a spontaneous recombination event in one of the cells caused a 
gain of two repeats in the cluster indicated by a closed circle to generate the new longer 
cluster indicated by an arrow. We also observe two additional major band changes 
(triangles) in sub-clones ‘F’ and ‘H’ that do show a corresponding visible minor band in 
the parental population at the open circle indicators. Evidently, the events that lead to 
these major banding changes happened late enough in the parental population expansion 
that the fraction of cells carrying the change is below the limit of detection for a minor 
band in the ‘CSB clonal’ population. Nevertheless, the number of minor and major 
banding alterations in the CSB-defective cells is not greatly larger than that seen in 
similar clonal analysis with either HeLa (Fig. 4.7A) or wild-type SV40-transformed 
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fibroblasts (Fig. 4.2A), leading us to conclude that the CSB-dependent repair pathway is 
not significantly involved in rDNA gene cluster stability. 
     We similarly detect no large increase in instability with loss of the NHEJ pathway. In 
experiments that quantify double-strand break mediated non-crossover gene conversion, 
loss of critical NHEJ proteins such as XRCC6, XRCC5, PRKDC (Ku70/80/DNA-PKcs) 
or XRCC4 cause an increase in recombination of between 3-fold and 5-fold (Pierce, Hu 
et al. 2001). Nevertheless, a non-clonal population of cells derived from a patient with a 
defect in DNA ligase IV, the obligate heterodimeric partner of XRCC4 (Wu, Frit et al. 
2009), appears gene cluster stable, with one clearly defined resolved major band and no 
apparent minor banding (Fig. 4.1C). To confirm this apparent stability, we compared 
rDNA banding patterns in clonal human isogenic NALM-6 cells, and NALM-6 cells in 
which DNA ligase IV was disrupted by gene targeting (Iiizumi, Nomura et al. 2006). In 
the wild-type NALM-6 cells, we observe one minor band in the non-clonal bulk 
population (Fig. 4.8B, arrow) that gave an altered major band in sub-clone ‘C’ of the 
three sub-clonal NALM-6 lines, likely the result of loss of one repeat from the gene 
cluster indicated by the closed circle. We likewise see a major band change in NALM-6 
clone ‘B’ from a late event arising from a small sub-population of the bulk parental line 
(open circle). In the DNA ligase IV knockout NALM-6 cells, we see one major band 
alteration in sub-clone ‘C’, again arising from a small sub-population in the ‘LIG4 ko 
bulk’ population. In none of the six clonal lines from either NALM-6 or NALM-6 lines 
knocked out for DNA ligase IV do we see minor bands, indicating that rapid ongoing 
recombination-mediated rearrangement of rDNA gene clusters is not occurring, and 
ruling out DNA ligase IV as a strong player in maintaining rDNA gene cluster stability. 
 
4.4: DISCUSSION 
     The GCI assay is philosophically similar to the microsatellite instability (MSI) assay 
for defective mismatch repair. In MSI+ lines, polymerase slippage at repetitive mono-, 
di- and tri-nucleotide short tandem repeats (STRs) generates expansions and contractions 
of the STR length, which are not subsequently corrected by mismatch repair (reviewed in 
(Laghi, Bianchi et al. 2008)). In contrast, the repeated sequences assayed here for GCI are 
thousands of base pairs in length, requiring a completely different underlying 
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biochemistry for stability than the microsatellites. We propose that the mechanism 
causing GCI is dysregulated homologous recombination, where the usual strong bias in 
favor of short-tract gene conversion without crossing over (Paques, Leung et al. 1998) 
has been lost or attenuated. The kind of crossover recombination reactions capable of 
producing the GCI we observe in the BLM-deficient cells is ordinarily highly suppressed. 
The known biochemical ability of BLM and partner proteins to dissolve double Holliday 
junctions, in combination with the ladder-like pattern of instability we describe here, is 
consistent with a crossover recombination mechanism for gene cluster destabilization in 
the absence of BLM. Nevertheless, we cannot rule out the possibility that gene cluster 
length alteration is a product of break-induced replication (BIR) (reviewed in (Llorente, 
Smith et al. 2008)), either in whole or in part. Indeed, a microhomology mediated break-
induced replication model has been recently proposed as a mechanism for the generation 
of many human genomic copy number variations (Hastings, Lupski et al. 2009). 
It is also formally possible that in the absence of BLM, the rDNA gene clusters we assay 
in this work are being broken and then rejoined by a translocation-like mechanism driven 
by NHEJ. Since NHEJ does not require alignment of homologous sequences as does 
recombination, generation of the single repeat 43 kb changes in gene cluster length we 
observe would additionally require the gene clusters to break at one specifically defined 
sequence within a unit repeat. Conceivably some kind of BLM-suppressed chromosome 
fragility structure could produce this kind of sequence-specific breakage pattern, 
potentially quadruplex-G sequences (Huber, Duquette et al. 2006) or hemicatenated 
replication structures (Fricke and Brill 2003). The lack of a significant increase in GCI in 
the absence of DNA ligase IV, however, argues that if rearrangements are initiated by 
frank chromosomal breaks, NHEJ is not a competing pathway for these breaks. 
Accordingly we do not favor the notion of frank double-strand breaks as the primary 
initiating events in rDNA GCI but prefer the previously suggested idea (Pierce, Hu et al. 
2001) that recombination can be initiated from one-sided double-strand ends arising from 
collapsed replication forks. It is attractive to speculate that this putative replication fork 
collapse is caused by the formation of quadruplex-G sequences in the G/C-rich rDNA, 
since the BLM protein efficiently unwinds quadruplex-G DNA (Sun, Karow et al. 1998). 
It will be interesting to determine whether loss of the BRIP1 (FANCJ) protein, which has 
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a similar ability to unwind quadruplex-G (London, Barber et al. 2008), will likewise 
cause rDNA GCI. 
     The human BLM protein has been characterized as facilitating the EXO1 mediated 5′–
3′ resection of double-strand breaks prior to allowing the loading of the RAD51 
recombinase (Gravel, Chapman et al. 2008; Nimonkar, Ozsoy et al. 2008). The highly 
elevated recombination phenotypes observed in the absence of BLM, however, argue 
against the requirement for this activity of BLM in either rDNA gene cluster 
recombination or SCE. Likewise, human BLM also possesses a single-stranded DNA 
(ssDNA) annealing activity (Cheok, Wu et al. 2005; Machwe, Xiao et al. 2005) that 
appears uninvolved in these particular recombination processes. In contrast, BLM also 
possesses an anti-recombinagenic capacity to remove invaded 3′ ssDNA tails from D-
loops (van Brabant, Ye et al. 2000; Bachrati, Borts et al. 2006), including the disruption 
of a pre-formed RAD51 filament (Bugreev, Yu et al. 2007). Loss of this BLM activity 
likely contributes to elevated recombination phenotypes in Bloom syndrome cells. 
     We assayed the repeated 43 kb genes comprising the rDNA gene clusters in the belief 
that these clusters were the most likely to show spontaneous recombination-mediated 
alterations due to their abundance, length, degree of sequence conservation and number 
of potentially interacting chromosomes. Intriguingly, the size of chromatin loops in HeLa 
cells has been characterized as averaging 86 kb (Jackson, Dickinson et al. 1990), which is 
the exact length of two rDNA genes and may be important in the propensity of 
recombination to alter rDNA gene cluster lengths. Looped chromatin generally may be an 
important intermediate in gene cluster recombination, and the tendency for chromatin 
loop domains to be long may protect shorter gene clusters from intramolecular 
recombination. It will be interesting to determine if the spontaneous gene cluster 
reorganization seen here in the rDNA can also be observed in smaller, less abundant non-
rDNA gene clusters (Warburton, Hasson et al. 2008), although we would predict having 
fewer potentially recombining gene clusters of shorter overall length would decrease the 
ability to sensitively detect alterations in other gene cluster loci. Consistent with a role in 
protecting particularly susceptible classes of gene clusters such as the rDNA from 
recombination, BLM protein sub-cellular localization includes the nucleolus (Sanz, 
Proytcheva et al. 2000),  possibly for the specific purpose of counteracting the potential 
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for recombination to destabilize the rDNA gene clusters that are also located in the 
nucleolus. Seen in this light, the nucleolus may function specifically as a recombination-
suppression sub-nuclear zone. It will also be of interest for future studies to determine 
whether chemical agents known to induce SCE lead to a parallel increase in GCI, and 
whether the GCI assay can be a useful measure of sub-microscopic genomic toxicity. 
     To a first-order approximation, by comparing the number of observed minor bands per 
clonal isolate, we find the rate of spontaneous alterations in gene cluster architecture to 
be over 100-fold elevated in cells lacking BLM (9.6 minor bands per clone) and 10-fold 
elevated in cells lacking ATM (0.9 minor bands per clone) compared with wild-type 
controls (0.08 minor bands per clone). It is intriguing that the rDNA GCI we observe in 
BLM and to a lesser extent in ATM cells parallels the increased cancer predisposition in 
Bloom syndrome and ataxia-telangiectasia patients. Particularly, because crossover 
recombination between low-copy human genomic repeats has the potential to generate 
enormous genomic instability through formation of dicentric and acentric chromosomes, 
it remains to be seen whether or not GCI, whether caused by functional loss of BLM or 
otherwise, is a common mechanism of genomic instability driving the etiology and 
progression of human cancer. 
 
4.5: METHODS 
 
Cell lines 
     Cell lines GM00637 (wt), GM09607 (ATM), GM08505 (BLM), GM13136 (FANCC), 
GM16097 (LIG1), GM16089 (LIG4), GM15989 (NBN), AG11395 (WRN), GM00739 
(CSB) were from the Coriell Cell Repository and maintained in minimal essential (MEM) 
with 10% fetal bovine serum (FBS). The lines GM06990 (wt), GM01652 (wt), GM02932 
(BLM), GM16375 (BLM) and GM03403 (BLM), also from the Coriell Cell Repository, 
were maintained in either MEM or RPMI media with 15% FBS. BJ-5ta and HeLa S3 
cells were from ATCC (CRL-4001 and CCL-2.2, respectively), grown in MEM with 10% 
FBS. CGM1 cells were from RIKEN, also grown in MEM with 10% FBS. The isogenic 
cell lines BLM-comp (GM08505 + BLM cDNA, also known as PSNF5) and BLM-vec 
(GM08505 + vector control, also known as PSNG13) were kindly provided by Hickson 
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(Gaymes, North et al. 2002) and maintained in MEM with 10% FBS with the addition of 
0.35 mg/ml G418. NALM-6 DNA ligase IV knockout cells have been previously 
described (Iiizumi, Nomura et al. 2006). All cell lines were grown at 37°C and in 5% 
CO2 in a humidified incubator. 
 
DNA isolation and Southern analysis 
     High molecular weight genomic DNA was isolated from cells in agarose, digested 
with EcoRV to liberate intact rDNA gene clusters, resolved on pulse-field gels with 
resolution from 10 kb to 1 Mb and probed with radiolabeled rDNA sequences according 
to methods given by Stults et al. (Stults, Killen et al. 2008). 
 
Western blotting 
     Cells were lysed with RIPA buffer [50 mm Tris–HCl (pH 7.4), 150 mm NaCl 1% NP-
40, 1% deoxycholate, 0.1% SDS and 1 mm EDTA] containing a cocktail of protease 
inhibitors (Pierce, cat. 78410) for 5 min at 4°C. Whole-cell lysates were separated on 8% 
SDS–polyacrylamide gels, and proteins transferred to a nitrocellulose membrane and 
subjected to western blotting analysis with rabbit anti-BLM antibody (Calbiochem, cat. 
DR1034) or rabbit anti-β-tubulin (Thermo, cat. RB-9249-P). The secondary antibody 
used was HRP-conjugated donkey anti-rabbit IgG (Pierce, cat. 31458). Blots were 
detected with ECL plus western blotting detection system (Pierce, cat. RPN2132) and 
visualized on a Storm 860 PhosphorImager (Molecular Dynamics) via 
chemifluorescence. 
 
Cytogenetics 
     SCEs were visualized in stained metaphase spreads according to Perry and Wolff 
(Perry and Wolff 1974) with minor modifications. 
 
shRNA 
     The plasmids pCPM-234 (deplete BLM) and pCPM-neg (negative control) were 
derived from plasmids V2HS_89234 and RHS1707 (Open Biosystems), respectively. The 
shRNA sequences were sub-cloned into the 3′ untranslated region of a puromycin 
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resistance gene and expressed in a derivative of the pCAGGS vector (Niwa, Yamamura 
et al. 1991) modified to be incapable of episomal replication. For semi-stable 
knockdowns, cells were transfected with 10 µg shRNA plasmids pCPM-234 or pCPM-
neg using a BTX ECM 830 square-wave electroporator: nine pulses, 150 V, 7 ms pulse 
duration, 1 s pulse interval, total volume 750 µl growth media. Stable integration of the 
plasmid was selected via puromycin resistance (300 ng/ml) for 1 week, at which time 
BLM knockdown was measured by western blotting followed by limited dilution sub-
cloning and expansion. 
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4.6: FIGURES 
 
 
Figure 4.1: Screening cell lines for gene cluster instability (GCI)(A) Experimental 
strategy. Digestion of genomic DNA with restriction enzymes that do not cut within 
an individual gene cluster repeat liberates intact gene clusters from bulk genomic 
DNA. Panel from Stults et al. (Stults, Killen et al. 2008; Bernstein, Gangloff et al. 
2010) (used with permission). (B) Schematic of GCI patterns in clonal cell lines. A 
single cell shows a well-defined pattern of gene cluster lengths (‘Initial Pattern’—
thick bands). Allowable, but currently unrepresented gene cluster lengths are shown 
as dotted lines. As mitotic division expands the clonal cell population in the absence 
of instability, gene cluster lengths are faithfully preserved (‘No GCI’). Alternatively, 
instability generates sub-populations within the expanding population with altered 
cluster lengths giving rise to lower intensity ‘minor bands’ (‘Low GCI’—thin bands 
indicated by arrows). High levels of instability generate a ladder-like pattern of 
minor banding with individual bands on the ladder differing by integer multiples of 
the unit repeat length (‘High GCI’). (C) Screening non-clonal cell populations. 
Cluster lengths are resolved up to 1 Mb in length, with sizes shown from yeast 
chromosome markers. Unresolved clusters larger than 1 Mb run together at the gel 
resolution limit (star). Cell lines indicated at the top. Minor bands indicated by 
arrows. The ladder-like banding pattern indicative of high GCI is seen in the gene 
clusters from the BLM deficient cells (rounded box). BJ-5ta: wild-type newborn 
foreskin fibroblasts immortalized by ectopic telomerase expression; CGM1, 
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GM06990: EBV-transformed wild-type lymphoblast lines; HeLa S3: cervical 
carcinoma cells; SV40-transformed fibroblast lines: WT: wild-type (GM00637); 
ATM: ataxia-telangiectasia mutated (GM09607); BLM: Bloom syndrome 
(GM08585); Fanc-C: Fanconi anemia complementation group C mutated 
(GM13136); Lig I: DNA ligase 1 defective (GM16097); Lig IV: DNA ligase IV 
defective (GM16089); NBS: Nijmegen breakage syndrome (GM15989). 
 
 
 
 
 
 
 
 
 
Figure 4. 2: GCI clonal analysis. (A) Wild-type SV40-transformed GM00637 
fibroblast cells. The gel resolves gene clusters up to 1 Mb in length (star). A clonal 
population derived from a single cell is shown in the leftmost lane. Sub-clones were 
derived by dilution plating to single cells with subsequent expansion. Minor bands 
indicated by arrows. Changes to the major banding pattern shown by triangles (new 
bands) and brackets (missing bands). (B) SV40-transformed fibroblast GM08505 
Bloom syndrome cells. The bulk population as received from Coriell is shown in the 
far left. Clonal populations derived from the expansion of plated single cells from 
this bulk population are shown in the right. Minor bands indicated by arrows. 
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Figure 4.3: Bloom syndrome GCI.  (A) rDNA gene clusters in non-clonal cell line 
populations resolved to 1 Mb (star). WT: wild-type lines: SV40-transformed 
(GM00637), EBV-transformed (GM06990). BLM Ash.1: Ashkenazi Jewish, Bloom 
syndrome registry #42 (GM08505); BLM F.C.: French-Canadian, Bloom syndrome 
registry #81 (GM16375); BLM Ash.2: Ashkenazi Jewish, Bloom syndrome registry 
#9 (GM03403); BLM-comp: same as BLM Ash.1 stably complemented with BLM 
cDNA; BLM-vec: same as BLM Ash.1 stably transfected with empty vector control. 
Rounded boxes show laddering pattern indicative of a GCI-high phenotype. (B) 
rDNA gene clusters in primary cells resolved to 1 Mb (star). WT primary: 
untransformed wild-type fibroblasts (GM01652); BLM primary: untransformed 
Bloom syndrome fibroblasts, Ashkenazi Jewish, Bloom syndrome registry #3 
(GM02932); Lambda: lambda phage concatemers (unit genome size=48 502 bp). 
Arrows show the minor banding pattern in BLM primary cells in the contrast-
enhanced rightmost panel. 
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 Figure 4.4: GCI in isogenic BLM and BLM-complemented human cells.  (A) BLM-
comp bulk population (leftmost lane) and single-cell derived clones resolved to 1 
Mb. On the right is a densitometric trace of the first four clonal BLM-comp lines 
with minor bands indicated by arrows. (B) BLM-vec bulk population (leftmost lane) 
and single-cell derived clones resolved to 1 Mb (star). On the right is a densitometric 
trace of the first four clonal BLM-vec lines with minor bands indicated by arrows. 
Notice the much larger quantity of minor bands observed in the vector-control 
BLM-defective clonal lines relative to the BLM complemented but otherwise 
isogenic clonal lines in (A). 
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Figure 4.5: shRNA expressing clonal lines.  Gene clusters resolved to 1 Mb (star). 
Changes to the major banding pattern are shown by open triangles (new bands) and 
brackets (missing bands). Arrows indicate new minor bands. (A) Sub-clones of a 
clonal wild-type GM00637 cell population, semi-stably transfected with a negative 
control shRNA. (B) Sub-clones of the same GM00637 clonal cell population, semi-
stably transfected with shRNA to knockdown BLM expression. (C) Western blot 
showing shRNA knockdown of BLM expression 1 week post-transfection. WT: 
clonal isolate of wild-type GM00637 cells; BLM: Bloom syndrome GM08505 cells; 
BLM shRNA: WT cells semi-stably transfected with pCPM-234 (knockdown BLM); 
neg shRNA: WT cells semi-stably transfected with pCPM-neg (negative control). β-
Tubulin is used as a loading control. 
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Figure 4.6: Werner syndrome clonal lines.  rDNA gene clusters from WRN-defective 
SV40-transformed fibroblasts (AG11395) resolved to 1 Mb (star). A clonal 
population derived from a single cell is shown in the leftmost lane. Sub-clones were 
derived by dilution plating to single cells with subsequent expansion. No alterations 
in major gene cluster lengths are observed, and neither are any minor-intensity 
bands.  
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Figure 4.7: HeLa versus ATM-deficient clonal analysis.   (A) HeLa cells. (B) ATM 
deficient cells. Gene clusters are resolved to 1 Mb (star). Changes to major banding 
patterns are indicated by open triangles. Arrows show new minor bands indicative 
of rearrangement during clonal expansion 
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Figure 4.8: CSB-deficient and wild-type versus DNA-ligase IV knockout cell clonal 
analysis.  (A) CSB-deficient cells. (B) Wild-type NALM-6 cells and NALM-6 cells 
gene targeted to inactivate DNA ligase IV. Gene clusters are resolved to 1 Mb (star). 
Changes to major banding patterns are indicated by open triangles. Brackets 
indicate loss of major bands. Minor bands are shown by arrows. Locations of 
predicted but unobserved minor bands in parental populations based on new major 
bands observed in clonally derived sub-populations (triangles) are shown by open 
circles. The fraction of cells in the parental population carrying clusters of these 
lengths is below the detection capability of the assay. 
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Figure 4.9: SCE analysis of BLM cells complemented with BLM cDNA BLM-comp 
cells are not completely complemented for the elevated SCE phenotype of Bloom 
syndrome cells 
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CHAPTER 5: Escherichia coli RECG IS A FUNCTIONAL ANALOG OF BLM, 
THE HUMAN BLOOM SYNDROME PROTIEN 
*This chapter has been published: Killen MW, Stults DM, Wilson WA, Pierce AJ.  
(Submited) 
 
5.1: SYNOPSIS 
   
  Defects in human BLM cause Bloom syndrome, notable for early development of 
tumors in a broad variety of tissues.  On the basis of sequence similarity, BLM has been 
identified as one of the five human homologs of RecQ from Escherichia coli.  
Nevertheless, biochemical characterization of the BLM protein indicates far greater 
functional similarity to the E. coli RecG protein.  To explore the possibility that BLM and 
RecG are functional analogs, we characterized cellular phenotypes of human BLM-
deficient cells stably expressing E. coli RecG.  We find that RecG largely complements 
the definitive elevated sister chromatid exchange phenotype of BLM cells and the more 
recently demonstrated gene cluster instability phenotype of BLM cells, both in a dose-
dependent manner.  In contrast, expression of RecG has no impact on these phenotypes in 
human cells with functional BLM.  Although human BLM protein has homology to E. 
coli RecQ, the biochemistry of BLM is a much closer match to that of E. coli RecG.  We 
demonstrate here the physiological relevance of these related biochemistries by showing 
that ectopic expression of RecG in human cells complements many of the functional 
cellular phenotypes associated with BLM deficiency.  Our complementation of human 
cellular disease phenotypes with a non-homologous bacterial protein provides new 
insights into the physiological function of the BLM protein and into the broader 
evolutionary biology of genomic stabilization.  RecG and BLM appear to be functional 
analogs, and are a potential example of convergent evolution. 
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5.2: INTRODUCTION 
 
     Human cells possess five proteins with clear sequence homology to the E. coli RecQ 
protein:  BLM, WRN, RECQL, RECQL4 and RECQL5.  These proteins are all 
implicated in preserving genomic integrity (reviewed in (Bernstein, Gangloff et al. 2010; 
Monnat 2010)).  Functionally, inherited homozygous defects in BLM, WRN or RECQL4 
cause human disease:  Bloom syndrome, Werner syndrome and Rothmund-
Thomson/RAPADILINO/Baller-Gerold syndromes respectively.  Bloom syndrome is 
particularly striking for its predisposition to early-onset malignancy with a broad 
distribution of cancer types similar to that seen with sporadic tumors in the general 
population (German 1997). 
     Sequence homology of BLM with RecQ notwithstanding, characterization of the in 
vitro activities of BLM demonstrates significant similarities to the biochemistry of the 
RecG protein.  Both BLM (Machwe, Xiao et al. 2006; Ralf, Hickson et al. 2006) and 
RecG (McGlynn, Lloyd et al. 2001; Robu, Inman et al. 2004) bind to and regress multi-
stranded DNA structures that model stalled replication forks.  Similarly, both BLM 
(Karow, Constantinou et al. 2000; Plank, Wu et al. 2006) and RecG (Whitby, Vincent et 
al. 1994; Grove, Harris et al. 2008) bind to and branch migrate Holliday junctions.  Both 
BLM (van Brabant, Ye et al. 2000; Bachrati, Borts et al. 2006) and RecG (McGlynn, Al-
Deib et al. 1997) dismantle D-loops where a 3'-OH ssDNA has invaded a homologous 
DNA duplex, although the mechanism by which RecG carries out this reaction is less 
well established (Briggs, Mahdi et al. 2004).  The manner by which RecG accomplishes 
these tasks is in large part made clear by its crystal structure (Singleton, Scaife et al. 
2001):  a RecG monomer binds at a model replication fork by inserting a C-terminal 
protein wedge domain into the fork.  The body of RecG then functions as a double 
stranded DNA translocase to pull the DNA template strands together through the body of 
the protein.  At such time as the nascent DNA strands encounter the wedge domain, they 
are stripped off and allowed to anneal together resulting in the formation of a Holliday 
junction.  As RecG continues to translocate on the dsDNA, the branch point of the 
Holliday junction is effectively migrated.  In the absence of high-resolution structural 
information it remains unclear precisely how BLM carries out these activities. 
109 
 
     The BLM protein also possesses activities it is not known to share with RecG.  BLM 
can act in concert with EXO1 at double stranded DNA ends to cause a 5'-3' single 
stranded resection that exposes a free ssDNA 3' end suitable for loading with Rad51 
(Nimonkar, Ozsoy et al. 2008), reminiscent of the combined activities of the E. coli RecQ 
helicase and RecJ 5'-3' exonuclease (Courcelle, Crowley et al. 1999; Handa, Morimatsu 
et al. 2009).  BLM has strong unwinding activity on G-quadruplex DNA structures (Sun, 
Karow et al. 1998) as well as both ssDNA annealing (Cheok, Wu et al. 2005) (Machwe, 
Xiao et al. 2005) and/or strand exchange activities (Chen and Brill 2010).  Notably, BLM 
has many well-characterized protein-protein interactions, including those with RMI1, 
C16orf75 (RMI2) and TOPOIIIα (Raynard, Bussen et al. 2006; Wu and Hickson 2006; 
Singh, Ali et al. 2008; Xu, Guo et al. 2008) that collectively mediate double-Holliday 
junction dissolution, as well as direct interaction with the Rad51 recombinase (Wu, 
Davies et al. 2001) and with the multi-component Fanconi anemia protein containing 
BRAFT complex (Meetei, Sechi et al. 2003).  In contrast, RecG functions in a largely 
monomeric manner (McGlynn, Mahdi et al. 2000). 
     The mechanistic similarities between BLM and RecG have led us and others (Amor-
Gueret 2006) to speculate that E. coli RecG and human BLM may be functional analogs.  
In order to test this hypothesis and to determine the extent to which the shared 
biochemical activities of BLM and RecG are responsible for suppressing the functional 
cellular phenotypes observed in human cells lacking BLM, we reasoned that suitable 
expression of RecG might complement a BLM defect.  The best characterized cellular 
phenotype of BLM deficiency is a 10-fold elevated frequency of sister chromatid 
exchanges (Chaganti, Schonberg et al. 1974), thought to represent a hyper-recombination 
phenotype indicative of elevated crossing-over and overall genomic instability.  In 
addition, we have recently demonstrated that BLM deficiency causes a striking 
destabilization of the highly repetitive human ribosomal RNA gene clusters (the 
‘rDNA’), with recombination-mediated genomic restructuring of these clusters increased 
100-fold over cells wild-type for BLM function (Killen, Stults et al. 2009).  Accordingly, 
we engineered several semi-humanized RecG protein expression systems and stably 
introduced these constructs into human cells either wild type or defective for the BLM 
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protein.  We then assayed the resulting RecG transgene expressing cells for changes in 
these two phenotypes. 
 
5.3: RESULTS 
 
     i) RecG expression complements the BLM elevated SCE phenotype 
We found a significant RecG dose-dependent decrease in SCEs per chromosome in BLM 
cells (Fig. 5.2A,C and Table 5.1) with high level expression of RecG reducing the 
elevation of SCEs by 75%.  In our hands, expression of the human BLM protein from a 
cDNA construct in BLM cells reduces this characteristic elevated SCE phenotype by 80% 
(Table 5.1 and (Killen, Stults et al. 2009)), so E. coli RecG expression is nearly as 
effective as the human protein.  RecG complemented the elevated BLM SCE phenotype 
either when expressed as an EGFP fusion protein or as a separate polypeptide co-
translated with EGFP.  Expression of EGFP alone without RecG in BLM cells has no 
statistically significant effect on SCE levels (Fig. 5.5, Table 5.1).  The RecG 
complementation of the BLM SCE phenotype was not restricted to the Ashkenazi Jewish 
founder BLM mutation (6-bp del/7-bp ins) because RecG also reduced the elevated SCE 
phenotype of a French-Canadian derived (S595X) BLM line (Fig. 5.3A, Table 5.1).  
RecG is expressed at a low level in “BLM FC: RecG fuse” cells (Fig. 5.3B), resulting in 
a less dramatic, 25% reduction in the elevated SCE phenotype, nevertheless in a 
statistically highly significant manner (P=0.0004, Mann-Whitney two-tailed test). 
ii) RecG has no effect on SCE levels in cells wild-type for the BLM protein 
In order to establish the BLM specificity of the RecG SCE reduction effect, we carefully 
examined SCE levels in two different wild-type lines that stably express high levels of 
either the RecG-EGFP fusion protein, or the bicistronic RecG/EGFP construct (Fig. 5.4).  
We found that high level RecG expression (Fig. 5.2B) had no effect on either the median 
levels of SCEs per chromosome or in the distribution of SCEs seen in either wild-type 
line (Table 5.1). 
iii) Loss of RecG expression restores the elevated SCE phenotype to BLM cells 
One of the clonal BLM lines stably expressing medium levels of the RecG-EGFP fusion 
protein (Fig. 5.5B, “BLM: RecG fuse med”) gradually lost EGFP expression during two 
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months of continuous cell culture in the absence of selection, presumably due to 
epigenetic silencing of the RecG-EGFP transgene.  In the resulting “BLM: lost RecG 
fuse” line, SCE levels were re-elevated to nearly those of either the parental BLM line, or 
the control BLM line containing a transgene for EGFP alone “BLM: EGFP” (Fig. 5.5A, 
Table 5.1), confirming that RecG expression is solely responsible for complementing the 
elevated SCE phenotype in BLM cells. 
iv) RecG expression reduces the elevated gene cluster instability (GCI) of BLM cells. 
Loss of BLM very strongly increases the rate of spontaneous recombination-mediated 
genomic restructuring in the highly repetitive human rRNA gene clusters (Killen, Stults 
et al. 2009).  In BLM cells, recombination alters gene cluster lengths on the order of every 
round of mitotic cell division, an approximate 100-fold increase over the rate in wild-type 
cells.  This rapid randomization of cluster lengths produces a diagnostic ladder-like 
electrophoretic karyotype with each rung on the ladder separated by the 48.5 kb unit 
length of the human rDNA repeat, particularly in the range of gene cluster lengths from 
250 kb to 550 kb (Fig. 5.6 – shaded in red, red side bracket).  The intensity of individual 
cluster bands is related to how early in the clonal expansion the mitotic recombination 
event took place, with more intense bands having arisen earlier in the expansion of a 
clonal population (Killen, Stults et al. 2009).  Expression of RecG complements this 
elevated GCI phenotype:  the rate of spontaneous cluster restructuring is greatly reduced 
(Fig. 5.6 – red carets) although as with complementation of the elevated SCE phenotype 
of BLM cells, there is a residual low level of GCI even with high levels of RecG 
expression.  Notably, expression of RecG is particularly effective at restabilizing gene 
clusters in the previously highly unstable 250 kb to 550 kb size range, as seen by the 
significant reduction of gene cluster lengths detected in this range. 
v) RecG expression does not affect gene cluster instability in wild-type cells. 
Expression of RecG as an independent polypeptide co-translated with EGFP did not have 
an obvious effect on gene cluster instability in a cell line wild-type for BLM protein (Fig. 
5.7) even though RecG is expressed at high level when measured by western detection of 
the co-translated EGFP protein in this line (Fig. 5.2B:  “WT:  RecG 2a”).  The changes to 
the banding pattern in the subclones relative to that of the parental clonal population 
represent mitotic recombination events that occurred sufficiently late in the expansion of 
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the parental clonal population as to be undetectable as visible minor-intensity banding.  
The relative small number of changes to major intensity bands in the subclones and the 
lack of detectable minor bands in any of the cell populations is consistent with the low 
levels of spontaneous gene cluster restructuring seen in other wild-type transformed 
human cell lines (Killen, Stults et al. 2009). 
 
5.4: DISCUSSION 
 
     We show here that expression of the E. coli RecG protein is able to complement two 
functional cellular phenotypes of BLM deficiency:  elevated sister chromatid exchange, 
and elevated gene cluster instability.  Although this result is in accord with the several 
shared biochemical activities of these two proteins, this functional complementation 
across different kingdoms of biology is surprising, particularly when considering that 
there appears to be no relationship of evolutionary sequence homology between RecG 
and BLM.  Both RecG and BLM are members of the DEXDc superfamily of helicase 
proteins, and both contain both DEXDc and HELICc subdomains (Marchler-Bauer, Lu et 
al. 2011), however, the E coli RecQ protein is the clear evolutionary homolog of BLM on 
the basis of sequence similarity within these two conserved domains.  Both RecG and 
BLM have extended amino acid sequences N-terminal to their DEXDc superfamily 
domains.  In BLM, this N-terminal half of the protein is not well-characterized; it seems 
likely that significant structure/function similarities to RecG may reside in this region. 
     The E. coli RecG protein, with essentially no sequence similarity to human BLM, 
would seem unlikely to engage in any of the well-characterized protein-protein 
interactions that are important for function of the BLM protein.  The capacity with which 
RecG can complement BLM cellular phenotypes suggests therefore that the primary 
physiological role of BLM is to perform the same molecular reactions that can be 
performed in a human cell by the RecG monomer alone, namely direct manipulations of 
DNA structures.  Secondary effects such as signaling through protein-protein interactions 
are likely to be of lesser physiological importance, at least at the cellular level.  Similarly, 
it would appear that precise regulation of the reactions carried out by the BLM protein 
are likewise largely unnecessary for function of the protein since RecG was constitutively 
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expressed in our experiments.  Conceivably, targeting of BLM by protein-protein 
interactions to DNA structures on which RecG can act may reduce the amount of BLM 
needed by the cell.  Activities of BLM not known to be shared by RecG, such as the 
unwinding of G-quadruplex DNA, must play a minor role in both sister chromatid 
exchange and gene cluster instability suppression, or alternatively, a G-quadruplex 
activity of RecG may remain to be discovered. 
     The role of BLM in human genomic stabilization is well-established.  In contrast, a 
major mechanistic role of RecG in E. coli genomic stabilization has only recently been 
elucidated.  In the absence of RecG, PriA initiates spurious replication forks throughout 
the bacterial genome, causing poorly-controlled genomic over-replication and 
compromised viability (Rudolph, Upton et al. 2009).  In the absence of RecG, cells have 
an absolute requirement for a ssDNA exonuclease activity, unless PriA is also eliminated 
(Rudolph, Mahdi et al. 2010).  It will be interesting to determine whether human BLM 
cells share this over-replicated phenotype.  Curiously, the E coli RecQ protein rather than 
protecting the cell from aberrant recombination structures as the human BLM and E. coli 
RecG proteins do, seems to act instead to promote their formation (Magner, Blankschien 
et al. 2007).  Cells lacking the UvrD-mediated inhibition of recombination and also 
lacking RecG are killed by formation of intermolecular recombination intermediates 
(IRIs) that interfere with correct genome segregation to daughter cells.  Formation of IRIs 
is caused by the action of RecQ and partner proteins and causes “death by 
recombination”.  Deletion of RecQ restores cellular viability (Fonville, Blankschien et al. 
2010).  An analogous phenotype in human cells might be the elevated formation of 
anaphase bridges in cells deficient for BLM (Chan, North et al. 2007).  One evolutionary 
interpretation consistent with our functional data here would be that although the ancient 
common protein ancestor of both RecQ and BLM was preserved in evolutionary decent 
through both lineages to provide a core helicase domain, the functionality of these 
proteins diverged in opposite directions.  Since there are no RecG homologs by sequence 
similarity in human cells, it would appear that at least one of the five human RecQ 
paralogs, BLM, was co-opted to perform the important recombination molecular 
transactions provided to E. coli by the RecG protein, and is an example of convergent 
evolution. 
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5.5: METHODS 
 
i) Protein expression constructs 
     The coding sequence for RecG was isolated from E. coli TOP10 (Invitrogen) genomic 
DNA with the addition of a consensus Kozak sequence (Kozak 1994)and the SV40 large 
T-antigen nuclear localization signal (PKKKRKV) by PCR using primers 
5'-ggggggggatccagccaccatggctccaaaaaaaaagcgcaaagtggcgatgaaaggtcgcctg and 
5'-gggggggatatcgcggccgcttacgcattcgagta (RecG sequences underlined) followed by 
cloning into the pCAGGS mammalian constitutive expression vector.  A cryptic 
polyadenylation sequence in the RecG coding sequence 5'-AATAAA (AsnLys) was 
removed via silent mutagenesis to 5'-AACAAG (AsnLys).  Carboxy-terminal additions 
of the enhanced green fluorescent protein (EGFP) coding sequence were constructed 
either to produce a RecG-EGFP fusion protein with a GSG linker peptide (Fig. 5.1A) 
“RecG fuse” (predicted molecular weight:  104.7 kDa), or to produce two proteins in a 
bi-cistronic manner:  RecG fused to the Strep-tag II for potential affinity purification 
(Maier, Drapal et al. 1998) followed by a GSG linker, the 2A polyprotein ‘self-cleaving’ 
sequence from Thosea asigna virus (Donnelly, Hughes et al. 2001; Szymczak, Workman 
et al. 2004), a VAT peptide linker and EGFP (Fig. 5.1B) “RecG 2a”.  In the bi-cistronic 
construct the predicted molecular weight of the RecG polypeptide is 80.8 kDa and the 
predicted molecular weight of the EGFP polypeptide is 27.3 kDa.  All final construct 
sequences were verified by direct DNA sequencing.  The EGFP expression vector used 
for subcloning the EGFP coding sequence was pEGFP-N1 (Clontech). 
ii) Cell lines 
     Cell lines used that are wild-type for BLM include the SV40-transformed fibroblast 
line GM00637 (Coriell) “WT” and the cervical carcinoma line HeLa S3 (ATCC) “HeLa.” 
Cell lines used that are deficient in BLM protein include GM08505 (Coriell) which are 
SV40 transformed fibroblasts derived from a Bloom syndrome patient homozygous for 
the Ashkenazi Jewish founder BLM mutation (6-bp del/7-bp ins) at nucleotide 2281 of 
the open reading frame, hereafter referred to as “BLM.”  A second BLM deficient line 
used was GM16375 (Coriell) which are EBV transformed lymphocytes from a French-
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Canadian Bloom syndrome patient homozygous for a C>A transversion resulting in a 
(S595X) termination mutation, hereafter referred to as “BLM FC”.  The BLM-defective 
line stably complemented by either BLM cDNA expression, or by a control empty vector 
are the lines PSNF5 “BLM: cDNA” and PSNG13 “BLM: vec” respectively (Gaymes, 
North et al. 2002) (kind gift from Ian Hickson) both derived from the GM08505 line.  
Lines were generally grown in MEM with 10% fetal bovine serum, with L-gln and 
antibiotic supplementation at 37C in a humidified 5% CO2 incubator. 
Stable cell lines were generated by electroporating either a RecG expression construct or 
a control EGFP expression construct into cells, followed by unselected cell population 
expansion, one round of flow-sorting enrichment for green fluorescent cells, further 
unselected expansion, and finally a second round of flow-sorting enrichment for green 
fluorescent cells.  Clonal and subclonal derivatives of these highly enriched fluorescent 
populations were subsequently derived by limiting dilution.  All of the transgene 
expressing cell lines generated and used in this work are either clonal or subclonal, with 
the exception of the “BLM FC: RecG fuse” line only:  BLM FC cells were transduced by 
a high-titer lentivirus (Welgen, Inc.) containing an expression cassette for the RecG-
EGFP fusion construct (Fig. 5.1A) and separated into green fluorescent and non-
fluorescent populations by flow sorting. 
iii) Sister chromatid exchange assays 
     Sister chromatid exchange assays were performed largely according to (Perry and 
Wolff 1974) with minor modifications (Killen, Stults et al. 2009).  Cellular metaphase 
spreads were imaged and scored individually by counting the number of visible 
exchanges and the number of chromosomes in each metaphase.  The resulting 
SCEs/chromosome figures were binned and plotted.  All statistical tests were performed 
using unbinned data. 
iv) Western blotting 
     Protein extracts were prepared using RIPA buffer as described previously (Killen, 
Stults et al. 2009).  All resolving SDS-PAGE gels used 9% acrylamide and were blotted 
onto Hybond-ECL nitrocellulose membrane (Amersham Biosciences, cat. #RPN68D).  
Primary antibodies used were:  rabbit anti-GFP (Cell Signaling Technologies, cat. 
#2555), rabbit anti-β-actin (Cell Signaling Technologies, cat. #4970), rabbit anti-β-
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tubulin (NeoMarkers, cat. #RB-9249-PO).  The secondary antibody was ImmunoPure 
Antibody donkey anti-rabbit IgG conjugated with horseradish peroxidase (Pierce, cat. 
#31458).  Blots were developed using an Amersham™ ECL Plus western blotting 
detection system (GE Healthcare, cat. #RPN2132) and imaged with a Storm 860 
PhosphorImager (Molecular Dynamics). 
v) GCI analysis 
     Gene cluster instability analysis was carried out as described previously (Killen, Stults 
et al. 2009).  Briefly, genomic DNA was prepared in the solid phase by digesting single 
cell suspensions in agarose with proteinase K in the presence of sarkosyl and EDTA, 
rinsed thoroughly and equilibrated in 50% glycerol/10 mM Tris/1 mM EDTA pH 8.0 and 
stored at -20C.  10 ml agarose slices containing approximately 1 mg genomic DNA were 
equilibrated in suitable restriction digestion buffer and digested overnight with EcoRV 
(New England Biolabs).  Digested DNA still in solid form was loaded into a 1% PFC 
agarose (Bio-Rad) gel and run in 0.5x TBE buffer (44.5 mM Tris base, 44.5 mM boric 
acid, 1 mM EDTA pH 8.0) using a CHEF-MAPPER system (Bio-Rad) at 14C.  Pulsed-
field electrophoretic conditions were a field strength of 6 V/cm with 120º separation 
between field vectors.  Field switch times varied from 3 seconds to 90 seconds with a 
‘ramp factor’ of 0.357.  Gels were run for 24 hours, then dried, rehydrated, probed with a 
radiolabeled probe specific for the human rDNA (Stults, Killen et al. 2008) and imaged 
with a Storm 860 PhosphorImager (Molecular Dynamics). 
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5.6: FIGURES 
 
 
 
 
Figure 5.1:  RecG expression constructs.  A) RecG expressed as a fusion protein 
with EGFP.  Lettering colors:  black: linker amino acids, red: nuclear localization 
signal, blue: RecG coding sequence, green: EGFP coding sequence.  B) RecG co-
translated with EGFP as two separate polypeptides.  Lettering colors:  black: linker 
amino acids, red: nuclear localization signal, blue: RecG coding sequence, brown: 
strep-tag II, purple: 2a ‘self-cleaving’ peptide, green: EGFP coding sequence.  
Dotted line represents the division of the precursor polyprotein into two 
independent polypeptides. 
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Figure 5.2:  RecG expression complements the BLM elevated SCE phenotype.  A) 
Normalized sister chromatid exchange frequencies.  “RecG 2a” denotes cells express 
RecG and EGFP as separate co-translated proteins.  “RecG fuse” denotes cells 
express RecG and EGFP together as a fusion protein. B) RecG expression levels.  
Protein extracts from the indicated cell lines are blotted with an anti-GFP antibody 
and with anti-b-actin as a loading control.  RecG-EGFP fusion proteins (105 kDa) 
are indicated with blue ovals.  EGFP is detected as a proxy biomarker for RecG in 
the “RecG 2a” co-translated lines.  C) Representative sister chromatid exchange 
metaphase spreads with sister chromatids differentially stained.  The harlequin 
staining pattern of the BLM cells is greatly reduced upon expression of RecG. 
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Table 5.1: The effect of RecG expression on SCEs per Chromosome 
Cells Median SCE/Chr. P(2) vs BLM: EGFP a Figure 
WT 0.10 b <0.0001 2,4 
WT: RecG 2a 0.10 b <0.0001 4 
HeLa 0.09 b <0.0001 4 
HeLa: RecG fuse 0.08 b <0.0001 4 
BLM 0.98 d 1 5 
BLM: empty vector 1.05 d 0.9283 - 
BLM: cDNA 0.28 c <0.0001 2 
BLM: RecG 2a high 0.33 c <0.0001 2 
BLM: RecG fuse high 0.34 <0.0001 2 
BLM: RecG 2a low 0.68 <0.0001 2 
BLM: RecG fuse low 0.85 0.0001 2 
BLM: EGFP 1.02 d 1 2,5 
BLM FC: RecG fuse 0.70 e <0.0001 3 
BLM FC 0.91 e 0.0011 3 
BLM: RecG fuse med 0.43 f <0.0001 5 
BLM: lost RecG fuse 0.86 f 0.0067 5 
a Mann-Whitney two-tailed test. 
b Differences between these distributions cannot be established.  P=0.5539 Kruskal-Wallis test 
for k=4. 
c P(2)=0.0332 for “BLM: cDNA” vs “BLM: RecG 2a high” by Mann-Whitney two-tailed test 
d Differences between these distributions cannot be established.  P=0.99 Kruskal-Wallis test for 
k=3. 
e P(2)=0.0004 Mann-Whitney two-tailed test. 
f P(2)<0.0001 Mann-Whitney two-tailed test. 
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Figure 5.3:  RecG expression reduces SCE in a French-Canadian BLM line.  A)  
Normalized sister chromatid exchange frequencies.  “BLM FC”:  EBV-
immortalized lymphocytes homozygous for an inactivating (S595X) mutation.  
“BLM FC: RecG fuse”:  the same cells expressing low levels of the RecG-EGFP 
fusion protein.  B)  Western blot showing relative protein levels.  Blue oval:  RecG-
EGFP fusion protein.  “BLM FC: RecG fuse”:  protein extract from French-
Canadian BLM cells stably expressing low levels of the RecG-EGFP fusion protein.  
“BLM FC”:  protein from French-Canadian BLM cells lacking a RecG transgene.  
“BLM: RecG fuse low”:  protein extract from Ashkenazi Jewish BLM cells 
complemented with RecG-EGFP (see also Fig. 2B for comparison of protein levels).  
Notice the different intensities of the β-actin loading control between the “BLM FC” 
extracts and the “BLM” extract. 
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Figure 5.4:  RecG expression has no effect on SCE levels in wild-type cells. 
Normalized sister chromatid exchange frequencies are shown. 
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Figure 5.5:  Loss of RecG expression in BLM cells restores the elevated SCE 
phenotype.  A) Normalized sister chromatid exchange frequencies are shown.  B) 
Loss of expression of RecG-fuse is shown by western blotting (blue ovals). 
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Figure 5.6:  RecG stabilizes the gene cluster instability of BLM cells.  Southern 
blotting detection of the rDNA clusters with resolution up to 1 Mb is shown.  Cluster 
lengths are calibrated by S. cerevisiae chromosome size markers.  Open star is the 1 
Mb resolution limit of the gel:  all clusters larger than 1 Mb co-localize to this band.  
Clonal populations are shown on the left of each panel, with a collection of subclones 
derived from this clonal population to the right.  Red carets:  mitotic recombination 
indicated by minor intensity gene cluster bands.  The zone of particularly high 
instability in the 250 kb to 550 kb size range is indicated by red shading and by the 
red dotted bracket at the right.  A) “BLM: RecG 2a high”: BLM cells stably 
expressing high levels of cotranslated RecG/EGFP.  B) The parental BLM line from 
which the “BLM: RecG 2a high” cells were derived. 
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Figure 5.7:  RecG has no effect on gene cluster instability in wild-type cells.    
Southern blotting detection of the rDNA clusters in wild-type cells stably expressing 
high levels of co-translated RecG/EGFP, “WT: RecG 2a”.  Cluster lengths resolved 
up to 1 Mb are shown.  Cluster lengths are calibrated by S. cerevisiae chromosome 
size markers.  Open star is the 1 Mb resolution limit of the gel:  all clusters larger 
than 1 Mb co-localize in this region.  See Fig. 2B for RecG expression levels by 
western blotting.  A clonal cell population is shown in the far left lane of the gel.  A 
collection of subclonal populations each derived from a single cell of this clonal 
population are shown to the right.  Plum circles:  relocated major band clusters.  
Blue braces:  former location of major band clusters from the parental clone. 
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
 
     In this dissertation genomic instability driven by dysregulated homologous 
recombination is explored as a potential mechanism of carcinogenesis.  A new assay is 
presented that employs gene cluster instability (GCI) as a sentinel biomarker of 
dysregulated homologous recombination.  This assay was used to demonstrate the 
incidence of this type of genomic instability in tissue from human cancer patients and to 
establish gene cluster instability as a primary phenotype of cells deficient in BLM 
protein. It was shown that the lack of BLM protein is solely responsible for the phenotype 
in the BLM deficient cell lines.  Since Bloom’s syndrome cells have been characterized 
as hyper-recombinatory and BS patients present with an extreme predisposition to a 
broad spectrum of cancers, BLM cells were explored as a model of generalized cancer to 
gain insight into the role that dysregulated homologous recombination might play in 
carcinogenesis.  Since the GCI phenotype is common to both BS and human cancer some 
of the unique biochemical characteristics of BLM that are thought to play a role in 
suppressing genomic instability were explored.  Using the gene cluster instability assay 
along with sister chromatid exchange analysis it was determined that these phenotypes of 
BLM deficient cells could be functionally complemented by the non-homologous 
bacterial protein RecG.  The fact that these proteins share specific biochemical activities 
but no structural or sequence homology has led to the speculation that it is these shared 
biochemical activities are important to suppressing this type of instability. Therefore it is 
plausible that these same biochemical pathways might be responsible for the instability 
observed in the gene clusters in BS patients and human cancer tissue. 
 
     The development of a new assay that uses gene cluster instability (GCI) as a sentinel 
biomarker for dysregulated homologous recombination is described in Chapter 2.  In 
short, this assay employs pulse-field gel electrophoresis (PFGE) to evaluate size changes 
of intact gene cluster liberated through enzymatic digestion of mega-base scale DNA 
preps.  The gene clusters are detected via an in-gel southern blotting technique. This 
assay allows the user to evaluate clonal isolates of a cell line or to compare cancerous 
tissue to normal blood and tissue.  Several gene clusters were explored in order to 
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determine the most useful prognosticator.  This assay was previously verified on blood 
from normal human volunteers while characterizing the human ribosomal gene cluster 
(rDNA) (Stults, Killen et al. 2008).  The results provided direct evidence of restructuring 
in the gene cluster architecture and validated that GCI was an extremely sensitive method 
to detect dysregulated homologous recombination.  In another publication this assay was 
used to investigate instability in the rDNA gene clusters in human cancer samples, where 
it was found that 50% of the human cancer samples tested had a GCI phenotype (Stults, 
Killen et al. 2009).  Of the gene clusters explored the rDNA gene cluster seemed to 
demonstrate the most sensitivity; however, due to its unique characteristics it was 
necessary to investigate these results in what would be considered a more normal gene 
cluster.  
 
     In chapter 3 the GAGE gene cluster was evaluated in normal human families and in 
human cancer.  This series of experiments were performed to complement the work 
mentioned above that demonstrated mitotic instability in the rDNA gene clusters in 
human cancer (Stults, Killen et al. 2008; Stults, Killen et al. 2009).  Although the rDNA 
proved to be the most sensitive substrate the unique qualities of the rDNA gene clusters 
required that other clustered sequences be considered.  As mentioned in chapter 1 the 
rDNA clusters are composed of more than 600 copies of a 43kb unit repeat that is 
dispersed across 5 different chromosomes and they are greater than 99.5% similar 
between copies.  These qualities, high local concentration, high sequence similarity and 
multiple copies make the rDNA clusters ideal substrates for HR. (Stults, Killen et al. 
2008)  However the rDNA has some other characteristics that might contribute to its 
behavior that are not common to most genes.  The rDNA is largely nucleolar and is 
transcribed by RNA Polymerase I, unlike the majority of genes, which are normally 
transcribed but RNA Polymerase II (Russell and Zomerdijk 2006).  The GAGE gene 
cluster is considered here as a more typical example of repetitive sequence found in the 
genome that would provide a substrate for dysregulated homologous recombination.  The 
genomic structure of the GAGE gene cluster is similar to the rDNA in that it has a high 
local concentration, high sequence similarity and multiple copies.  However, the unit 
repeat of the gene that produces the GAGE transcript is only 9.6 kb making it 
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considerably smaller than the rDNA unit repeat (Hofmann, Caballero et al. 2008).  The 
multiple copies of the GAGE gene are structured as a tandemly repeated cluster of at 
least 15 gene copies at Xp11.23 and are oriented in a head-to-tail manner, without any 
intervening sequences.  Thus they are also similar to the rDNA genomic structure 
although they have significantly fewer unit repeats which make these loci more similar to 
gene clusters elsewhere in the genome (Warburton, Hasson et al. 2008).  Most 
importantly, the GAGE gene clusters have not been observed to have any of the 
replication or localization abnormalities found in the rDNA gene clusters.   
 
     The results in chapter 3 demonstrate low levels of meiotic rearrangement in families 
and detectable mitotic rearrangement in adult solid tumors which concurs with the data 
reported previously (Stults, Killen et al. 2008; Stults, Killen et al. 2009).  GAGE cluster 
alterations were detected in 5% of the adult solid tumors tested.  This is greatly reduced 
from the greater than 50% restructuring found in the rDNA gene clusters of the same 
patients.  But observing these events in 5% of the population is remarkable compared to 
the rDNA since the rDNA clusters compose more than 0.5% of the human genome and 
the GAGE clusters account for less than 0.007% of the genome.  That is a 70-fold 
reduction in available sequence yet there is only a 10-fold decrease in observed events.  It 
is also an interesting observation that the cancer patients in which GAGE cluster 
restructuring occurred also  exhibited rDNA restructuring in there disease, suggesting a 
potential mechanistic link (Stults, Killen et al. 2009).  Additionally, restructuring events 
were only observed in the diseased tissue, never in the normal tissue or blood as was the 
observation in the rDNA (Stults, Killen et al. 2009).      
 
     Both the GAGE data here and the rDNA data presented previously provide a strong 
causal argument for Gene Cluster Instability and by extension dysregulated homologous 
recombination driving carcinogenesis.  However, that argument in itself suffers the crux 
of whether genomic instability was the cause or the consequence of tumorgenesis. This 
causality dilemma is further complicated by the fact that the mechanism by which GCI 
occurs is unknown.  Although the mechanistic requirements of HR make it the logical 
choice by which these restructuring events could occur this has not been verified.  To 
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investigate this relationship a new series of experiments is necessary.  Ideally, one could 
induce GCI in human cells and determine if it leads to carcinogenesis.  However, how to 
accomplish this is not immediately clear.  Fortunately, the work in Chapter 4 led to a 
potential cell culture model that provides a corresponding human phenotype.  
 
     In Chapter 4 the newly developed GCI assay was employed to characterize cells 
deficient for the BLM protein associated with human Bloom’s syndrome.  Initially we 
screened a panel of cell lines derived from patients exhibiting defects in a variety of DNA 
repair pathways, including various known human chromosomal instability disorders. 
Only the cell line derived from a BS patient was strongly destabilized.  This is very 
interesting since one of the most prevalent phenotypes associated with BS is a strong 
predisposition to cancer.  This predisposition is not associated with a specific type of 
cancer, so this disease is often used as a model for generalized cancer by us and others.   
To use this as a model it became important to establish that the absence of the BLM 
protein was responsible for the GCI phenotype observed.   
 
    The results presented in chapter 4 show that a high-GCI phenotype is present in 
multiple BLM cell lines, some of which have different mutations, all of which abolish 
BLM protein production.  In fact, high GCI was observed in every BLM cell line tested 
including a primary cell line.  There was a 100-fold increase in the cellular GCI 
phenotype in cell lines derived from BS patients.  To complement these observation two 
methods were used to demonstrate that BLM was solely responsible for the phenotype 
observed.  First shRNA was used to knock down BLM in wild-type fibroblast.  This 
caused a significant increase in both GCI and SCE.  Additionally, a BS cell line was 
obtained whose BLM expression was reconstituted by stable expression of the full length 
BLM cDNA and it was used to show that reconstitution of the protein complemented the 
genomic instability phenotypes demonstrated previously.  From this data it was 
determined that the absence of BLM directly leads to genomic instability as demonstrated 
by GCI and SCE.   Taken together with the fact that there is a 100-fold increase in cancer 
risk for Bloom’s Syndrome patients compared to normal individuals, this data suggests 
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that GCI is likely a precursor to cancer and one of the mechanisms that serves as a 
driving force of carcinogenesis. 
 
     The data from chapter 3 and 4 support the hypothesis that Gene Cluster Instability 
could be a driving mechanism of carcinogenesis; however, there are alternatives that 
must be considered.  A deficiency in the BLM protein causes cancer, but how it causes 
cancer is unclear.  The drastic increase in GCI and SCE is strongly suggestive that NAHR 
is responsible, but this evidence is still circumstantial.  Although it has now been 
established that both an increase in GCI and SCE are phenotypes of BLM cells, it is not 
absolute that these two phenotypes arise from the same mechanism.  It has long been 
hypothesized that the increase in SCE in BS is a result in dysregulated homologous 
recombination.  It is likely that this is also the mechanism underpinning gene cluster 
instability.  However, there is no evidence that GCI and SCE arise from the same 
consequences.  Therefore both types of instability could contribute to carcinogenesis, but 
neither can be established as a root cause until it is demonstrated that they are caused by a 
common mechanism.  This hypothesis also discounts the other know defects associated 
with BS.  For instance Bloom’s Syndrome is known to result in a drastic increase in loss 
of heterozygosity (LOH).  This defect could also drive carcinogenesis.  Although, it is 
hypothesized that LOH is also a result of dysregulated homologous recombination.  So it 
is left to determine if dysregulated homologous recombination is the underlining 
mechanism behind all of these phenotypes.  Some insight might be gained by comparing 
normal and cancer tissue from Bloom’s Syndrome patients.  This might indicate the 
prevalence of GCI, SCE and LOH in the cancer tissue.  However, it is unlikely that this 
experiment will be undertaken in the foreseeable future.  The small patient pool would 
make the logistics of collecting a sufficient amount of samples nearly impossible.  
Another potential would be to adapt the GCI assay to mice in order to exploit the mouse 
model of Bloom’s syndrome.  However, perhaps a more straight forward method of 
determining the involvement of dysregulated homologous recombination in BLM cells 
would be to employ a reporter gene.  It was recently reported that BLM knockdown in 
cell lines contain an I-SCEI driven reporter construct specifically increased the frequency 
of HR events that produced deletions by crossovers while leaving the over-all frequency 
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of HR events unchanged.  This work provides some evidence that loss of BLM can 
increase genomic instability by provoking an increased frequency of HR events of a 
potentially deleterious nature (Wang, Smith et al. 2011).  However, since the reporter 
system used is based on selection, it does not accurately reflect the concise population 
that results from repair in this mutant background.  To address this we developed a new 
reporter gene, XRDRE that functions to repair a single DSB introduced by the homing 
endonuclease I-SCEI.  XRDRE is designed to quantify dysregulated homologous 
recombination as a result of crossing over and distinguish it from gene conversion (GC).  
Additionally, the repair product is easily assayable by flow cytometry since it produces 
function red fluorescent protein. Unfortunately, there was not a sufficient amount of time 
to collect this data.  However, this is a definite avenue of investigation for future work.   
 
     In order to explore the link between GCI and dysregulated homologous recombination 
in BLM cells Chapter 5 explores the physiological relevance of the established 
biochemistry of BLM.  BLM is a RecQ helicase and is a homolog of E. coli RecQ.  BLM 
and RecQ share some biochemical activities, however, the activities that are believed to 
explain BLM’s role in HR are not shared with RecQ.  Those biochemical interactions 
overlap with the known biochemical properties of another E. coli protein, RecG.  BLM 
and RecG are both branch migration-specific helicases and display greater helicase 
activity on four-way junction DNA substrates such as Holliday junctions than they do on 
other DNA substrates.  These activities are thought to be essential for normal HR.  
Chapter 5 explores the experimental complementation of BLM deficient cells via ectopic 
expression of RecG.   Since BLM and RecG share no homology in their amino acid 
sequences any interactions with accessory proteins can be ruled out.  Thus any 
complementation can be attributed solely to their shared biochemical activities.  Indeed 
ectopic expression of RecG complements both the SCE and GCI phenotypes of BLM 
deficient cells to the same level as complementation with the BLM protein.  RecG and 
BLM appear to be functional analogs, and are a potential example of convergent 
evolution.  This type of convergent evolution is not unheard of, even within the 
recombination repair pathway there are other examples. For instance RecO and RAD52 
are functional analogs despite almost no sequence similarity (Kolodner, Fishel et al. 
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1985).  More importantly from this it becomes apparent that the prevalent biological 
involvement of BLM in HR stems from these shared biochemical activities.    
 
     Taken together this data points to one of several conclusions, first it is possible that 
the loss of BLM leads to the initiation of more DNA lesions because of the loss of 
capacity to unwind quadruplex-G DNA.  This might cause additional recombination 
initiation in the G/C-rich rDNA repeats.  Likewise, if replication forks stall and collapse 
at quadruplex-G structures that might have been processed by BLM and this could lead to 
more lesions.  A second possibility is that the loss of BLM decreases the cells capacity to 
dismantle Holliday junctions resulting in more recombination intermediates being 
repaired with crossing-over rather than GC.  It is also possible that although the 
biochemistry for BLM is well established, it may not accurately depict the physiological 
relevant enzymatic functions of BLM.  With this in mind the data supports the hypothesis 
that the overlapping biochemical activities of BLM and RecG are germane to BLM’s 
primary physiological function and could explain how BLM acts to suppress genomic 
instability.  Still there is no direct proof that BLM and RecG are functioning through the 
same pathway.  It will be necessary to establish if RecG functions through the same 
mechanism as BLM.  Since the cells that are functionally complemented with RecG 
express a protein tagged with EGFP they lend themselves to microscopic studies.  Thus 
exploration of RecG localization to sites of DNA damage should be explored.  Another 
recently established association of BLM is its localization to anaphase bridges (Chan, 
North et al. 2007).  This too could be investigated in the RecG-EGFP expressing cells.  
Since the data also indicates that one or all of the three biochemical activities common to 
both BLM and RecG is germane to observed phenotype it would also be pertinent to 
attempt disrupting these pathways using the tools presented here to evaluate their 
physiological prevalence.   
 
     It was my intentions for this work to provide insight into carcinogenesis and outline 
how dysregulated homologous recombination might contribute to this process.  Although, 
the work herein encroaches upon these goals, it provides just as many questions.  
Fortunately it also provides some new tools to begin investigating these questions.  Since 
136 
 
I have already integrated XRDRE into BLM deficient cells the most obvious and 
immediate work that should be done is to differentiate between GC and NAHR in these 
cells in order to determine if the loss of BLM protein increases homology directed repair 
with associated cross-over.  Also as a result of my work I have integrated XRDRE and 
DRGFP into HeLa cells.  These cells could easily be used to screen siRNA libraries to 
determine which genes modulate HR.  The role of genome instability in the development 
of cancer continues to evoke intense debate. To address these critical issues it is clearly 
important to understand the mechanisms that give rise to genome instability.  Through 
these studies it might be possible to establish the mechanism by which BLM suppresses 
genomic instability. Resolving this mechanism may provide insight to how instability can 
arise from HR and how it can lead to the gross genomic alterations often associated with 
cancer. 
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